id	sid	tid	token	lemma	pos
iajs-3656	1	1	230	230	NUM
iajs-3656	1	2	©	©	PROPN
iajs-3656	1	3	2025	2025	NUM
iajs-3656	1	4	the	the	DET
iajs-3656	1	5	author(s	author(s	NOUN
iajs-3656	1	6	)	)	PUNCT
iajs-3656	1	7	.	.	PUNCT
iajs-3656	2	1	published	publish	VERB
iajs-3656	2	2	by	by	ADP
iajs-3656	2	3	college	college	NOUN
iajs-3656	2	4	of	of	ADP
iajs-3656	2	5	education	education	NOUN
iajs-3656	2	6	for	for	ADP
iajs-3656	2	7	pure	pure	ADJ
iajs-3656	2	8	science	science	NOUN
iajs-3656	2	9	(	(	PUNCT
iajs-3656	2	10	ibn	ibn	PROPN
iajs-3656	2	11	al	al	PROPN
iajs-3656	2	12	-	-	PUNCT
iajs-3656	2	13	haitham	haitham	PROPN
iajs-3656	2	14	)	)	PUNCT
iajs-3656	2	15	,	,	PUNCT
iajs-3656	2	16	university	university	NOUN
iajs-3656	2	17	of	of	ADP
iajs-3656	2	18	baghdad	baghdad	PROPN
iajs-3656	2	19	.	.	PUNCT
iajs-3656	3	1	this	this	PRON
iajs-3656	3	2	is	be	AUX
iajs-3656	3	3	an	an	DET
iajs-3656	3	4	open	open	ADJ
iajs-3656	3	5	-	-	PUNCT
iajs-3656	3	6	access	access	NOUN
iajs-3656	3	7	article	article	NOUN
iajs-3656	3	8	distributed	distribute	VERB
iajs-3656	3	9	under	under	ADP
iajs-3656	3	10	the	the	DET
iajs-3656	3	11	terms	term	NOUN
iajs-3656	3	12	of	of	ADP
iajs-3656	3	13	the	the	DET
iajs-3656	3	14	creative	creative	ADJ
iajs-3656	3	15	commons	common	NOUN
iajs-3656	3	16	attribution	attribution	NOUN
iajs-3656	3	17	4.0	4.0	NUM
iajs-3656	3	18	international	international	ADJ
iajs-3656	3	19	license	license	NOUN
iajs-3656	3	20	evaluation	evaluation	NOUN
iajs-3656	3	21	of	of	ADP
iajs-3656	3	22	some	some	DET
iajs-3656	3	23	proteins	protein	NOUN
iajs-3656	3	24	as	as	ADP
iajs-3656	3	25	potential	potential	ADJ
iajs-3656	3	26	markers	marker	NOUN
iajs-3656	3	27	in	in	ADP
iajs-3656	3	28	different	different	ADJ
iajs-3656	3	29	durations	duration	NOUN
iajs-3656	3	30	of	of	ADP
iajs-3656	3	31	diabetic	diabetic	ADJ
iajs-3656	3	32	patients	patient	NOUN
iajs-3656	3	33	type	type	VERB
iajs-3656	3	34	2	2	NUM
iajs-3656	3	35	sarah	sarah	PROPN
iajs-3656	3	36	sameer	sameer	PROPN
iajs-3656	3	37	sami	sami	PROPN
iajs-3656	3	38	1,2	1,2	NUM
iajs-3656	3	39	*	*	PUNCT
iajs-3656	3	40	and	and	CCONJ
iajs-3656	3	41	ekhlass	ekhlass	PROPN
iajs-3656	3	42	m.	m.	PROPN
iajs-3656	3	43	taha	taha	PROPN
iajs-3656	3	44	2	2	NUM
iajs-3656	3	45	1	1	NUM
iajs-3656	3	46	department	department	NOUN
iajs-3656	3	47	of	of	ADP
iajs-3656	3	48	clinical	clinical	ADJ
iajs-3656	3	49	laboratory	laboratory	NOUN
iajs-3656	3	50	sciences	sciences	PROPN
iajs-3656	3	51	,	,	PUNCT
iajs-3656	3	52	college	college	NOUN
iajs-3656	3	53	of	of	ADP
iajs-3656	3	54	pharmacy	pharmacy	NOUN
iajs-3656	3	55	,	,	PUNCT
iajs-3656	3	56	mustansiriyah	mustansiriyah	NOUN
iajs-3656	3	57	university	university	NOUN
iajs-3656	3	58	,	,	PUNCT
iajs-3656	3	59	baghdad	baghdad	PROPN
iajs-3656	3	60	,	,	PUNCT
iajs-3656	3	61	iraq	iraq	PROPN
iajs-3656	3	62	.	.	PUNCT
iajs-3656	4	1	2	2	NUM
iajs-3656	4	2	department	department	NOUN
iajs-3656	4	3	of	of	ADP
iajs-3656	4	4	chemistry	chemistry	NOUN
iajs-3656	4	5	,	,	PUNCT
iajs-3656	4	6	college	college	NOUN
iajs-3656	4	7	of	of	ADP
iajs-3656	4	8	science	science	NOUN
iajs-3656	4	9	for	for	ADP
iajs-3656	4	10	women	woman	NOUN
iajs-3656	4	11	,	,	PUNCT
iajs-3656	4	12	university	university	NOUN
iajs-3656	4	13	of	of	ADP
iajs-3656	4	14	baghdad	baghdad	PROPN
iajs-3656	4	15	,	,	PUNCT
iajs-3656	4	16	baghdad	baghdad	PROPN
iajs-3656	4	17	,	,	PUNCT
iajs-3656	4	18	iraq	iraq	PROPN
iajs-3656	4	19	.	.	PUNCT
iajs-3656	5	1	*	*	PUNCT
iajs-3656	5	2	corresponding	correspond	VERB
iajs-3656	5	3	author	author	NOUN
iajs-3656	5	4	.	.	PUNCT
iajs-3656	6	1	received	receive	VERB
iajs-3656	6	2	:	:	PUNCT
iajs-3656	6	3	7	7	NUM
iajs-3656	6	4	july	july	PROPN
iajs-3656	6	5	2023	2023	NUM
iajs-3656	6	6	accepted	accept	VERB
iajs-3656	6	7	:	:	PUNCT
iajs-3656	6	8	27	27	NUM
iajs-3656	6	9	august	august	PROPN
iajs-3656	6	10	2023	2023	NUM
iajs-3656	6	11	published	publish	VERB
iajs-3656	6	12	:	:	PUNCT
iajs-3656	6	13	20	20	NUM
iajs-3656	6	14	october	october	NOUN
iajs-3656	6	15	2025	2025	NUM
iajs-3656	6	16	doi.org/10.30526/38.4.3656	doi.org/10.30526/38.4.3656	NOUN
iajs-3656	6	17	abstract	abstract	ADJ
iajs-3656	6	18	type	type	NOUN
iajs-3656	6	19	2	2	NUM
iajs-3656	6	20	diabetic	diabetic	ADJ
iajs-3656	6	21	mellitus	mellitus	NOUN
iajs-3656	6	22	(	(	PUNCT
iajs-3656	6	23	t2	t2	NOUN
iajs-3656	6	24	dm	dm	PROPN
iajs-3656	6	25	)	)	PUNCT
iajs-3656	6	26	is	be	AUX
iajs-3656	6	27	growing	grow	VERB
iajs-3656	6	28	rapidly	rapidly	ADV
iajs-3656	6	29	around	around	ADP
iajs-3656	6	30	the	the	DET
iajs-3656	6	31	world	world	NOUN
iajs-3656	6	32	,	,	PUNCT
iajs-3656	6	33	due	due	ADJ
iajs-3656	6	34	in	in	ADP
iajs-3656	6	35	large	large	ADJ
iajs-3656	6	36	part	part	NOUN
iajs-3656	6	37	to	to	ADP
iajs-3656	6	38	significant	significant	ADJ
iajs-3656	6	39	changes	change	NOUN
iajs-3656	6	40	in	in	ADP
iajs-3656	6	41	the	the	DET
iajs-3656	6	42	modern	modern	ADJ
iajs-3656	6	43	human	human	ADJ
iajs-3656	6	44	lifestyle	lifestyle	NOUN
iajs-3656	6	45	.	.	PUNCT
iajs-3656	7	1	t2	t2	NOUN
iajs-3656	7	2	dm	dm	PROPN
iajs-3656	7	3	and	and	CCONJ
iajs-3656	7	4	its	its	PRON
iajs-3656	7	5	complications	complication	NOUN
iajs-3656	7	6	are	be	AUX
iajs-3656	7	7	affected	affect	VERB
iajs-3656	7	8	by	by	ADP
iajs-3656	7	9	a	a	DET
iajs-3656	7	10	complex	complex	ADJ
iajs-3656	7	11	interplay	interplay	NOUN
iajs-3656	7	12	of	of	ADP
iajs-3656	7	13	genetic	genetic	ADJ
iajs-3656	7	14	,	,	PUNCT
iajs-3656	7	15	life	life	NOUN
iajs-3656	7	16	course	course	NOUN
iajs-3656	7	17	,	,	PUNCT
iajs-3656	7	18	ecological	ecological	ADJ
iajs-3656	7	19	,	,	PUNCT
iajs-3656	7	20	cultural	cultural	ADJ
iajs-3656	7	21	,	,	PUNCT
iajs-3656	7	22	socioeconomic	socioeconomic	ADJ
iajs-3656	7	23	,	,	PUNCT
iajs-3656	7	24	cognitivepsychological	cognitivepsychological	ADJ
iajs-3656	7	25	-	-	PUNCT
iajs-3656	7	26	behavioral	behavioral	ADJ
iajs-3656	7	27	,	,	PUNCT
iajs-3656	7	28	and	and	CCONJ
iajs-3656	7	29	access	access	NOUN
iajs-3656	7	30	to	to	ADP
iajs-3656	7	31	care	care	NOUN
iajs-3656	7	32	factors	factor	NOUN
iajs-3656	7	33	that	that	PRON
iajs-3656	7	34	influence	influence	VERB
iajs-3656	7	35	regional	regional	ADJ
iajs-3656	7	36	variations	variation	NOUN
iajs-3656	7	37	in	in	ADP
iajs-3656	7	38	disease	disease	NOUN
iajs-3656	7	39	burden	burden	NOUN
iajs-3656	7	40	and	and	CCONJ
iajs-3656	7	41	care	care	VERB
iajs-3656	7	42	quality	quality	NOUN
iajs-3656	7	43	by	by	ADP
iajs-3656	7	44	gender	gender	NOUN
iajs-3656	7	45	.	.	PUNCT
iajs-3656	8	1	this	this	DET
iajs-3656	8	2	study	study	NOUN
iajs-3656	8	3	aims	aim	VERB
iajs-3656	8	4	to	to	PART
iajs-3656	8	5	investigate	investigate	VERB
iajs-3656	8	6	the	the	DET
iajs-3656	8	7	role	role	NOUN
iajs-3656	8	8	of	of	ADP
iajs-3656	8	9	laminin	laminin	NOUN
iajs-3656	8	10	subunit	subunit	NOUN
iajs-3656	8	11	alpha	alpha	NOUN
iajs-3656	8	12	2	2	NUM
iajs-3656	8	13	(	(	PUNCT
iajs-3656	8	14	lama2	lama2	NOUN
iajs-3656	8	15	)	)	PUNCT
iajs-3656	8	16	,	,	PUNCT
iajs-3656	8	17	mixed	mixed	ADJ
iajs-3656	8	18	lineage	lineage	NOUN
iajs-3656	8	19	leukemia	leukemia	NOUN
iajs-3656	8	20	4	4	NUM
iajs-3656	8	21	(	(	PUNCT
iajs-3656	8	22	mll4	mll4	PROPN
iajs-3656	8	23	)	)	PUNCT
iajs-3656	8	24	,	,	PUNCT
iajs-3656	8	25	plexin	plexin	PROPN
iajs-3656	8	26	domain	domain	NOUN
iajs-3656	8	27	containing	contain	VERB
iajs-3656	8	28	2	2	NUM
iajs-3656	8	29	(	(	PUNCT
iajs-3656	8	30	plxdc2	plxdc2	NOUN
iajs-3656	8	31	)	)	PUNCT
iajs-3656	8	32	,	,	PUNCT
iajs-3656	8	33	and	and	CCONJ
iajs-3656	8	34	protein	protein	NOUN
iajs-3656	8	35	z	z	NOUN
iajs-3656	8	36	(	(	PUNCT
iajs-3656	8	37	porz	porz	NOUN
iajs-3656	8	38	)	)	PUNCT
iajs-3656	8	39	as	as	ADP
iajs-3656	8	40	potential	potential	ADJ
iajs-3656	8	41	biomarkers	biomarker	NOUN
iajs-3656	8	42	for	for	ADP
iajs-3656	8	43	t2	t2	NOUN
iajs-3656	8	44	dm	dm	NOUN
iajs-3656	8	45	at	at	ADP
iajs-3656	8	46	different	different	ADJ
iajs-3656	8	47	durations	duration	NOUN
iajs-3656	8	48	of	of	ADP
iajs-3656	8	49	the	the	DET
iajs-3656	8	50	disease	disease	NOUN
iajs-3656	8	51	.	.	PUNCT
iajs-3656	9	1	these	these	DET
iajs-3656	9	2	biomarkers	biomarker	NOUN
iajs-3656	9	3	were	be	AUX
iajs-3656	9	4	assessed	assess	VERB
iajs-3656	9	5	using	use	VERB
iajs-3656	9	6	an	an	DET
iajs-3656	9	7	enzyme	enzyme	NOUN
iajs-3656	9	8	-	-	PUNCT
iajs-3656	9	9	linked	link	VERB
iajs-3656	9	10	immunosorbent	immunosorbent	NOUN
iajs-3656	9	11	assay	assay	ADV
iajs-3656	9	12	.	.	PUNCT
iajs-3656	10	1	while	while	SCONJ
iajs-3656	10	2	biochemical	biochemical	ADJ
iajs-3656	10	3	parameters	parameter	NOUN
iajs-3656	10	4	(	(	PUNCT
iajs-3656	10	5	fsg	fsg	PROPN
iajs-3656	10	6	)	)	PUNCT
iajs-3656	10	7	and	and	CCONJ
iajs-3656	10	8	lipid	lipid	NOUN
iajs-3656	10	9	profiles	profile	NOUN
iajs-3656	10	10	were	be	AUX
iajs-3656	10	11	measured	measure	VERB
iajs-3656	10	12	spectrophotometrically	spectrophotometrically	ADV
iajs-3656	10	13	.	.	PUNCT
iajs-3656	11	1	hba1c	hba1c	NOUN
iajs-3656	11	2	using	use	VERB
iajs-3656	11	3	hplc	hplc	NOUN
iajs-3656	11	4	.	.	PUNCT
iajs-3656	12	1	the	the	DET
iajs-3656	12	2	volunteer	volunteer	NOUN
iajs-3656	12	3	individuals	individual	NOUN
iajs-3656	12	4	were	be	AUX
iajs-3656	12	5	subdivided	subdivide	VERB
iajs-3656	12	6	into	into	ADP
iajs-3656	12	7	five	five	NUM
iajs-3656	12	8	groups	group	NOUN
iajs-3656	12	9	:	:	PUNCT
iajs-3656	12	10	group	group	NOUN
iajs-3656	12	11	i	i	PRON
iajs-3656	12	12	:	:	PUNCT
iajs-3656	12	13	dm	dm	X
iajs-3656	12	14	with	with	ADP
iajs-3656	12	15	duration	duration	NOUN
iajs-3656	12	16	of	of	ADP
iajs-3656	12	17	disease	disease	NOUN
iajs-3656	12	18	less	less	ADJ
iajs-3656	12	19	than	than	ADP
iajs-3656	12	20	1	1	NUM
iajs-3656	12	21	year	year	NOUN
iajs-3656	12	22	,	,	PUNCT
iajs-3656	12	23	group	group	NOUN
iajs-3656	12	24	ii	ii	PROPN
iajs-3656	12	25	:	:	PUNCT
iajs-3656	12	26	dm	dm	X
iajs-3656	12	27	with	with	ADP
iajs-3656	12	28	duration	duration	NOUN
iajs-3656	12	29	of	of	ADP
iajs-3656	12	30	disease	disease	NOUN
iajs-3656	12	31	from	from	ADP
iajs-3656	12	32	1	1	NUM
iajs-3656	12	33	-	-	SYM
iajs-3656	12	34	5	5	NUM
iajs-3656	12	35	years	year	NOUN
iajs-3656	12	36	,	,	PUNCT
iajs-3656	12	37	group	group	NOUN
iajs-3656	12	38	iii	iii	PROPN
iajs-3656	12	39	:	:	PUNCT
iajs-3656	13	1	dm	dm	NOUN
iajs-3656	13	2	with	with	ADP
iajs-3656	13	3	duration	duration	NOUN
iajs-3656	13	4	of	of	ADP
iajs-3656	13	5	disease	disease	NOUN
iajs-3656	13	6	from	from	ADP
iajs-3656	13	7	5	5	NUM
iajs-3656	13	8	-	-	SYM
iajs-3656	13	9	10	10	NUM
iajs-3656	13	10	years	year	NOUN
iajs-3656	13	11	,	,	PUNCT
iajs-3656	13	12	group	group	NOUN
iajs-3656	13	13	iv	iv	NUM
iajs-3656	13	14	:	:	PUNCT
iajs-3656	13	15	dm	dm	NOUN
iajs-3656	13	16	with	with	ADP
iajs-3656	13	17	duration	duration	NOUN
iajs-3656	13	18	of	of	ADP
iajs-3656	13	19	disease	disease	NOUN
iajs-3656	13	20	more	more	ADJ
iajs-3656	13	21	than	than	ADP
iajs-3656	13	22	10	10	NUM
iajs-3656	13	23	years	year	NOUN
iajs-3656	13	24	,	,	PUNCT
iajs-3656	13	25	group	group	NOUN
iajs-3656	13	26	v	v	NOUN
iajs-3656	13	27	:	:	PUNCT
iajs-3656	13	28	healthy	healthy	ADJ
iajs-3656	13	29	control	control	NOUN
iajs-3656	13	30	.	.	PUNCT
iajs-3656	14	1	results	result	NOUN
iajs-3656	14	2	showed	show	VERB
iajs-3656	14	3	a	a	DET
iajs-3656	14	4	significant	significant	ADJ
iajs-3656	14	5	difference	difference	NOUN
iajs-3656	14	6	among	among	ADP
iajs-3656	14	7	the	the	DET
iajs-3656	14	8	studied	study	VERB
iajs-3656	14	9	groups	group	NOUN
iajs-3656	14	10	in	in	ADP
iajs-3656	14	11	lama2	lama2	NOUN
iajs-3656	14	12	and	and	CCONJ
iajs-3656	14	13	plxdc2	plxdc2	NOUN
iajs-3656	14	14	.	.	PUNCT
iajs-3656	15	1	in	in	ADP
iajs-3656	15	2	contrast	contrast	NOUN
iajs-3656	15	3	,	,	PUNCT
iajs-3656	15	4	no	no	DET
iajs-3656	15	5	significant	significant	ADJ
iajs-3656	15	6	difference	difference	NOUN
iajs-3656	15	7	was	be	AUX
iajs-3656	15	8	observed	observe	VERB
iajs-3656	15	9	in	in	ADP
iajs-3656	15	10	mll4	mll4	PROPN
iajs-3656	15	11	and	and	CCONJ
iajs-3656	15	12	por	por	PROPN
iajs-3656	15	13	z.	z.	PROPN
iajs-3656	15	14	it	it	PRON
iajs-3656	15	15	has	have	AUX
iajs-3656	15	16	been	be	AUX
iajs-3656	15	17	concluded	conclude	VERB
iajs-3656	15	18	that	that	SCONJ
iajs-3656	15	19	lama2	lama2	NOUN
iajs-3656	15	20	and	and	CCONJ
iajs-3656	15	21	plxdc2	plxdc2	NOUN
iajs-3656	15	22	are	be	AUX
iajs-3656	15	23	involved	involve	VERB
iajs-3656	15	24	in	in	ADP
iajs-3656	15	25	the	the	DET
iajs-3656	15	26	duration	duration	NOUN
iajs-3656	15	27	of	of	ADP
iajs-3656	15	28	the	the	DET
iajs-3656	15	29	disease	disease	NOUN
iajs-3656	15	30	.	.	PUNCT
iajs-3656	16	1	keywords	keyword	NOUN
iajs-3656	16	2	:	:	PUNCT
iajs-3656	16	3	laminin	laminin	NOUN
iajs-3656	16	4	subunit	subunit	NOUN
iajs-3656	16	5	alpha	alpha	NOUN
iajs-3656	16	6	2	2	NUM
iajs-3656	16	7	,	,	PUNCT
iajs-3656	16	8	mixed	mixed	ADJ
iajs-3656	16	9	lineage	lineage	NOUN
iajs-3656	16	10	leukemia	leukemia	NOUN
iajs-3656	16	11	4	4	NUM
iajs-3656	16	12	,	,	PUNCT
iajs-3656	16	13	plexin	plexin	ADJ
iajs-3656	16	14	domain	domain	NOUN
iajs-3656	16	15	containing	contain	VERB
iajs-3656	16	16	2	2	NUM
iajs-3656	16	17	,	,	PUNCT
iajs-3656	16	18	protein	protein	NOUN
iajs-3656	16	19	z	z	NOUN
iajs-3656	16	20	,	,	PUNCT
iajs-3656	16	21	type	type	NOUN
iajs-3656	16	22	2	2	NUM
iajs-3656	16	23	diabetes	diabetes	NOUN
iajs-3656	16	24	.	.	PUNCT
iajs-3656	17	1	1	1	X
iajs-3656	17	2	.	.	X
iajs-3656	17	3	introduction	introduction	NOUN
iajs-3656	17	4	type	type	NOUN
iajs-3656	17	5	2	2	NUM
iajs-3656	17	6	diabetic	diabetic	ADJ
iajs-3656	17	7	mellitus	mellitus	NOUN
iajs-3656	17	8	(	(	PUNCT
iajs-3656	17	9	t2	t2	NOUN
iajs-3656	17	10	dm	dm	PROPN
iajs-3656	17	11	)	)	PUNCT
iajs-3656	17	12	is	be	AUX
iajs-3656	17	13	growing	grow	VERB
iajs-3656	17	14	rapidly	rapidly	ADV
iajs-3656	17	15	around	around	ADP
iajs-3656	17	16	the	the	DET
iajs-3656	17	17	world	world	NOUN
iajs-3656	17	18	,	,	PUNCT
iajs-3656	17	19	due	due	ADJ
iajs-3656	17	20	in	in	ADP
iajs-3656	17	21	large	large	ADJ
iajs-3656	17	22	part	part	NOUN
iajs-3656	17	23	to	to	ADP
iajs-3656	17	24	significant	significant	ADJ
iajs-3656	17	25	changes	change	NOUN
iajs-3656	17	26	in	in	ADP
iajs-3656	17	27	the	the	DET
iajs-3656	17	28	modern	modern	ADJ
iajs-3656	17	29	human	human	ADJ
iajs-3656	17	30	lifestyle	lifestyle	NOUN
iajs-3656	17	31	(	(	PUNCT
iajs-3656	17	32	1	1	NUM
iajs-3656	17	33	)	)	PUNCT
iajs-3656	17	34	.	.	PUNCT
iajs-3656	18	1	diabetes	diabetes	NOUN
iajs-3656	18	2	mellitus	mellitus	NOUN
iajs-3656	18	3	is	be	AUX
iajs-3656	18	4	a	a	DET
iajs-3656	18	5	complicated	complicated	ADJ
iajs-3656	18	6	long	long	ADJ
iajs-3656	18	7	-	-	PUNCT
iajs-3656	18	8	term	term	NOUN
iajs-3656	18	9	condition	condition	NOUN
iajs-3656	18	10	linked	link	VERB
iajs-3656	18	11	to	to	ADP
iajs-3656	18	12	elevated	elevated	ADJ
iajs-3656	18	13	blood	blood	NOUN
iajs-3656	18	14	glucose	glucose	NOUN
iajs-3656	18	15	levels	level	NOUN
iajs-3656	18	16	,	,	PUNCT
iajs-3656	18	17	known	know	VERB
iajs-3656	18	18	as	as	ADP
iajs-3656	18	19	hyperglycemia	hyperglycemia	NOUN
iajs-3656	18	20	,	,	PUNCT
iajs-3656	18	21	resulting	result	VERB
iajs-3656	18	22	from	from	ADP
iajs-3656	18	23	insufficient	insufficient	ADJ
iajs-3656	18	24	insulin	insulin	NOUN
iajs-3656	18	25	production	production	NOUN
iajs-3656	18	26	,	,	PUNCT
iajs-3656	18	27	function	function	NOUN
iajs-3656	18	28	,	,	PUNCT
iajs-3656	18	29	or	or	CCONJ
iajs-3656	18	30	both	both	PRON
iajs-3656	18	31	.	.	PUNCT
iajs-3656	19	1	to	to	PART
iajs-3656	19	2	enhance	enhance	VERB
iajs-3656	19	3	the	the	DET
iajs-3656	19	4	management	management	NOUN
iajs-3656	19	5	of	of	ADP
iajs-3656	19	6	dm	dm	NOUN
iajs-3656	19	7	and	and	CCONJ
iajs-3656	19	8	ensure	ensure	VERB
iajs-3656	19	9	adequate	adequate	ADJ
iajs-3656	19	10	care	care	NOUN
iajs-3656	19	11	for	for	ADP
iajs-3656	19	12	adults	adult	NOUN
iajs-3656	19	13	with	with	ADP
iajs-3656	19	14	the	the	DET
iajs-3656	19	15	condition	condition	NOUN
iajs-3656	19	16	,	,	PUNCT
iajs-3656	19	17	it	it	PRON
iajs-3656	19	18	is	be	AUX
iajs-3656	19	19	crucial	crucial	ADJ
iajs-3656	19	20	to	to	PART
iajs-3656	19	21	gain	gain	VERB
iajs-3656	19	22	a	a	DET
iajs-3656	19	23	better	well	ADJ
iajs-3656	19	24	comprehension	comprehension	NOUN
iajs-3656	19	25	of	of	ADP
iajs-3656	19	26	how	how	SCONJ
iajs-3656	19	27	age	age	NOUN
iajs-3656	19	28	at	at	ADP
iajs-3656	19	29	diagnosis	diagnosis	NOUN
iajs-3656	19	30	and	and	CCONJ
iajs-3656	19	31	duration	duration	NOUN
iajs-3656	19	32	of	of	ADP
iajs-3656	19	33	diabetes	diabetes	NOUN
iajs-3656	19	34	relate	relate	VERB
iajs-3656	19	35	to	to	ADP
iajs-3656	19	36	diabetes	diabetes	NOUN
iajs-3656	19	37	-	-	PUNCT
iajs-3656	19	38	related	relate	VERB
iajs-3656	19	39	outcomes	outcome	NOUN
iajs-3656	19	40	.	.	PUNCT
iajs-3656	20	1	individuals	individual	NOUN
iajs-3656	20	2	who	who	PRON
iajs-3656	20	3	are	be	AUX
iajs-3656	20	4	diagnosed	diagnose	VERB
iajs-3656	20	5	with	with	ADP
iajs-3656	20	6	diabetes	diabetes	NOUN
iajs-3656	20	7	at	at	ADP
iajs-3656	20	8	different	different	ADJ
iajs-3656	20	9	ages	age	NOUN
iajs-3656	20	10	exhibit	exhibit	VERB
iajs-3656	20	11	distinct	distinct	ADJ
iajs-3656	20	12	characteristics	characteristic	NOUN
iajs-3656	21	1	both	both	CCONJ
iajs-3656	21	2	initially	initially	ADV
iajs-3656	21	3	and	and	CCONJ
iajs-3656	21	4	as	as	SCONJ
iajs-3656	21	5	time	time	NOUN
iajs-3656	21	6	progresses	progress	VERB
iajs-3656	21	7	.	.	PUNCT
iajs-3656	22	1	a	a	DET
iajs-3656	22	2	person	person	NOUN
iajs-3656	22	3	diagnosed	diagnose	VERB
iajs-3656	22	4	with	with	ADP
iajs-3656	22	5	diabetes	diabetes	NOUN
iajs-3656	22	6	at	at	ADP
iajs-3656	22	7	a	a	DET
iajs-3656	22	8	specific	specific	ADJ
iajs-3656	22	9	age	age	NOUN
iajs-3656	22	10	may	may	AUX
iajs-3656	22	11	differ	differ	VERB
iajs-3656	22	12	significantly	significantly	ADV
iajs-3656	22	13	from	from	ADP
iajs-3656	22	14	another	another	DET
iajs-3656	22	15	individual	individual	NOUN
iajs-3656	22	16	diagnosed	diagnose	VERB
iajs-3656	22	17	at	at	ADP
iajs-3656	22	18	a	a	DET
iajs-3656	22	19	different	different	ADJ
iajs-3656	22	20	age	age	NOUN
iajs-3656	22	21	in	in	ADP
iajs-3656	22	22	terms	term	NOUN
iajs-3656	22	23	of	of	ADP
iajs-3656	22	24	their	their	PRON
iajs-3656	22	25	baseline	baseline	NOUN
iajs-3656	22	26	attributes	attribute	NOUN
iajs-3656	22	27	and	and	CCONJ
iajs-3656	22	28	how	how	SCONJ
iajs-3656	22	29	their	their	PRON
iajs-3656	22	30	condition	condition	NOUN
iajs-3656	22	31	evolves	evolve	VERB
iajs-3656	22	32	(	(	PUNCT
iajs-3656	22	33	2	2	NUM
iajs-3656	22	34	-	-	SYM
iajs-3656	22	35	4	4	NUM
iajs-3656	22	36	)	)	PUNCT
iajs-3656	22	37	.	.	PUNCT
iajs-3656	23	1	numerous	numerous	ADJ
iajs-3656	23	2	studies	study	NOUN
iajs-3656	23	3	https://orcid.org/0009-0009-4707-9063	https://orcid.org/0009-0009-4707-9063	PROPN
iajs-3656	23	4	mailto:sarah.alsalman@uomustansiriyah.edu.iq	mailto:sarah.alsalman@uomustansiriyah.edu.iq	PROPN
iajs-3656	23	5	https://orcid.org/0000-0002-6866-8600	https://orcid.org/0000-0002-6866-8600	PROPN
iajs-3656	23	6	mailto:ikhlasmb_chem@csw.uobaghdad.edu.iq	mailto:ikhlasmb_chem@csw.uobaghdad.edu.iq	VERB
iajs-3656	23	7	https://orcid.org/0009-0009-4707-9063	https://orcid.org/0009-0009-4707-9063	PROPN
iajs-3656	23	8	mailto:sarah.alsalman@uomustansiriyah.edu.iq	mailto:sarah.alsalman@uomustansiriyah.edu.iq	PROPN
iajs-3656	23	9	https://orcid.org/0000-0002-6866-8600	https://orcid.org/0000-0002-6866-8600	PROPN
iajs-3656	23	10	mailto:ikhlasmb_chem@csw.uobaghdad.edu.iq	mailto:ikhlasmb_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3656	23	11	https://orcid.org/0009-0009-4707-9063	https://orcid.org/0009-0009-4707-9063	PROPN
iajs-3656	23	12	mailto:sarah.alsalman@uomustansiriyah.edu.iq	mailto:sarah.alsalman@uomustansiriyah.edu.iq	PROPN
iajs-3656	23	13	https://orcid.org/0000-0002-6866-8600	https://orcid.org/0000-0002-6866-8600	PROPN
iajs-3656	23	14	mailto:ikhlasmb_chem@csw.uobaghdad.edu.iq	mailto:ikhlasmb_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3656	23	15	https://orcid.org/0009-0009-4707-9063	https://orcid.org/0009-0009-4707-9063	PROPN
iajs-3656	23	16	mailto:sarah.alsalman@uomustansiriyah.edu.iq	mailto:sarah.alsalman@uomustansiriyah.edu.iq	PROPN
iajs-3656	23	17	https://orcid.org/0000-0002-6866-8600	https://orcid.org/0000-0002-6866-8600	PROPN
iajs-3656	23	18	mailto:ikhlasmb_chem@csw.uobaghdad.edu.iq	mailto:ikhlasmb_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3656	23	19	https://orcid.org/0009-0009-4707-9063	https://orcid.org/0009-0009-4707-9063	PROPN
iajs-3656	23	20	mailto:sarah.alsalman@uomustansiriyah.edu.iq	mailto:sarah.alsalman@uomustansiriyah.edu.iq	PROPN
iajs-3656	23	21	https://orcid.org/0000-0002-6866-8600	https://orcid.org/0000-0002-6866-8600	PROPN
iajs-3656	23	22	mailto:ikhlasmb_chem@csw.uobaghdad.edu.iq	mailto:ikhlasmb_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3656	23	23	https://orcid.org/0009-0009-4707-9063	https://orcid.org/0009-0009-4707-9063	PROPN
iajs-3656	23	24	mailto:sarah.alsalman@uomustansiriyah.edu.iq	mailto:sarah.alsalman@uomustansiriyah.edu.iq	PROPN
iajs-3656	23	25	https://orcid.org/0000-0002-6866-8600	https://orcid.org/0000-0002-6866-8600	PROPN
iajs-3656	23	26	mailto:ikhlasmb_chem@csw.uobaghdad.edu.iq	mailto:ikhlasmb_chem@csw.uobaghdad.edu.iq	ADJ
iajs-3656	23	27	ihjpas	ihjpa	NOUN
iajs-3656	23	28	.	.	PUNCT
iajs-3656	24	1	2025	2025	NUM
iajs-3656	24	2	,	,	PUNCT
iajs-3656	24	3	38(4	38(4	NUM
iajs-3656	24	4	)	)	PUNCT
iajs-3656	24	5	231	231	NUM
iajs-3656	24	6	have	have	AUX
iajs-3656	24	7	demonstrated	demonstrate	VERB
iajs-3656	24	8	the	the	DET
iajs-3656	24	9	impact	impact	NOUN
iajs-3656	24	10	of	of	ADP
iajs-3656	24	11	lifestyle	lifestyle	NOUN
iajs-3656	24	12	modifications	modification	NOUN
iajs-3656	24	13	,	,	PUNCT
iajs-3656	24	14	such	such	ADJ
iajs-3656	24	15	as	as	ADP
iajs-3656	24	16	regular	regular	ADJ
iajs-3656	24	17	physical	physical	ADJ
iajs-3656	24	18	activity	activity	NOUN
iajs-3656	24	19	and	and	CCONJ
iajs-3656	24	20	healthy	healthy	ADJ
iajs-3656	24	21	eating	eating	NOUN
iajs-3656	24	22	habits	habit	NOUN
iajs-3656	24	23	,	,	PUNCT
iajs-3656	24	24	in	in	ADP
iajs-3656	24	25	preventing	prevent	VERB
iajs-3656	24	26	or	or	CCONJ
iajs-3656	24	27	delaying	delay	VERB
iajs-3656	24	28	the	the	DET
iajs-3656	24	29	onset	onset	NOUN
iajs-3656	24	30	of	of	ADP
iajs-3656	24	31	t2md	t2md	PUNCT
iajs-3656	24	32	.	.	PUNCT
iajs-3656	25	1	the	the	DET
iajs-3656	25	2	diabetes	diabetes	NOUN
iajs-3656	25	3	prevention	prevention	NOUN
iajs-3656	25	4	program	program	NOUN
iajs-3656	25	5	,	,	PUNCT
iajs-3656	25	6	a	a	DET
iajs-3656	25	7	landmark	landmark	ADJ
iajs-3656	25	8	clinical	clinical	ADJ
iajs-3656	25	9	trial	trial	NOUN
iajs-3656	25	10	,	,	PUNCT
iajs-3656	25	11	showed	show	VERB
iajs-3656	25	12	that	that	SCONJ
iajs-3656	25	13	lifestyle	lifestyle	NOUN
iajs-3656	25	14	interventions	intervention	NOUN
iajs-3656	25	15	,	,	PUNCT
iajs-3656	25	16	including	include	VERB
iajs-3656	25	17	a	a	DET
iajs-3656	25	18	modest	modest	ADJ
iajs-3656	25	19	weight	weight	NOUN
iajs-3656	25	20	loss	loss	NOUN
iajs-3656	25	21	and	and	CCONJ
iajs-3656	25	22	increased	increase	VERB
iajs-3656	25	23	physical	physical	ADJ
iajs-3656	25	24	activity	activity	NOUN
iajs-3656	25	25	,	,	PUNCT
iajs-3656	25	26	can	can	AUX
iajs-3656	25	27	reduce	reduce	VERB
iajs-3656	25	28	the	the	DET
iajs-3656	25	29	risk	risk	NOUN
iajs-3656	25	30	of	of	ADP
iajs-3656	25	31	developing	develop	VERB
iajs-3656	25	32	t2	t2	NOUN
iajs-3656	25	33	dm	dm	VERB
iajs-3656	25	34	by	by	ADP
iajs-3656	25	35	up	up	ADP
iajs-3656	25	36	to	to	PART
iajs-3656	25	37	58	58	NUM
iajs-3656	25	38	%	%	NOUN
iajs-3656	25	39	in	in	ADP
iajs-3656	25	40	high	high	ADJ
iajs-3656	25	41	-	-	PUNCT
iajs-3656	25	42	risk	risk	NOUN
iajs-3656	25	43	individuals	individual	NOUN
iajs-3656	25	44	(	(	PUNCT
iajs-3656	25	45	5	5	NUM
iajs-3656	25	46	-	-	SYM
iajs-3656	25	47	7	7	NUM
iajs-3656	25	48	)	)	PUNCT
iajs-3656	25	49	.	.	PUNCT
iajs-3656	26	1	out	out	ADP
iajs-3656	26	2	of	of	ADP
iajs-3656	26	3	the	the	DET
iajs-3656	26	4	various	various	ADJ
iajs-3656	26	5	conditions	condition	NOUN
iajs-3656	26	6	referred	refer	VERB
iajs-3656	26	7	to	to	ADP
iajs-3656	26	8	as	as	ADP
iajs-3656	26	9	"	"	PUNCT
iajs-3656	26	10	diseases	disease	NOUN
iajs-3656	26	11	of	of	ADP
iajs-3656	26	12	civilization	civilization	NOUN
iajs-3656	26	13	,	,	PUNCT
iajs-3656	26	14	"	"	PUNCT
iajs-3656	26	15	dm	dm	PROPN
iajs-3656	26	16	currently	currently	ADV
iajs-3656	26	17	ranks	rank	VERB
iajs-3656	26	18	high	high	ADV
iajs-3656	26	19	in	in	ADP
iajs-3656	26	20	terms	term	NOUN
iajs-3656	26	21	of	of	ADP
iajs-3656	26	22	the	the	DET
iajs-3656	26	23	rapid	rapid	ADJ
iajs-3656	26	24	increase	increase	NOUN
iajs-3656	26	25	in	in	ADP
iajs-3656	26	26	rates	rate	NOUN
iajs-3656	26	27	of	of	ADP
iajs-3656	26	28	illness	illness	NOUN
iajs-3656	26	29	,	,	PUNCT
iajs-3656	26	30	disability	disability	NOUN
iajs-3656	26	31	,	,	PUNCT
iajs-3656	26	32	and	and	CCONJ
iajs-3656	26	33	death	death	NOUN
iajs-3656	26	34	(	(	PUNCT
iajs-3656	26	35	8)	8)	NUM
iajs-3656	26	36	.	.	PUNCT
iajs-3656	27	1	globally	globally	ADV
iajs-3656	27	2	,	,	PUNCT
iajs-3656	27	3	there	there	PRON
iajs-3656	27	4	are	be	VERB
iajs-3656	27	5	currently	currently	ADV
iajs-3656	27	6	more	more	ADJ
iajs-3656	27	7	than	than	ADP
iajs-3656	27	8	460	460	NUM
iajs-3656	27	9	million	million	NUM
iajs-3656	27	10	individuals	individual	NOUN
iajs-3656	27	11	living	live	VERB
iajs-3656	27	12	with	with	ADP
iajs-3656	27	13	diabetes	diabetes	NOUN
iajs-3656	27	14	.	.	PUNCT
iajs-3656	28	1	however	however	ADV
iajs-3656	28	2	,	,	PUNCT
iajs-3656	28	3	according	accord	VERB
iajs-3656	28	4	to	to	ADP
iajs-3656	28	5	the	the	DET
iajs-3656	28	6	projections	projection	NOUN
iajs-3656	28	7	of	of	ADP
iajs-3656	28	8	the	the	DET
iajs-3656	28	9	international	international	ADJ
iajs-3656	28	10	diabetes	diabetes	NOUN
iajs-3656	28	11	federation	federation	NOUN
iajs-3656	28	12	,	,	PUNCT
iajs-3656	28	13	that	that	DET
iajs-3656	28	14	number	number	NOUN
iajs-3656	28	15	is	be	AUX
iajs-3656	28	16	expected	expect	VERB
iajs-3656	28	17	to	to	PART
iajs-3656	28	18	increase	increase	VERB
iajs-3656	28	19	to	to	ADP
iajs-3656	28	20	642	642	NUM
iajs-3656	28	21	million	million	NUM
iajs-3656	28	22	by	by	ADP
iajs-3656	28	23	the	the	DET
iajs-3656	28	24	year	year	NOUN
iajs-3656	28	25	2040	2040	NUM
iajs-3656	28	26	(	(	PUNCT
iajs-3656	28	27	9,10	9,10	NUM
iajs-3656	28	28	)	)	PUNCT
iajs-3656	28	29	.	.	PUNCT
iajs-3656	29	1	many	many	ADJ
iajs-3656	29	2	factors	factor	NOUN
iajs-3656	29	3	contribute	contribute	VERB
iajs-3656	29	4	to	to	ADP
iajs-3656	29	5	the	the	DET
iajs-3656	29	6	development	development	NOUN
iajs-3656	29	7	of	of	ADP
iajs-3656	29	8	t2	t2	NOUN
iajs-3656	29	9	dm	dm	X
iajs-3656	29	10	(	(	PUNCT
iajs-3656	29	11	11	11	NUM
iajs-3656	29	12	)	)	PUNCT
iajs-3656	29	13	.	.	PUNCT
iajs-3656	30	1	moreover	moreover	ADV
iajs-3656	30	2	,	,	PUNCT
iajs-3656	30	3	to	to	PART
iajs-3656	30	4	identify	identify	VERB
iajs-3656	30	5	genetic	genetic	ADJ
iajs-3656	30	6	and	and	CCONJ
iajs-3656	30	7	protein	protein	NOUN
iajs-3656	30	8	markers	marker	NOUN
iajs-3656	30	9	for	for	ADP
iajs-3656	30	10	future	future	ADJ
iajs-3656	30	11	t2	t2	NOUN
iajs-3656	30	12	dm	dm	NOUN
iajs-3656	30	13	,	,	PUNCT
iajs-3656	30	14	significant	significant	ADJ
iajs-3656	30	15	efforts	effort	NOUN
iajs-3656	30	16	have	have	AUX
iajs-3656	30	17	been	be	AUX
iajs-3656	30	18	made	make	VERB
iajs-3656	30	19	.	.	PUNCT
iajs-3656	31	1	therefore	therefore	ADV
iajs-3656	31	2	,	,	PUNCT
iajs-3656	31	3	protein	protein	NOUN
iajs-3656	31	4	markers	marker	NOUN
iajs-3656	31	5	are	be	AUX
iajs-3656	31	6	the	the	DET
iajs-3656	31	7	most	most	ADV
iajs-3656	31	8	common	common	ADJ
iajs-3656	31	9	and	and	CCONJ
iajs-3656	31	10	have	have	AUX
iajs-3656	31	11	been	be	AUX
iajs-3656	31	12	successful	successful	ADJ
iajs-3656	31	13	in	in	ADP
iajs-3656	31	14	diagnosing	diagnose	VERB
iajs-3656	31	15	diabetes	diabetes	NOUN
iajs-3656	31	16	,	,	PUNCT
iajs-3656	31	17	though	though	SCONJ
iajs-3656	31	18	not	not	PART
iajs-3656	31	19	specifically	specifically	ADV
iajs-3656	31	20	at	at	ADP
iajs-3656	31	21	the	the	DET
iajs-3656	31	22	beginning	beginning	NOUN
iajs-3656	31	23	of	of	ADP
iajs-3656	31	24	the	the	DET
iajs-3656	31	25	disease	disease	NOUN
iajs-3656	31	26	or	or	CCONJ
iajs-3656	31	27	in	in	ADP
iajs-3656	31	28	the	the	DET
iajs-3656	31	29	early	early	ADJ
iajs-3656	31	30	stages	stage	NOUN
iajs-3656	31	31	of	of	ADP
iajs-3656	31	32	its	its	PRON
iajs-3656	31	33	progression	progression	NOUN
iajs-3656	31	34	(	(	PUNCT
iajs-3656	31	35	12	12	NUM
iajs-3656	31	36	)	)	PUNCT
iajs-3656	31	37	.	.	PUNCT
iajs-3656	32	1	it	it	PRON
iajs-3656	32	2	has	have	AUX
iajs-3656	32	3	been	be	AUX
iajs-3656	32	4	found	find	VERB
iajs-3656	32	5	that	that	SCONJ
iajs-3656	32	6	the	the	DET
iajs-3656	32	7	laminin	laminin	NOUN
iajs-3656	32	8	subunit	subunit	NOUN
iajs-3656	32	9	alpha	alpha	NOUN
iajs-3656	32	10	2	2	NUM
iajs-3656	32	11	(	(	PUNCT
iajs-3656	32	12	lama2	lama2	NOUN
iajs-3656	32	13	)	)	PUNCT
iajs-3656	32	14	mutation	mutation	NOUN
iajs-3656	32	15	has	have	AUX
iajs-3656	32	16	been	be	AUX
iajs-3656	32	17	associated	associate	VERB
iajs-3656	32	18	with	with	ADP
iajs-3656	32	19	merosin	merosin	NOUN
iajs-3656	32	20	-	-	PUNCT
iajs-3656	32	21	deficient	deficient	ADJ
iajs-3656	32	22	congenital	congenital	ADJ
iajs-3656	32	23	muscular	muscular	ADJ
iajs-3656	32	24	dystrophy	dystrophy	NOUN
iajs-3656	32	25	(	(	PUNCT
iajs-3656	32	26	13	13	NUM
iajs-3656	32	27	)	)	PUNCT
iajs-3656	32	28	.	.	PUNCT
iajs-3656	33	1	according	accord	VERB
iajs-3656	33	2	to	to	ADP
iajs-3656	33	3	studies	study	NOUN
iajs-3656	33	4	,	,	PUNCT
iajs-3656	33	5	mixed	mixed	ADJ
iajs-3656	33	6	lineage	lineage	NOUN
iajs-3656	33	7	leukemia	leukemia	NOUN
iajs-3656	33	8	4	4	NUM
iajs-3656	33	9	(	(	PUNCT
iajs-3656	33	10	mll4	mll4	PROPN
iajs-3656	33	11	)	)	PUNCT
iajs-3656	33	12	collaborates	collaborate	NOUN
iajs-3656	33	13	with	with	ADP
iajs-3656	33	14	transcription	transcription	NOUN
iajs-3656	33	15	factors	factor	NOUN
iajs-3656	33	16	to	to	PART
iajs-3656	33	17	control	control	VERB
iajs-3656	33	18	the	the	DET
iajs-3656	33	19	function	function	NOUN
iajs-3656	33	20	of	of	ADP
iajs-3656	33	21	islet	islet	NOUN
iajs-3656	33	22	βcells	βcell	NOUN
iajs-3656	33	23	(	(	PUNCT
iajs-3656	33	24	14	14	NUM
iajs-3656	33	25	)	)	PUNCT
iajs-3656	33	26	.	.	PUNCT
iajs-3656	34	1	as	as	SCONJ
iajs-3656	34	2	the	the	DET
iajs-3656	34	3	nervous	nervous	ADJ
iajs-3656	34	4	system	system	NOUN
iajs-3656	34	5	develops	develop	VERB
iajs-3656	34	6	,	,	PUNCT
iajs-3656	34	7	the	the	DET
iajs-3656	34	8	regulation	regulation	NOUN
iajs-3656	34	9	of	of	ADP
iajs-3656	34	10	differentiation	differentiation	NOUN
iajs-3656	34	11	and	and	CCONJ
iajs-3656	34	12	proliferation	proliferation	NOUN
iajs-3656	34	13	is	be	AUX
iajs-3656	34	14	attributed	attribute	VERB
iajs-3656	34	15	to	to	ADP
iajs-3656	34	16	the	the	DET
iajs-3656	34	17	known	know	VERB
iajs-3656	34	18	role	role	NOUN
iajs-3656	34	19	of	of	ADP
iajs-3656	34	20	plexin	plexin	ADJ
iajs-3656	34	21	domain	domain	NOUN
iajs-3656	34	22	containing	contain	VERB
iajs-3656	34	23	2	2	NUM
iajs-3656	34	24	(	(	PUNCT
iajs-3656	34	25	plxdc2	plxdc2	NOUN
iajs-3656	34	26	)	)	PUNCT
iajs-3656	34	27	.	.	PUNCT
iajs-3656	35	1	the	the	DET
iajs-3656	35	2	protein	protein	NOUN
iajs-3656	35	3	zdependent	zdependent	NOUN
iajs-3656	35	4	protease	protease	NOUN
iajs-3656	35	5	inhibitor	inhibitor	NOUN
iajs-3656	35	6	(	(	PUNCT
iajs-3656	35	7	por	por	PROPN
iajs-3656	35	8	z	z	PROPN
iajs-3656	35	9	)	)	PUNCT
iajs-3656	35	10	,	,	PUNCT
iajs-3656	35	11	a	a	DET
iajs-3656	35	12	powerful	powerful	ADJ
iajs-3656	35	13	down	down	NOUN
iajs-3656	35	14	-	-	PUNCT
iajs-3656	35	15	regulator	regulator	NOUN
iajs-3656	35	16	of	of	ADP
iajs-3656	35	17	coagulation	coagulation	NOUN
iajs-3656	35	18	factor	factor	NOUN
iajs-3656	35	19	xa	xa	PROPN
iajs-3656	35	20	,	,	PUNCT
iajs-3656	35	21	has	have	AUX
iajs-3656	35	22	recently	recently	ADV
iajs-3656	35	23	been	be	AUX
iajs-3656	35	24	demonstrated	demonstrate	VERB
iajs-3656	35	25	to	to	PART
iajs-3656	35	26	require	require	VERB
iajs-3656	35	27	por	por	PROPN
iajs-3656	35	28	z	z	NOUN
iajs-3656	35	29	as	as	ADP
iajs-3656	35	30	a	a	DET
iajs-3656	35	31	crucial	crucial	ADJ
iajs-3656	35	32	cofactor	cofactor	NOUN
iajs-3656	35	33	.	.	PUNCT
iajs-3656	36	1	consequently	consequently	ADV
iajs-3656	36	2	,	,	PUNCT
iajs-3656	36	3	it	it	PRON
iajs-3656	36	4	is	be	AUX
iajs-3656	36	5	suggested	suggest	VERB
iajs-3656	36	6	that	that	SCONJ
iajs-3656	36	7	protein	protein	NOUN
iajs-3656	36	8	z	z	NOUN
iajs-3656	36	9	deficiency	deficiency	NOUN
iajs-3656	36	10	causes	cause	VERB
iajs-3656	36	11	a	a	DET
iajs-3656	36	12	prothrombotic	prothrombotic	ADJ
iajs-3656	36	13	condition	condition	NOUN
iajs-3656	36	14	(	(	PUNCT
iajs-3656	36	15	15	15	NUM
iajs-3656	36	16	)	)	PUNCT
iajs-3656	36	17	.	.	PUNCT
iajs-3656	37	1	this	this	DET
iajs-3656	37	2	study	study	NOUN
iajs-3656	37	3	aims	aim	VERB
iajs-3656	37	4	to	to	PART
iajs-3656	37	5	investigate	investigate	VERB
iajs-3656	37	6	the	the	DET
iajs-3656	37	7	role	role	NOUN
iajs-3656	37	8	of	of	ADP
iajs-3656	37	9	lama2	lama2	PROPN
iajs-3656	37	10	,	,	PUNCT
iajs-3656	37	11	mll4	mll4	PROPN
iajs-3656	37	12	,	,	PUNCT
iajs-3656	37	13	plxdc2	plxdc2	NOUN
iajs-3656	37	14	,	,	PUNCT
iajs-3656	37	15	and	and	CCONJ
iajs-3656	37	16	porz	porz	NOUN
iajs-3656	37	17	as	as	ADP
iajs-3656	37	18	potential	potential	ADJ
iajs-3656	37	19	biomarkers	biomarker	NOUN
iajs-3656	37	20	for	for	ADP
iajs-3656	37	21	t2	t2	NOUN
iajs-3656	37	22	dm	dm	NOUN
iajs-3656	37	23	at	at	ADP
iajs-3656	37	24	different	different	ADJ
iajs-3656	37	25	durations	duration	NOUN
iajs-3656	37	26	of	of	ADP
iajs-3656	37	27	the	the	DET
iajs-3656	37	28	disease	disease	NOUN
iajs-3656	37	29	.	.	PUNCT
iajs-3656	38	1	2	2	X
iajs-3656	38	2	.	.	X
iajs-3656	38	3	materials	material	NOUN
iajs-3656	38	4	and	and	CCONJ
iajs-3656	38	5	methods	method	NOUN
iajs-3656	38	6	2.1	2.1	NUM
iajs-3656	38	7	.	.	PUNCT
iajs-3656	39	1	study	study	NOUN
iajs-3656	39	2	groups	group	NOUN
iajs-3656	39	3	the	the	DET
iajs-3656	39	4	current	current	ADJ
iajs-3656	39	5	study	study	NOUN
iajs-3656	39	6	was	be	AUX
iajs-3656	39	7	included	include	VERB
iajs-3656	39	8	100	100	NUM
iajs-3656	39	9	patients	patient	NOUN
iajs-3656	39	10	with	with	ADP
iajs-3656	39	11	t2	t2	NOUN
iajs-3656	39	12	dm	dm	NOUN
iajs-3656	39	13	that	that	PRON
iajs-3656	39	14	divided	divide	VERB
iajs-3656	39	15	to	to	ADP
iajs-3656	39	16	five	five	NUM
iajs-3656	39	17	subgroup	subgroup	NOUN
iajs-3656	39	18	gi	gi	NOUN
iajs-3656	39	19	:	:	PUNCT
iajs-3656	39	20	dm	dm	X
iajs-3656	39	21	with	with	ADP
iajs-3656	39	22	duration	duration	NOUN
iajs-3656	39	23	of	of	ADP
iajs-3656	39	24	disease	disease	NOUN
iajs-3656	39	25	less	less	ADJ
iajs-3656	39	26	than	than	ADP
iajs-3656	39	27	1	1	NUM
iajs-3656	39	28	year	year	NOUN
iajs-3656	39	29	,	,	PUNCT
iajs-3656	39	30	gii	gii	NOUN
iajs-3656	39	31	:	:	PUNCT
iajs-3656	39	32	dm	dm	NOUN
iajs-3656	39	33	with	with	ADP
iajs-3656	39	34	duration	duration	NOUN
iajs-3656	39	35	of	of	ADP
iajs-3656	39	36	disease	disease	NOUN
iajs-3656	39	37	from	from	ADP
iajs-3656	39	38	1	1	NUM
iajs-3656	39	39	-	-	SYM
iajs-3656	39	40	5	5	NUM
iajs-3656	39	41	years	year	NOUN
iajs-3656	39	42	,	,	PUNCT
iajs-3656	39	43	giii	giii	NOUN
iajs-3656	39	44	:	:	PUNCT
iajs-3656	39	45	dm	dm	NOUN
iajs-3656	39	46	with	with	ADP
iajs-3656	39	47	duration	duration	NOUN
iajs-3656	39	48	of	of	ADP
iajs-3656	39	49	disease	disease	NOUN
iajs-3656	39	50	from	from	ADP
iajs-3656	39	51	5	5	NUM
iajs-3656	39	52	-	-	SYM
iajs-3656	39	53	10	10	NUM
iajs-3656	39	54	years	year	NOUN
iajs-3656	39	55	,	,	PUNCT
iajs-3656	39	56	giv	giv	PROPN
iajs-3656	39	57	:	:	PUNCT
iajs-3656	39	58	dm	dm	NOUN
iajs-3656	39	59	with	with	ADP
iajs-3656	39	60	duration	duration	NOUN
iajs-3656	39	61	of	of	ADP
iajs-3656	39	62	disease	disease	NOUN
iajs-3656	39	63	more	more	ADJ
iajs-3656	39	64	than	than	ADP
iajs-3656	39	65	10	10	NUM
iajs-3656	39	66	years	year	NOUN
iajs-3656	39	67	,	,	PUNCT
iajs-3656	39	68	gv	gv	ADP
iajs-3656	39	69	:	:	PUNCT
iajs-3656	39	70	healthy	healthy	ADJ
iajs-3656	39	71	control	control	NOUN
iajs-3656	39	72	with	with	ADP
iajs-3656	39	73	age	age	NOUN
iajs-3656	39	74	ranging	range	VERB
iajs-3656	39	75	from	from	ADP
iajs-3656	39	76	30	30	NUM
iajs-3656	39	77	-	-	SYM
iajs-3656	39	78	65	65	NUM
iajs-3656	39	79	years	year	NOUN
iajs-3656	39	80	old	old	ADJ
iajs-3656	39	81	.	.	PUNCT
iajs-3656	40	1	the	the	DET
iajs-3656	40	2	study	study	NOUN
iajs-3656	40	3	was	be	AUX
iajs-3656	40	4	conducted	conduct	VERB
iajs-3656	40	5	at	at	ADP
iajs-3656	40	6	the	the	DET
iajs-3656	40	7	national	national	ADJ
iajs-3656	40	8	diabetes	diabetes	NOUN
iajs-3656	40	9	center	center	NOUN
iajs-3656	40	10	at	at	ADP
iajs-3656	40	11	mustansiriyah	mustansiriyah	PROPN
iajs-3656	40	12	university	university	PROPN
iajs-3656	40	13	in	in	ADP
iajs-3656	40	14	baghdad	baghdad	PROPN
iajs-3656	40	15	,	,	PUNCT
iajs-3656	40	16	iraq	iraq	PROPN
iajs-3656	40	17	,	,	PUNCT
iajs-3656	40	18	from	from	ADP
iajs-3656	40	19	january	january	PROPN
iajs-3656	40	20	to	to	ADP
iajs-3656	40	21	march	march	PROPN
iajs-3656	40	22	2022	2022	NUM
iajs-3656	40	23	,	,	PUNCT
iajs-3656	40	24	and	and	CCONJ
iajs-3656	40	25	involved	involve	VERB
iajs-3656	40	26	the	the	DET
iajs-3656	40	27	recruitment	recruitment	NOUN
iajs-3656	40	28	of	of	ADP
iajs-3656	40	29	volunteers	volunteer	NOUN
iajs-3656	40	30	.	.	PUNCT
iajs-3656	41	1	2.2	2.2	NUM
iajs-3656	41	2	.	.	PUNCT
iajs-3656	41	3	exclusion	exclusion	NOUN
iajs-3656	41	4	criteria	criterion	NOUN
iajs-3656	41	5	the	the	DET
iajs-3656	41	6	diabetic	diabetic	ADJ
iajs-3656	41	7	patients	patient	NOUN
iajs-3656	41	8	included	include	VERB
iajs-3656	41	9	in	in	ADP
iajs-3656	41	10	the	the	DET
iajs-3656	41	11	study	study	NOUN
iajs-3656	41	12	did	do	AUX
iajs-3656	41	13	not	not	PART
iajs-3656	41	14	have	have	VERB
iajs-3656	41	15	any	any	DET
iajs-3656	41	16	preexisting	preexist	VERB
iajs-3656	41	17	conditions	condition	NOUN
iajs-3656	41	18	such	such	ADJ
iajs-3656	41	19	as	as	ADP
iajs-3656	41	20	heart	heart	NOUN
iajs-3656	41	21	disease	disease	NOUN
iajs-3656	41	22	,	,	PUNCT
iajs-3656	41	23	liver	liver	NOUN
iajs-3656	41	24	disease	disease	NOUN
iajs-3656	41	25	,	,	PUNCT
iajs-3656	41	26	kidney	kidney	NOUN
iajs-3656	41	27	disease	disease	NOUN
iajs-3656	41	28	,	,	PUNCT
iajs-3656	41	29	or	or	CCONJ
iajs-3656	41	30	hypertension	hypertension	NOUN
iajs-3656	41	31	.	.	PUNCT
iajs-3656	42	1	additionally	additionally	ADV
iajs-3656	42	2	,	,	PUNCT
iajs-3656	42	3	individuals	individual	NOUN
iajs-3656	42	4	who	who	PRON
iajs-3656	42	5	were	be	AUX
iajs-3656	42	6	smokers	smoker	NOUN
iajs-3656	42	7	or	or	CCONJ
iajs-3656	42	8	had	have	VERB
iajs-3656	42	9	other	other	ADJ
iajs-3656	42	10	complications	complication	NOUN
iajs-3656	42	11	related	relate	VERB
iajs-3656	42	12	to	to	ADP
iajs-3656	42	13	diabetes	diabetes	NOUN
iajs-3656	42	14	were	be	AUX
iajs-3656	42	15	not	not	PART
iajs-3656	42	16	included	include	VERB
iajs-3656	42	17	in	in	ADP
iajs-3656	42	18	the	the	DET
iajs-3656	42	19	study	study	NOUN
iajs-3656	42	20	.	.	PUNCT
iajs-3656	43	1	healthy	healthy	ADJ
iajs-3656	43	2	individuals	individual	NOUN
iajs-3656	43	3	,	,	PUNCT
iajs-3656	43	4	without	without	ADP
iajs-3656	43	5	diabetes	diabetes	NOUN
iajs-3656	43	6	,	,	PUNCT
iajs-3656	43	7	hypertension	hypertension	NOUN
iajs-3656	43	8	,	,	PUNCT
iajs-3656	43	9	or	or	CCONJ
iajs-3656	43	10	any	any	DET
iajs-3656	43	11	other	other	ADJ
iajs-3656	43	12	acute	acute	NOUN
iajs-3656	43	13	illnesses	illness	NOUN
iajs-3656	43	14	,	,	PUNCT
iajs-3656	43	15	were	be	AUX
iajs-3656	43	16	chosen	choose	VERB
iajs-3656	43	17	as	as	ADP
iajs-3656	43	18	the	the	DET
iajs-3656	43	19	control	control	NOUN
iajs-3656	43	20	group	group	NOUN
iajs-3656	43	21	.	.	PUNCT
iajs-3656	44	1	additionally	additionally	ADV
iajs-3656	44	2	,	,	PUNCT
iajs-3656	44	3	they	they	PRON
iajs-3656	44	4	had	have	VERB
iajs-3656	44	5	no	no	DET
iajs-3656	44	6	previous	previous	ADJ
iajs-3656	44	7	history	history	NOUN
iajs-3656	44	8	of	of	ADP
iajs-3656	44	9	smoking	smoking	NOUN
iajs-3656	44	10	or	or	CCONJ
iajs-3656	44	11	drinking	drinking	NOUN
iajs-3656	44	12	alcohol	alcohol	NOUN
iajs-3656	44	13	.	.	PUNCT
iajs-3656	45	1	2.3	2.3	NUM
iajs-3656	45	2	.	.	PUNCT
iajs-3656	46	1	blood	blood	NOUN
iajs-3656	46	2	sampling	sample	VERB
iajs-3656	46	3	after	after	ADP
iajs-3656	46	4	a	a	DET
iajs-3656	46	5	10	10	NUM
iajs-3656	46	6	to	to	PART
iajs-3656	46	7	12	12	NUM
iajs-3656	46	8	-	-	PUNCT
iajs-3656	46	9	hour	hour	NOUN
iajs-3656	46	10	overnight	overnight	ADV
iajs-3656	46	11	fast	fast	ADV
iajs-3656	46	12	,	,	PUNCT
iajs-3656	46	13	each	each	DET
iajs-3656	46	14	patient	patient	NOUN
iajs-3656	46	15	and	and	CCONJ
iajs-3656	46	16	control	control	NOUN
iajs-3656	46	17	had	have	VERB
iajs-3656	46	18	their	their	PRON
iajs-3656	46	19	blood	blood	NOUN
iajs-3656	46	20	drawn	draw	VERB
iajs-3656	46	21	.	.	PUNCT
iajs-3656	47	1	the	the	DET
iajs-3656	47	2	blood	blood	NOUN
iajs-3656	47	3	sample	sample	NOUN
iajs-3656	47	4	was	be	AUX
iajs-3656	47	5	separated	separate	VERB
iajs-3656	47	6	into	into	ADP
iajs-3656	47	7	a	a	DET
iajs-3656	47	8	gel	gel	NOUN
iajs-3656	47	9	tube	tube	NOUN
iajs-3656	47	10	to	to	PART
iajs-3656	47	11	separate	separate	VERB
iajs-3656	47	12	the	the	DET
iajs-3656	47	13	serum	serum	NOUN
iajs-3656	47	14	,	,	PUNCT
iajs-3656	47	15	then	then	ADV
iajs-3656	47	16	the	the	DET
iajs-3656	47	17	serum	serum	NOUN
iajs-3656	47	18	was	be	AUX
iajs-3656	47	19	used	use	VERB
iajs-3656	47	20	to	to	PART
iajs-3656	47	21	measure	measure	VERB
iajs-3656	47	22	the	the	DET
iajs-3656	47	23	levels	level	NOUN
iajs-3656	47	24	of	of	ADP
iajs-3656	47	25	lama2	lama2	PROPN
iajs-3656	47	26	,	,	PUNCT
iajs-3656	47	27	mll4	mll4	PROPN
iajs-3656	47	28	,	,	PUNCT
iajs-3656	47	29	plxdc2	plxdc2	NOUN
iajs-3656	47	30	,	,	PUNCT
iajs-3656	47	31	and	and	CCONJ
iajs-3656	47	32	proz	proz	ADV
iajs-3656	47	33	.	.	PUNCT
iajs-3656	48	1	the	the	DET
iajs-3656	48	2	hlc-723gx	hlc-723gx	ADJ
iajs-3656	48	3	automated	automate	VERB
iajs-3656	48	4	glycohemoglobin	glycohemoglobin	PROPN
iajs-3656	48	5	analyzer	analyzer	NOUN
iajs-3656	48	6	from	from	ADP
iajs-3656	48	7	tosoh	tosoh	NOUN
iajs-3656	48	8	was	be	AUX
iajs-3656	48	9	used	use	VERB
iajs-3656	48	10	to	to	PART
iajs-3656	48	11	measure	measure	VERB
iajs-3656	48	12	glycated	glycate	VERB
iajs-3656	48	13	hemoglobin	hemoglobin	NOUN
iajs-3656	48	14	(	(	PUNCT
iajs-3656	48	15	hba1c	hba1c	PROPN
iajs-3656	48	16	)	)	PUNCT
iajs-3656	48	17	.	.	PUNCT
iajs-3656	49	1	bio	bio	PROPN
iajs-3656	49	2	system	system	PROPN
iajs-3656	49	3	spain	spain	PROPN
iajs-3656	49	4	supplied	supply	VERB
iajs-3656	49	5	kits	kit	NOUN
iajs-3656	49	6	for	for	ADP
iajs-3656	49	7	the	the	DET
iajs-3656	49	8	enzymatic	enzymatic	ADJ
iajs-3656	49	9	colorimetric	colorimetric	ADJ
iajs-3656	49	10	measurement	measurement	NOUN
iajs-3656	49	11	of	of	ADP
iajs-3656	49	12	serum	serum	NOUN
iajs-3656	49	13	fasting	fast	VERB
iajs-3656	49	14	blood	blood	NOUN
iajs-3656	49	15	glucose	glucose	NOUN
iajs-3656	49	16	(	(	PUNCT
iajs-3656	49	17	fbg	fbg	PROPN
iajs-3656	49	18	)	)	PUNCT
iajs-3656	49	19	,	,	PUNCT
iajs-3656	49	20	total	total	ADJ
iajs-3656	49	21	cholesterol	cholesterol	NOUN
iajs-3656	49	22	(	(	PUNCT
iajs-3656	49	23	tc	tc	NOUN
iajs-3656	49	24	)	)	PUNCT
iajs-3656	49	25	,	,	PUNCT
iajs-3656	49	26	triglycerides	triglyceride	NOUN
iajs-3656	49	27	(	(	PUNCT
iajs-3656	49	28	tg	tg	NOUN
iajs-3656	49	29	)	)	PUNCT
iajs-3656	49	30	,	,	PUNCT
iajs-3656	49	31	and	and	CCONJ
iajs-3656	49	32	high	high	ADJ
iajs-3656	49	33	-	-	PUNCT
iajs-3656	49	34	density	density	NOUN
iajs-3656	49	35	lipoprotein	lipoprotein	ADJ
iajs-3656	49	36	(	(	PUNCT
iajs-3656	49	37	hdl	hdl	NOUN
iajs-3656	49	38	)	)	PUNCT
iajs-3656	49	39	.	.	PUNCT
iajs-3656	50	1	lama2	lama2	NOUN
iajs-3656	50	2	and	and	CCONJ
iajs-3656	50	3	plxdc2	plxdc2	NOUN
iajs-3656	50	4	quantities	quantity	NOUN
iajs-3656	50	5	were	be	AUX
iajs-3656	50	6	assessed	assess	VERB
iajs-3656	50	7	using	use	VERB
iajs-3656	50	8	sandwich	sandwich	NOUN
iajs-3656	50	9	enzyme	enzyme	NOUN
iajs-3656	50	10	ihjpas	ihjpa	NOUN
iajs-3656	50	11	.	.	PUNCT
iajs-3656	51	1	2025	2025	NUM
iajs-3656	51	2	,	,	PUNCT
iajs-3656	51	3	38(4	38(4	NUM
iajs-3656	51	4	)	)	PUNCT
iajs-3656	51	5	232	232	NUM
iajs-3656	51	6	immunoassay	immunoassay	ADJ
iajs-3656	51	7	methods	method	NOUN
iajs-3656	51	8	with	with	ADP
iajs-3656	51	9	a	a	DET
iajs-3656	51	10	cusabio	cusabio	NOUN
iajs-3656	51	11	kit	kit	NOUN
iajs-3656	51	12	from	from	ADP
iajs-3656	51	13	the	the	DET
iajs-3656	51	14	usa	usa	PROPN
iajs-3656	51	15	.	.	PROPN
iajs-3656	51	16	serum	serum	PROPN
iajs-3656	51	17	mll4	mll4	PROPN
iajs-3656	51	18	levels	level	NOUN
iajs-3656	51	19	were	be	AUX
iajs-3656	51	20	determined	determine	VERB
iajs-3656	51	21	through	through	ADP
iajs-3656	51	22	competitive	competitive	ADJ
iajs-3656	51	23	enzyme	enzyme	NOUN
iajs-3656	51	24	immunoassay	immunoassay	ADJ
iajs-3656	51	25	techniques	technique	NOUN
iajs-3656	51	26	using	use	VERB
iajs-3656	51	27	a	a	DET
iajs-3656	51	28	kit	kit	NOUN
iajs-3656	51	29	from	from	ADP
iajs-3656	51	30	biosource	biosource	NOUN
iajs-3656	51	31	,	,	PUNCT
iajs-3656	51	32	usa	usa	PROPN
iajs-3656	51	33	,	,	PUNCT
iajs-3656	51	34	while	while	SCONJ
iajs-3656	51	35	proz	proz	ADV
iajs-3656	51	36	was	be	AUX
iajs-3656	51	37	supplied	supply	VERB
iajs-3656	51	38	from	from	ADP
iajs-3656	51	39	the	the	DET
iajs-3656	51	40	uk	uk	PROPN
iajs-3656	51	41	,	,	PUNCT
iajs-3656	51	42	houston	houston	PROPN
iajs-3656	51	43	.	.	PUNCT
iajs-3656	52	1	2.4	2.4	NUM
iajs-3656	52	2	.	.	PUNCT
iajs-3656	53	1	statistical	statistical	ADJ
iajs-3656	53	2	analysis	analysis	NOUN
iajs-3656	53	3	the	the	DET
iajs-3656	53	4	analysis	analysis	NOUN
iajs-3656	53	5	of	of	ADP
iajs-3656	53	6	the	the	DET
iajs-3656	53	7	outcomes	outcome	NOUN
iajs-3656	53	8	was	be	AUX
iajs-3656	53	9	conducted	conduct	VERB
iajs-3656	53	10	using	use	VERB
iajs-3656	53	11	the	the	DET
iajs-3656	53	12	statistical	statistical	ADJ
iajs-3656	53	13	analysis	analysis	NOUN
iajs-3656	53	14	program	program	NOUN
iajs-3656	53	15	spss	spss	PROPN
iajs-3656	53	16	25	25	NUM
iajs-3656	53	17	.	.	PUNCT
iajs-3656	54	1	the	the	DET
iajs-3656	54	2	main	main	ADJ
iajs-3656	54	3	findings	finding	NOUN
iajs-3656	54	4	were	be	AUX
iajs-3656	54	5	presented	present	VERB
iajs-3656	54	6	using	use	VERB
iajs-3656	54	7	descriptive	descriptive	ADJ
iajs-3656	54	8	statistics	statistic	NOUN
iajs-3656	54	9	,	,	PUNCT
iajs-3656	54	10	and	and	CCONJ
iajs-3656	54	11	group	group	NOUN
iajs-3656	54	12	comparisons	comparison	NOUN
iajs-3656	54	13	were	be	AUX
iajs-3656	54	14	performed	perform	VERB
iajs-3656	54	15	using	use	VERB
iajs-3656	54	16	the	the	DET
iajs-3656	54	17	one	one	NUM
iajs-3656	54	18	-	-	PUNCT
iajs-3656	54	19	way	way	NOUN
iajs-3656	54	20	anova	anova	PROPN
iajs-3656	54	21	test	test	NOUN
iajs-3656	54	22	(	(	PUNCT
iajs-3656	54	23	16	16	NUM
iajs-3656	54	24	)	)	PUNCT
iajs-3656	54	25	.	.	PUNCT
iajs-3656	55	1	3	3	X
iajs-3656	55	2	.	.	NOUN
iajs-3656	55	3	results	result	VERB
iajs-3656	55	4	some	some	DET
iajs-3656	55	5	biochemical	biochemical	ADJ
iajs-3656	55	6	characteristics	characteristic	NOUN
iajs-3656	55	7	were	be	AUX
iajs-3656	55	8	measured	measure	VERB
iajs-3656	55	9	in	in	ADP
iajs-3656	55	10	the	the	DET
iajs-3656	55	11	study	study	NOUN
iajs-3656	55	12	population	population	NOUN
iajs-3656	55	13	;	;	PUNCT
iajs-3656	55	14	the	the	DET
iajs-3656	55	15	results	result	NOUN
iajs-3656	55	16	are	be	AUX
iajs-3656	55	17	illustrated	illustrate	VERB
iajs-3656	55	18	in	in	ADP
iajs-3656	55	19	table	table	NOUN
iajs-3656	55	20	1	1	NUM
iajs-3656	55	21	.	.	PUNCT
iajs-3656	55	22	statistically	statistically	ADV
iajs-3656	55	23	significant	significant	ADJ
iajs-3656	55	24	differences	difference	NOUN
iajs-3656	55	25	appeared	appear	VERB
iajs-3656	55	26	between	between	ADP
iajs-3656	55	27	the	the	DET
iajs-3656	55	28	study	study	NOUN
iajs-3656	55	29	groups	group	NOUN
iajs-3656	55	30	,	,	PUNCT
iajs-3656	55	31	depending	depend	VERB
iajs-3656	55	32	on	on	ADP
iajs-3656	55	33	the	the	DET
iajs-3656	55	34	duration	duration	NOUN
iajs-3656	55	35	of	of	ADP
iajs-3656	55	36	the	the	DET
iajs-3656	55	37	disease	disease	NOUN
iajs-3656	55	38	,	,	PUNCT
iajs-3656	55	39	for	for	ADP
iajs-3656	55	40	all	all	DET
iajs-3656	55	41	included	include	VERB
iajs-3656	55	42	parameters	parameter	NOUN
iajs-3656	55	43	:	:	PUNCT
iajs-3656	55	44	age	age	NOUN
iajs-3656	55	45	and	and	CCONJ
iajs-3656	55	46	bmi	bmi	NOUN
iajs-3656	55	47	.	.	PUNCT
iajs-3656	56	1	also	also	ADV
iajs-3656	56	2	,	,	PUNCT
iajs-3656	56	3	the	the	DET
iajs-3656	56	4	results	result	NOUN
iajs-3656	56	5	showed	show	VERB
iajs-3656	56	6	significant	significant	ADJ
iajs-3656	56	7	differences	difference	NOUN
iajs-3656	56	8	between	between	ADP
iajs-3656	56	9	groups	group	NOUN
iajs-3656	56	10	in	in	ADP
iajs-3656	56	11	table	table	NOUN
iajs-3656	56	12	2	2	NUM
iajs-3656	56	13	for	for	ADP
iajs-3656	56	14	fsg	fsg	PROPN
iajs-3656	56	15	and	and	CCONJ
iajs-3656	56	16	hba1c	hba1c	PROPN
iajs-3656	56	17	.	.	PUNCT
iajs-3656	57	1	moreover	moreover	ADV
iajs-3656	57	2	,	,	PUNCT
iajs-3656	57	3	tc	tc	INTJ
iajs-3656	57	4	,	,	PUNCT
iajs-3656	57	5	tg	tg	PROPN
iajs-3656	57	6	,	,	PUNCT
iajs-3656	57	7	ldl	ldl	NOUN
iajs-3656	57	8	,	,	PUNCT
iajs-3656	57	9	vldl	vldl	NOUN
iajs-3656	57	10	,	,	PUNCT
iajs-3656	57	11	and	and	CCONJ
iajs-3656	57	12	aip	aip	PROPN
iajs-3656	57	13	were	be	AUX
iajs-3656	57	14	significantly	significantly	ADV
iajs-3656	57	15	elevated	elevate	VERB
iajs-3656	57	16	in	in	ADP
iajs-3656	57	17	all	all	DET
iajs-3656	57	18	dm	dm	PROPN
iajs-3656	57	19	patient	patient	ADJ
iajs-3656	57	20	groups	group	NOUN
iajs-3656	57	21	compared	compare	VERB
iajs-3656	57	22	to	to	ADP
iajs-3656	57	23	the	the	DET
iajs-3656	57	24	control	control	NOUN
iajs-3656	57	25	,	,	PUNCT
iajs-3656	57	26	as	as	SCONJ
iajs-3656	57	27	shown	show	VERB
iajs-3656	57	28	in	in	ADP
iajs-3656	57	29	table	table	NOUN
iajs-3656	57	30	3	3	NUM
iajs-3656	57	31	.	.	PUNCT
iajs-3656	58	1	also	also	ADV
iajs-3656	58	2	,	,	PUNCT
iajs-3656	58	3	all	all	DET
iajs-3656	58	4	the	the	DET
iajs-3656	58	5	parameters	parameter	NOUN
iajs-3656	58	6	showed	show	VERB
iajs-3656	58	7	significant	significant	ADJ
iajs-3656	58	8	increments	increment	NOUN
iajs-3656	58	9	between	between	ADP
iajs-3656	58	10	groups	group	NOUN
iajs-3656	58	11	of	of	ADP
iajs-3656	58	12	dms	dms	NOUN
iajs-3656	58	13	in	in	ADP
iajs-3656	58	14	different	different	ADJ
iajs-3656	58	15	durations	duration	NOUN
iajs-3656	58	16	.	.	PUNCT
iajs-3656	59	1	in	in	ADP
iajs-3656	59	2	table	table	NOUN
iajs-3656	59	3	4	4	NUM
iajs-3656	59	4	,	,	PUNCT
iajs-3656	59	5	the	the	DET
iajs-3656	59	6	results	result	NOUN
iajs-3656	59	7	revealed	reveal	VERB
iajs-3656	59	8	a	a	DET
iajs-3656	59	9	considerable	considerable	ADJ
iajs-3656	59	10	effect	effect	NOUN
iajs-3656	59	11	in	in	ADP
iajs-3656	59	12	four	four	NUM
iajs-3656	59	13	groups	group	NOUN
iajs-3656	59	14	compared	compare	VERB
iajs-3656	59	15	to	to	ADP
iajs-3656	59	16	the	the	DET
iajs-3656	59	17	control	control	NOUN
iajs-3656	59	18	in	in	ADP
iajs-3656	59	19	lama2	lama2	PROPN
iajs-3656	59	20	,	,	PUNCT
iajs-3656	59	21	mll4	mll4	PROPN
iajs-3656	59	22	,	,	PUNCT
iajs-3656	59	23	plxdc2	plxdc2	NOUN
iajs-3656	59	24	,	,	PUNCT
iajs-3656	59	25	and	and	CCONJ
iajs-3656	59	26	proz	proz	ADJ
iajs-3656	59	27	levels	level	NOUN
iajs-3656	59	28	table	table	VERB
iajs-3656	59	29	1	1	NUM
iajs-3656	59	30	.	.	PUNCT
iajs-3656	60	1	distribution	distribution	NOUN
iajs-3656	60	2	of	of	ADP
iajs-3656	60	3	mean	mean	ADJ
iajs-3656	60	4	age	age	NOUN
iajs-3656	60	5	and	and	CCONJ
iajs-3656	60	6	bmi	bmi	NOUN
iajs-3656	60	7	for	for	ADP
iajs-3656	60	8	all	all	DET
iajs-3656	60	9	studied	study	VERB
iajs-3656	60	10	groups	group	NOUN
iajs-3656	60	11	.	.	PUNCT
iajs-3656	61	1	parameter	parameter	PROPN
iajs-3656	61	2	mean±sd	mean±sd	PROPN
iajs-3656	61	3	group	group	NOUN
iajs-3656	61	4	1	1	NUM
iajs-3656	61	5	group	group	NOUN
iajs-3656	61	6	2	2	NUM
iajs-3656	61	7	group	group	NOUN
iajs-3656	61	8	3	3	NUM
iajs-3656	61	9	group	group	NOUN
iajs-3656	61	10	4	4	NUM
iajs-3656	61	11	group	group	NOUN
iajs-3656	61	12	5	5	NUM
iajs-3656	61	13	age	age	NOUN
iajs-3656	61	14	(	(	PUNCT
iajs-3656	61	15	years	year	NOUN
iajs-3656	61	16	)	)	PUNCT
iajs-3656	61	17	47.0	47.0	NUM
iajs-3656	61	18	±	±	NUM
iajs-3656	61	19	9.0	9.0	NUM
iajs-3656	61	20	a	a	DET
iajs-3656	61	21	51.0	51.0	NUM
iajs-3656	61	22	±	±	NUM
iajs-3656	61	23	6.0	6.0	NUM
iajs-3656	61	24	b	b	NOUN
iajs-3656	61	25	51.0	51.0	NUM
iajs-3656	61	26	±	±	NUM
iajs-3656	61	27	7	7	NUM
iajs-3656	61	28	.0	.0	NUM
iajs-3656	62	1	c	c	NOUN
iajs-3656	62	2	53.0	53.0	NUM
iajs-3656	62	3	±	±	NUM
iajs-3656	62	4	6.0	6.0	NUM
iajs-3656	62	5	d	d	NOUN
iajs-3656	62	6	42.0	42.0	NUM
iajs-3656	62	7	±	±	NUM
iajs-3656	62	8	9.0	9.0	NUM
iajs-3656	62	9	pvalue	pvalue	NOUN
iajs-3656	62	10	=	=	NOUN
iajs-3656	62	11	0.0001	0.0001	NUM
iajs-3656	62	12	bmi	bmi	NOUN
iajs-3656	62	13	(	(	PUNCT
iajs-3656	62	14	kg	kg	NOUN
iajs-3656	62	15	/	/	SYM
iajs-3656	62	16	m	m	VERB
iajs-3656	62	17	2	2	NUM
iajs-3656	62	18	)	)	PUNCT
iajs-3656	62	19	30.0	30.0	NUM
iajs-3656	62	20	±	±	NUM
iajs-3656	62	21	7.0	7.0	NUM
iajs-3656	62	22	a	a	DET
iajs-3656	62	23	33.40	33.40	NUM
iajs-3656	62	24	±	±	NUM
iajs-3656	62	25	5.0	5.0	NUM
iajs-3656	62	26	b	b	NOUN
iajs-3656	62	27	29.40	29.40	NUM
iajs-3656	62	28	±	±	NUM
iajs-3656	62	29	4.0	4.0	NUM
iajs-3656	62	30	c	c	NOUN
iajs-3656	62	31	29.90	29.90	NUM
iajs-3656	62	32	±	±	NUM
iajs-3656	62	33	5.90	5.90	NUM
iajs-3656	62	34	d	d	PROPN
iajs-3656	62	35	25.90	25.90	NUM
iajs-3656	62	36	±	±	NUM
iajs-3656	62	37	3.0	3.0	NUM
iajs-3656	62	38	pvalue	pvalue	NOUN
iajs-3656	62	39	=	=	NOUN
iajs-3656	62	40	0.0001	0.0001	NUM
iajs-3656	62	41	*	*	PUNCT
iajs-3656	62	42	significantly	significantly	ADV
iajs-3656	62	43	using	use	VERB
iajs-3656	62	44	oneway	oneway	PROPN
iajs-3656	62	45	-	-	PUNCT
iajs-3656	62	46	anova	anova	PROPN
iajs-3656	62	47	and	and	CCONJ
iajs-3656	62	48	at	at	ADP
iajs-3656	62	49	the	the	DET
iajs-3656	62	50	0.05	0.05	NUM
iajs-3656	62	51	level	level	NOUN
iajs-3656	62	52	,	,	PUNCT
iajs-3656	62	53	a	a	PRON
iajs-3656	62	54	)	)	PUNCT
iajs-3656	62	55	indicate	indicate	VERB
iajs-3656	62	56	significant	significant	ADJ
iajs-3656	62	57	difference	difference	NOUN
iajs-3656	62	58	between	between	ADP
iajs-3656	62	59	g5	g5	NOUN
iajs-3656	62	60	and	and	CCONJ
iajs-3656	62	61	g1	g1	NOUN
iajs-3656	62	62	,	,	PUNCT
iajs-3656	62	63	b	b	X
iajs-3656	62	64	)	)	PUNCT
iajs-3656	62	65	indicate	indicate	VERB
iajs-3656	62	66	significant	significant	ADJ
iajs-3656	62	67	difference	difference	NOUN
iajs-3656	62	68	between	between	ADP
iajs-3656	62	69	g5	g5	NOUN
iajs-3656	62	70	and	and	CCONJ
iajs-3656	62	71	g2	g2	PROPN
iajs-3656	62	72	,	,	PUNCT
iajs-3656	62	73	c	c	X
iajs-3656	62	74	)	)	PUNCT
iajs-3656	62	75	indicate	indicate	VERB
iajs-3656	62	76	significant	significant	ADJ
iajs-3656	62	77	difference	difference	NOUN
iajs-3656	62	78	between	between	ADP
iajs-3656	62	79	g5	g5	NOUN
iajs-3656	62	80	and	and	CCONJ
iajs-3656	62	81	g3	g3	NOUN
iajs-3656	62	82	,	,	PUNCT
iajs-3656	62	83	d	d	PROPN
iajs-3656	62	84	)	)	PUNCT
iajs-3656	62	85	indicate	indicate	VERB
iajs-3656	62	86	significant	significant	ADJ
iajs-3656	62	87	difference	difference	NOUN
iajs-3656	62	88	between	between	ADP
iajs-3656	62	89	g5	g5	NOUN
iajs-3656	62	90	and	and	CCONJ
iajs-3656	62	91	g4	g4	NOUN
iajs-3656	62	92	.	.	PUNCT
iajs-3656	62	93	table	table	NOUN
iajs-3656	62	94	2	2	NUM
iajs-3656	62	95	.	.	PUNCT
iajs-3656	62	96	distribution	distribution	NOUN
iajs-3656	62	97	of	of	ADP
iajs-3656	62	98	mean	mean	PROPN
iajs-3656	62	99	hba1c	hba1c	PROPN
iajs-3656	62	100	and	and	CCONJ
iajs-3656	62	101	fsg	fsg	PROPN
iajs-3656	62	102	for	for	ADP
iajs-3656	62	103	all	all	DET
iajs-3656	62	104	studied	study	VERB
iajs-3656	62	105	groups	group	NOUN
iajs-3656	62	106	.	.	PUNCT
iajs-3656	63	1	parameter	parameter	PROPN
iajs-3656	63	2	mean±sd	mean±sd	PROPN
iajs-3656	63	3	group	group	NOUN
iajs-3656	63	4	1	1	NUM
iajs-3656	63	5	group	group	NOUN
iajs-3656	63	6	2	2	NUM
iajs-3656	63	7	group	group	NOUN
iajs-3656	63	8	3	3	NUM
iajs-3656	63	9	group	group	NOUN
iajs-3656	63	10	4	4	NUM
iajs-3656	63	11	group	group	NOUN
iajs-3656	63	12	5	5	NUM
iajs-3656	63	13	hba1c	hba1c	PROPN
iajs-3656	63	14	(	(	PUNCT
iajs-3656	63	15	%	%	INTJ
iajs-3656	63	16	)	)	PUNCT
iajs-3656	63	17	9.20	9.20	NUM
iajs-3656	63	18	±	±	NUM
iajs-3656	63	19	2.40	2.40	NUM
iajs-3656	63	20	a	a	DET
iajs-3656	63	21	8.90	8.90	NUM
iajs-3656	63	22	±	±	NUM
iajs-3656	63	23	2.0	2.0	NUM
iajs-3656	63	24	b	b	SYM
iajs-3656	63	25	9.40	9.40	NUM
iajs-3656	63	26	±	±	NUM
iajs-3656	63	27	2.40	2.40	NUM
iajs-3656	63	28	c	c	PROPN
iajs-3656	63	29	8.40	8.40	NUM
iajs-3656	63	30	±	±	NUM
iajs-3656	63	31	1.80	1.80	NUM
iajs-3656	63	32	d	d	SYM
iajs-3656	63	33	5.20	5.20	NUM
iajs-3656	63	34	±	±	NOUN
iajs-3656	63	35	0.30	0.30	NUM
iajs-3656	63	36	p	p	ADJ
iajs-3656	63	37	-	-	PUNCT
iajs-3656	63	38	value	value	NOUN
iajs-3656	63	39	=	=	NOUN
iajs-3656	63	40	0.0001	0.0001	NUM
iajs-3656	63	41	fsg	fsg	NOUN
iajs-3656	63	42	(	(	PUNCT
iajs-3656	63	43	mg	mg	PROPN
iajs-3656	63	44	/	/	SYM
iajs-3656	63	45	dl	dl	NOUN
iajs-3656	63	46	)	)	PUNCT
iajs-3656	63	47	303.0	303.0	NUM
iajs-3656	63	48	±	±	NOUN
iajs-3656	63	49	00.40	00.40	NUM
iajs-3656	63	50	a	a	DET
iajs-3656	63	51	307.60	307.60	NUM
iajs-3656	63	52	±	±	NUM
iajs-3656	63	53	8.90	8.90	NUM
iajs-3656	63	54	b	b	PROPN
iajs-3656	63	55	208.20	208.20	NUM
iajs-3656	63	56	±	±	NOUN
iajs-3656	63	57	7.29	7.29	NUM
iajs-3656	63	58	c	c	NOUN
iajs-3656	63	59	088.80	088.80	NUM
iajs-3656	63	60	±	±	NUM
iajs-3656	63	61	5.44	5.44	NUM
iajs-3656	63	62	d	d	NOUN
iajs-3656	63	63	88.10	88.10	NUM
iajs-3656	63	64	±	±	NUM
iajs-3656	63	65	6.30	6.30	NUM
iajs-3656	63	66	p	p	NOUN
iajs-3656	63	67	-	-	PUNCT
iajs-3656	63	68	value	value	NOUN
iajs-3656	63	69	=	=	NOUN
iajs-3656	63	70	0.0001	0.0001	NUM
iajs-3656	63	71	*	*	PUNCT
iajs-3656	63	72	significantly	significantly	ADV
iajs-3656	63	73	using	use	VERB
iajs-3656	63	74	oneway	oneway	PROPN
iajs-3656	63	75	-	-	PUNCT
iajs-3656	63	76	anova	anova	PROPN
iajs-3656	63	77	and	and	CCONJ
iajs-3656	63	78	at	at	ADP
iajs-3656	63	79	the	the	DET
iajs-3656	63	80	0.05	0.05	NUM
iajs-3656	63	81	level	level	NOUN
iajs-3656	63	82	,	,	PUNCT
iajs-3656	63	83	a	a	PRON
iajs-3656	63	84	)	)	PUNCT
iajs-3656	63	85	indicate	indicate	VERB
iajs-3656	63	86	significant	significant	ADJ
iajs-3656	63	87	difference	difference	NOUN
iajs-3656	63	88	between	between	ADP
iajs-3656	63	89	g5	g5	NOUN
iajs-3656	63	90	and	and	CCONJ
iajs-3656	63	91	g1	g1	NOUN
iajs-3656	63	92	,	,	PUNCT
iajs-3656	63	93	b	b	X
iajs-3656	63	94	)	)	PUNCT
iajs-3656	63	95	indicate	indicate	VERB
iajs-3656	63	96	significant	significant	ADJ
iajs-3656	63	97	difference	difference	NOUN
iajs-3656	63	98	between	between	ADP
iajs-3656	63	99	g5	g5	NOUN
iajs-3656	63	100	and	and	CCONJ
iajs-3656	63	101	g2	g2	PROPN
iajs-3656	63	102	,	,	PUNCT
iajs-3656	64	1	c	c	X
iajs-3656	64	2	)	)	PUNCT
iajs-3656	64	3	indicate	indicate	VERB
iajs-3656	64	4	significant	significant	ADJ
iajs-3656	64	5	difference	difference	NOUN
iajs-3656	64	6	between	between	ADP
iajs-3656	64	7	g5	g5	NOUN
iajs-3656	64	8	and	and	CCONJ
iajs-3656	64	9	g3	g3	NOUN
iajs-3656	64	10	,	,	PUNCT
iajs-3656	64	11	d	d	PROPN
iajs-3656	64	12	)	)	PUNCT
iajs-3656	64	13	indicate	indicate	VERB
iajs-3656	64	14	significant	significant	ADJ
iajs-3656	64	15	difference	difference	NOUN
iajs-3656	64	16	between	between	ADP
iajs-3656	64	17	g5	g5	NOUN
iajs-3656	64	18	and	and	CCONJ
iajs-3656	64	19	g4	g4	NOUN
iajs-3656	64	20	.	.	PUNCT
iajs-3656	65	1	ihjpas	ihjpas	PROPN
iajs-3656	65	2	.	.	PUNCT
iajs-3656	66	1	2025	2025	NUM
iajs-3656	66	2	,	,	PUNCT
iajs-3656	66	3	38(4	38(4	NUM
iajs-3656	66	4	)	)	PUNCT
iajs-3656	66	5	233	233	NUM
iajs-3656	66	6	table	table	NOUN
iajs-3656	66	7	3	3	NUM
iajs-3656	66	8	.	.	PUNCT
iajs-3656	66	9	distribution	distribution	NOUN
iajs-3656	66	10	of	of	ADP
iajs-3656	66	11	mean	mean	ADJ
iajs-3656	66	12	lipid	lipid	NOUN
iajs-3656	66	13	profile	profile	NOUN
iajs-3656	66	14	for	for	ADP
iajs-3656	66	15	all	all	DET
iajs-3656	66	16	studied	study	VERB
iajs-3656	66	17	groups	group	NOUN
iajs-3656	66	18	.	.	PUNCT
iajs-3656	67	1	parameter	parameter	PROPN
iajs-3656	67	2	mean±sd	mean±sd	PROPN
iajs-3656	67	3	group	group	NOUN
iajs-3656	67	4	1	1	NUM
iajs-3656	67	5	group	group	NOUN
iajs-3656	67	6	2	2	NUM
iajs-3656	67	7	group	group	NOUN
iajs-3656	67	8	3	3	NUM
iajs-3656	67	9	group	group	NOUN
iajs-3656	67	10	4	4	NUM
iajs-3656	67	11	group	group	NOUN
iajs-3656	67	12	5	5	NUM
iajs-3656	67	13	cholesterol	cholesterol	NOUN
iajs-3656	67	14	(	(	PUNCT
iajs-3656	67	15	mg	mg	PROPN
iajs-3656	67	16	/	/	SYM
iajs-3656	67	17	dl	dl	NOUN
iajs-3656	67	18	)	)	PUNCT
iajs-3656	67	19	198.0	198.0	NUM
iajs-3656	67	20	±	±	NUM
iajs-3656	67	21	4.70	4.70	NUM
iajs-3656	67	22	a	a	DET
iajs-3656	67	23	189.0	189.0	NUM
iajs-3656	67	24	±	±	NUM
iajs-3656	67	25	5.70	5.70	NUM
iajs-3656	67	26	b	b	NOUN
iajs-3656	67	27	213.0	213.0	NUM
iajs-3656	67	28	±	±	NUM
iajs-3656	67	29	6.30	6.30	NUM
iajs-3656	67	30	c	c	PROPN
iajs-3656	67	31	207.0	207.0	NUM
iajs-3656	67	32	±	±	NUM
iajs-3656	67	33	4.60	4.60	NUM
iajs-3656	67	34	d	d	NUM
iajs-3656	67	35	124.0	124.0	NUM
iajs-3656	67	36	±	±	NUM
iajs-3656	67	37	3.30	3.30	NUM
iajs-3656	67	38	p	p	NOUN
iajs-3656	67	39	-	-	PUNCT
iajs-3656	67	40	value	value	NOUN
iajs-3656	67	41	=	=	SYM
iajs-3656	67	42	0.001	0.001	NUM
iajs-3656	67	43	tg	tg	PROPN
iajs-3656	67	44	(	(	PUNCT
iajs-3656	67	45	mg	mg	PROPN
iajs-3656	67	46	/	/	SYM
iajs-3656	67	47	dl	dl	NOUN
iajs-3656	67	48	)	)	PUNCT
iajs-3656	67	49	157.0	157.0	NUM
iajs-3656	67	50	±	±	NUM
iajs-3656	67	51	6.90	6.90	NUM
iajs-3656	67	52	a	a	DET
iajs-3656	67	53	176.50	176.50	NUM
iajs-3656	67	54	±	±	NUM
iajs-3656	67	55	7.90	7.90	NUM
iajs-3656	67	56	b	b	NOUN
iajs-3656	67	57	167.6±57	167.6±57	NUM
iajs-3656	67	58	c	c	NOUN
iajs-3656	67	59	165.30	165.30	NUM
iajs-3656	67	60	±	±	NUM
iajs-3656	67	61	6.70	6.70	NUM
iajs-3656	67	62	d	d	PROPN
iajs-3656	67	63	95.60	95.60	NUM
iajs-3656	67	64	±	±	NUM
iajs-3656	67	65	2.30	2.30	NUM
iajs-3656	67	66	p	p	NOUN
iajs-3656	67	67	-	-	PUNCT
iajs-3656	67	68	value	value	NOUN
iajs-3656	67	69	=	=	SYM
iajs-3656	67	70	0.001	0.001	NUM
iajs-3656	67	71	ldl	ldl	NOUN
iajs-3656	67	72	(	(	PUNCT
iajs-3656	67	73	mg	mg	PROPN
iajs-3656	67	74	/	/	SYM
iajs-3656	67	75	dl	dl	NOUN
iajs-3656	67	76	)	)	PUNCT
iajs-3656	67	77	111.70	111.70	NUM
iajs-3656	67	78	±	±	NUM
iajs-3656	67	79	5.30	5.30	NUM
iajs-3656	67	80	a	a	DET
iajs-3656	67	81	116.20	116.20	NUM
iajs-3656	67	82	±	±	NUM
iajs-3656	67	83	5.70	5.70	NUM
iajs-3656	67	84	b	b	NOUN
iajs-3656	67	85	134.8±	134.8±	NUM
iajs-3656	67	86	67	67	NUM
iajs-3656	67	87	c	c	PROPN
iajs-3656	67	88	132.60	132.60	NUM
iajs-3656	67	89	±	±	NUM
iajs-3656	67	90	4.0	4.0	NUM
iajs-3656	67	91	d	d	SYM
iajs-3656	67	92	50.20	50.20	NUM
iajs-3656	67	93	±	±	NUM
iajs-3656	67	94	1.90	1.90	NUM
iajs-3656	67	95	p	p	NOUN
iajs-3656	67	96	-	-	PUNCT
iajs-3656	67	97	value	value	NOUN
iajs-3656	67	98	=	=	SYM
iajs-3656	67	99	0.001	0.001	NUM
iajs-3656	67	100	hdl	hdl	NOUN
iajs-3656	67	101	(	(	PUNCT
iajs-3656	67	102	mg	mg	PROPN
iajs-3656	67	103	/	/	SYM
iajs-3656	67	104	dl	dl	PROPN
iajs-3656	67	105	)	)	PUNCT
iajs-3656	67	106	49.60	49.60	NUM
iajs-3656	67	107	±	±	NUM
iajs-3656	67	108	16.0	16.0	NUM
iajs-3656	67	109	a	a	DET
iajs-3656	67	110	41.80	41.80	NUM
iajs-3656	67	111	±	±	NUM
iajs-3656	67	112	16.0	16.0	NUM
iajs-3656	67	113	b	b	NOUN
iajs-3656	67	114	53.3±	53.3±	NUM
iajs-3656	67	115	31	31	NUM
iajs-3656	67	116	c	c	NOUN
iajs-3656	67	117	39.30	39.30	NUM
iajs-3656	67	118	±	±	NOUN
iajs-3656	67	119	9.0	9.0	NUM
iajs-3656	67	120	d	d	SYM
iajs-3656	67	121	51.90	51.90	NUM
iajs-3656	67	122	±	±	NUM
iajs-3656	67	123	1.0	1.0	NUM
iajs-3656	67	124	p	p	NOUN
iajs-3656	67	125	-	-	PUNCT
iajs-3656	67	126	value	value	NOUN
iajs-3656	67	127	=	=	NOUN
iajs-3656	67	128	0.05	0.05	NUM
iajs-3656	67	129	vldl	vldl	NOUN
iajs-3656	67	130	(	(	PUNCT
iajs-3656	67	131	mg	mg	PROPN
iajs-3656	67	132	/	/	SYM
iajs-3656	67	133	dl	dl	NOUN
iajs-3656	67	134	)	)	PUNCT
iajs-3656	67	135	32.0	32.0	NUM
iajs-3656	67	136	±	±	NOUN
iajs-3656	67	137	14.0	14.0	NUM
iajs-3656	67	138	a	a	DET
iajs-3656	67	139	36.10	36.10	NUM
iajs-3656	67	140	±	±	NUM
iajs-3656	67	141	16.0	16.0	NUM
iajs-3656	67	142	b	b	PROPN
iajs-3656	67	143	33.40	33.40	NUM
iajs-3656	67	144	±	±	NUM
iajs-3656	67	145	11.0	11.0	NUM
iajs-3656	67	146	c	c	NOUN
iajs-3656	67	147	33.0	33.0	NUM
iajs-3656	67	148	±	±	NUM
iajs-3656	67	149	13.0	13.0	NUM
iajs-3656	67	150	d	d	PROPN
iajs-3656	67	151	19.90	19.90	NUM
iajs-3656	67	152	±	±	NUM
iajs-3656	67	153	4.70	4.70	NUM
iajs-3656	67	154	p	p	NOUN
iajs-3656	67	155	-	-	PUNCT
iajs-3656	67	156	value	value	NOUN
iajs-3656	67	157	=	=	SYM
iajs-3656	67	158	0.001	0.001	NUM
iajs-3656	67	159	aip	aip	PROPN
iajs-3656	67	160	0.49	0.49	NUM
iajs-3656	67	161	±	±	NUM
iajs-3656	67	162	0.20	0.20	NUM
iajs-3656	67	163	a	a	DET
iajs-3656	67	164	0.60	0.60	NUM
iajs-3656	67	165	±	±	NUM
iajs-3656	67	166	0.20	0.20	NUM
iajs-3656	67	167	b	b	PROPN
iajs-3656	67	168	0.52	0.52	NUM
iajs-3656	67	169	±	±	NUM
iajs-3656	67	170	0.20	0.20	NUM
iajs-3656	67	171	c	c	PROPN
iajs-3656	67	172	0.59	0.59	NUM
iajs-3656	67	173	±	±	NUM
iajs-3656	67	174	0.22	0.22	NUM
iajs-3656	67	175	d	d	NOUN
iajs-3656	67	176	0.28	0.28	NUM
iajs-3656	67	177	±	±	NUM
iajs-3656	67	178	0.04	0.04	NUM
iajs-3656	67	179	p	p	NOUN
iajs-3656	67	180	-	-	PUNCT
iajs-3656	67	181	value	value	NOUN
iajs-3656	67	182	=	=	NOUN
iajs-3656	67	183	0.003	0.003	NUM
iajs-3656	67	184	*	*	PUNCT
iajs-3656	67	185	significantly	significantly	ADV
iajs-3656	67	186	using	use	VERB
iajs-3656	67	187	oneway	oneway	PROPN
iajs-3656	67	188	-	-	PUNCT
iajs-3656	67	189	anova	anova	PROPN
iajs-3656	67	190	and	and	CCONJ
iajs-3656	67	191	at	at	ADP
iajs-3656	67	192	the	the	DET
iajs-3656	67	193	0.05	0.05	NUM
iajs-3656	67	194	level	level	NOUN
iajs-3656	67	195	,	,	PUNCT
iajs-3656	67	196	a	a	PRON
iajs-3656	67	197	)	)	PUNCT
iajs-3656	67	198	indicate	indicate	VERB
iajs-3656	67	199	significant	significant	ADJ
iajs-3656	67	200	difference	difference	NOUN
iajs-3656	67	201	between	between	ADP
iajs-3656	67	202	g5	g5	NOUN
iajs-3656	67	203	and	and	CCONJ
iajs-3656	67	204	g1	g1	NOUN
iajs-3656	67	205	,	,	PUNCT
iajs-3656	67	206	b	b	X
iajs-3656	67	207	)	)	PUNCT
iajs-3656	67	208	indicate	indicate	VERB
iajs-3656	67	209	significant	significant	ADJ
iajs-3656	67	210	difference	difference	NOUN
iajs-3656	67	211	between	between	ADP
iajs-3656	67	212	g5	g5	NOUN
iajs-3656	67	213	and	and	CCONJ
iajs-3656	67	214	g2	g2	PROPN
iajs-3656	67	215	,	,	PUNCT
iajs-3656	67	216	c	c	X
iajs-3656	67	217	)	)	PUNCT
iajs-3656	67	218	indicate	indicate	VERB
iajs-3656	67	219	significant	significant	ADJ
iajs-3656	67	220	difference	difference	NOUN
iajs-3656	67	221	between	between	ADP
iajs-3656	67	222	g5	g5	NOUN
iajs-3656	67	223	and	and	CCONJ
iajs-3656	67	224	g3	g3	NOUN
iajs-3656	67	225	,	,	PUNCT
iajs-3656	67	226	d	d	PROPN
iajs-3656	67	227	)	)	PUNCT
iajs-3656	67	228	indicate	indicate	VERB
iajs-3656	67	229	significant	significant	ADJ
iajs-3656	67	230	difference	difference	NOUN
iajs-3656	67	231	between	between	ADP
iajs-3656	67	232	g5	g5	NOUN
iajs-3656	67	233	and	and	CCONJ
iajs-3656	67	234	g4	g4	NOUN
iajs-3656	67	235	.	.	PUNCT
iajs-3656	67	236	table	table	NOUN
iajs-3656	67	237	4	4	NUM
iajs-3656	67	238	.	.	PUNCT
iajs-3656	67	239	distribution	distribution	NOUN
iajs-3656	67	240	of	of	ADP
iajs-3656	67	241	mean	mean	PROPN
iajs-3656	67	242	lama	lama	PROPN
iajs-3656	67	243	,	,	PUNCT
iajs-3656	67	244	mll4	mll4	PROPN
iajs-3656	67	245	,	,	PUNCT
iajs-3656	67	246	plxdc2	plxdc2	NOUN
iajs-3656	67	247	,	,	PUNCT
iajs-3656	67	248	and	and	CCONJ
iajs-3656	67	249	proz	proz	ADV
iajs-3656	67	250	for	for	ADP
iajs-3656	67	251	all	all	DET
iajs-3656	67	252	studied	study	VERB
iajs-3656	67	253	groups	group	NOUN
iajs-3656	67	254	.	.	PUNCT
iajs-3656	68	1	*	*	PUNCT
iajs-3656	68	2	significant	significant	ADJ
iajs-3656	68	3	using	use	VERB
iajs-3656	68	4	oneway	oneway	PROPN
iajs-3656	68	5	-	-	PUNCT
iajs-3656	68	6	anova	anova	PROPN
iajs-3656	68	7	and	and	CCONJ
iajs-3656	68	8	at	at	ADP
iajs-3656	68	9	0.05	0.05	NUM
iajs-3656	68	10	level	level	NOUN
iajs-3656	68	11	,	,	PUNCT
iajs-3656	68	12	a	a	PRON
iajs-3656	68	13	)	)	PUNCT
iajs-3656	68	14	indicate	indicate	VERB
iajs-3656	68	15	significant	significant	ADJ
iajs-3656	68	16	difference	difference	NOUN
iajs-3656	68	17	between	between	ADP
iajs-3656	68	18	g5	g5	NOUN
iajs-3656	68	19	and	and	CCONJ
iajs-3656	68	20	g1	g1	NOUN
iajs-3656	68	21	,	,	PUNCT
iajs-3656	68	22	b	b	X
iajs-3656	68	23	)	)	PUNCT
iajs-3656	68	24	indicate	indicate	VERB
iajs-3656	68	25	significant	significant	ADJ
iajs-3656	68	26	difference	difference	NOUN
iajs-3656	68	27	between	between	ADP
iajs-3656	68	28	g5	g5	NOUN
iajs-3656	68	29	and	and	CCONJ
iajs-3656	68	30	g2	g2	PROPN
iajs-3656	68	31	,	,	PUNCT
iajs-3656	68	32	c	c	X
iajs-3656	68	33	)	)	PUNCT
iajs-3656	68	34	indicate	indicate	VERB
iajs-3656	68	35	significant	significant	ADJ
iajs-3656	68	36	difference	difference	NOUN
iajs-3656	68	37	between	between	ADP
iajs-3656	68	38	g5	g5	NOUN
iajs-3656	68	39	and	and	CCONJ
iajs-3656	68	40	g3	g3	NOUN
iajs-3656	68	41	,	,	PUNCT
iajs-3656	68	42	d	d	PROPN
iajs-3656	68	43	)	)	PUNCT
iajs-3656	68	44	indicate	indicate	VERB
iajs-3656	68	45	significant	significant	ADJ
iajs-3656	68	46	difference	difference	NOUN
iajs-3656	68	47	between	between	ADP
iajs-3656	68	48	g5	g5	NOUN
iajs-3656	68	49	and	and	CCONJ
iajs-3656	68	50	g4	g4	NOUN
iajs-3656	68	51	.	.	PUNCT
iajs-3656	69	1	4	4	X
iajs-3656	69	2	.	.	X
iajs-3656	69	3	discussion	discussion	VERB
iajs-3656	69	4	the	the	DET
iajs-3656	69	5	duration	duration	NOUN
iajs-3656	69	6	of	of	ADP
iajs-3656	69	7	t2	t2	NOUN
iajs-3656	69	8	dm	dm	PROPN
iajs-3656	69	9	can	can	AUX
iajs-3656	69	10	significantly	significantly	ADV
iajs-3656	69	11	impact	impact	VERB
iajs-3656	69	12	various	various	ADJ
iajs-3656	69	13	factors	factor	NOUN
iajs-3656	69	14	,	,	PUNCT
iajs-3656	69	15	such	such	ADJ
iajs-3656	69	16	as	as	ADP
iajs-3656	69	17	fsg	fsg	PROPN
iajs-3656	69	18	,	,	PUNCT
iajs-3656	69	19	hba1c	hba1c	PROPN
iajs-3656	69	20	,	,	PUNCT
iajs-3656	69	21	and	and	CCONJ
iajs-3656	69	22	lipid	lipid	NOUN
iajs-3656	69	23	profile	profile	NOUN
iajs-3656	69	24	.	.	PUNCT
iajs-3656	70	1	studies	study	NOUN
iajs-3656	70	2	have	have	AUX
iajs-3656	70	3	shown	show	VERB
iajs-3656	70	4	that	that	SCONJ
iajs-3656	70	5	as	as	ADP
iajs-3656	70	6	the	the	DET
iajs-3656	70	7	duration	duration	NOUN
iajs-3656	70	8	of	of	ADP
iajs-3656	70	9	t2	t2	NOUN
iajs-3656	70	10	dm	dm	NOUN
iajs-3656	70	11	increases	increase	NOUN
iajs-3656	70	12	,	,	PUNCT
iajs-3656	70	13	there	there	PRON
iajs-3656	70	14	is	be	VERB
iajs-3656	70	15	a	a	DET
iajs-3656	70	16	gradual	gradual	ADJ
iajs-3656	70	17	deterioration	deterioration	NOUN
iajs-3656	70	18	in	in	ADP
iajs-3656	70	19	glycemic	glycemic	ADJ
iajs-3656	70	20	control	control	NOUN
iajs-3656	70	21	,	,	PUNCT
iajs-3656	70	22	as	as	SCONJ
iajs-3656	70	23	evidenced	evidence	VERB
iajs-3656	70	24	by	by	ADP
iajs-3656	70	25	higher	high	ADJ
iajs-3656	70	26	levels	level	NOUN
iajs-3656	70	27	of	of	ADP
iajs-3656	70	28	fsg	fsg	PROPN
iajs-3656	70	29	and	and	CCONJ
iajs-3656	70	30	hba1c	hba1c	PROPN
iajs-3656	70	31	.	.	PUNCT
iajs-3656	71	1	a	a	DET
iajs-3656	71	2	study	study	NOUN
iajs-3656	71	3	(	(	PUNCT
iajs-3656	71	4	17	17	NUM
iajs-3656	71	5	-	-	SYM
iajs-3656	71	6	20	20	NUM
iajs-3656	71	7	)	)	PUNCT
iajs-3656	71	8	observed	observe	VERB
iajs-3656	71	9	that	that	SCONJ
iajs-3656	71	10	individuals	individual	NOUN
iajs-3656	71	11	with	with	ADP
iajs-3656	71	12	longer	long	ADJ
iajs-3656	71	13	dm	dm	PROPN
iajs-3656	71	14	durations	duration	NOUN
iajs-3656	71	15	had	have	AUX
iajs-3656	71	16	elevated	elevate	VERB
iajs-3656	71	17	hba1c	hba1c	ADJ
iajs-3656	71	18	levels	level	NOUN
iajs-3656	71	19	,	,	PUNCT
iajs-3656	71	20	indicating	indicate	VERB
iajs-3656	71	21	poorer	poor	ADJ
iajs-3656	71	22	long	long	ADJ
iajs-3656	71	23	-	-	PUNCT
iajs-3656	71	24	term	term	NOUN
iajs-3656	71	25	glucose	glucose	NOUN
iajs-3656	71	26	management	management	NOUN
iajs-3656	71	27	(	(	PUNCT
iajs-3656	71	28	21	21	NUM
iajs-3656	71	29	,	,	PUNCT
iajs-3656	71	30	22	22	NUM
iajs-3656	71	31	)	)	PUNCT
iajs-3656	71	32	.	.	PUNCT
iajs-3656	72	1	this	this	DET
iajs-3656	72	2	finding	finding	NOUN
iajs-3656	72	3	aligns	align	VERB
iajs-3656	72	4	with	with	ADP
iajs-3656	72	5	the	the	DET
iajs-3656	72	6	results	result	NOUN
iajs-3656	72	7	presented	present	VERB
iajs-3656	72	8	in	in	ADP
iajs-3656	72	9	table	table	NOUN
iajs-3656	72	10	2	2	NUM
iajs-3656	72	11	.	.	PUNCT
iajs-3656	73	1	moreover	moreover	ADV
iajs-3656	73	2	,	,	PUNCT
iajs-3656	73	3	as	as	SCONJ
iajs-3656	73	4	shown	show	VERB
iajs-3656	73	5	in	in	ADP
iajs-3656	73	6	table	table	NOUN
iajs-3656	73	7	3	3	NUM
iajs-3656	73	8	,	,	PUNCT
iajs-3656	73	9	statistically	statistically	ADV
iajs-3656	73	10	significant	significant	ADJ
iajs-3656	73	11	differences	difference	NOUN
iajs-3656	73	12	were	be	AUX
iajs-3656	73	13	found	find	VERB
iajs-3656	73	14	between	between	ADP
iajs-3656	73	15	the	the	DET
iajs-3656	73	16	study	study	NOUN
iajs-3656	73	17	groups	group	NOUN
iajs-3656	73	18	,	,	PUNCT
iajs-3656	73	19	depending	depend	VERB
iajs-3656	73	20	on	on	ADP
iajs-3656	73	21	the	the	DET
iajs-3656	73	22	duration	duration	NOUN
iajs-3656	73	23	of	of	ADP
iajs-3656	73	24	the	the	DET
iajs-3656	73	25	disease	disease	NOUN
iajs-3656	73	26	,	,	PUNCT
iajs-3656	73	27	as	as	ADV
iajs-3656	73	28	well	well	ADV
iajs-3656	73	29	as	as	ADP
iajs-3656	73	30	between	between	ADP
iajs-3656	73	31	healthy	healthy	ADJ
iajs-3656	73	32	controls	control	NOUN
iajs-3656	73	33	and	and	CCONJ
iajs-3656	73	34	the	the	DET
iajs-3656	73	35	other	other	ADJ
iajs-3656	73	36	groups	group	NOUN
iajs-3656	73	37	.	.	PUNCT
iajs-3656	74	1	furthermore	furthermore	ADV
iajs-3656	74	2	,	,	PUNCT
iajs-3656	74	3	an	an	DET
iajs-3656	74	4	extended	extended	ADJ
iajs-3656	74	5	duration	duration	NOUN
iajs-3656	74	6	of	of	ADP
iajs-3656	74	7	t2	t2	NOUN
iajs-3656	74	8	dm	dm	PROPN
iajs-3656	74	9	has	have	AUX
iajs-3656	74	10	been	be	AUX
iajs-3656	74	11	associated	associate	VERB
iajs-3656	74	12	with	with	ADP
iajs-3656	74	13	dyslipidemia	dyslipidemia	NOUN
iajs-3656	74	14	,	,	PUNCT
iajs-3656	74	15	characterized	characterize	VERB
iajs-3656	74	16	by	by	ADP
iajs-3656	74	17	increased	increase	VERB
iajs-3656	74	18	levels	level	NOUN
iajs-3656	74	19	of	of	ADP
iajs-3656	74	20	tc	tc	NOUN
iajs-3656	74	21	,	,	PUNCT
iajs-3656	74	22	ldl	ldl	NOUN
iajs-3656	74	23	,	,	PUNCT
iajs-3656	74	24	and	and	CCONJ
iajs-3656	74	25	tg	tg	PROPN
iajs-3656	74	26	,	,	PUNCT
iajs-3656	74	27	alongside	alongside	SCONJ
iajs-3656	74	28	decreased	decrease	VERB
iajs-3656	74	29	hdl	hdl	PROPN
iajs-3656	74	30	cholesterol	cholesterol	PROPN
iajs-3656	74	31	levels	level	NOUN
iajs-3656	74	32	;	;	PUNCT
iajs-3656	74	33	tg	tg	PROPN
iajs-3656	74	34	levels	level	NOUN
iajs-3656	74	35	increased	increase	VERB
iajs-3656	74	36	,	,	PUNCT
iajs-3656	74	37	and	and	CCONJ
iajs-3656	74	38	glucose	glucose	NOUN
iajs-3656	74	39	metabolism	metabolism	NOUN
iajs-3656	74	40	was	be	AUX
iajs-3656	74	41	impaired	impaired	ADJ
iajs-3656	74	42	.	.	PUNCT
iajs-3656	75	1	even	even	ADV
iajs-3656	75	2	if	if	SCONJ
iajs-3656	75	3	the	the	DET
iajs-3656	75	4	effects	effect	NOUN
iajs-3656	75	5	of	of	ADP
iajs-3656	75	6	weight	weight	NOUN
iajs-3656	75	7	gain	gain	NOUN
iajs-3656	75	8	are	be	AUX
iajs-3656	75	9	kept	keep	VERB
iajs-3656	75	10	under	under	ADP
iajs-3656	75	11	control	control	NOUN
iajs-3656	75	12	,	,	PUNCT
iajs-3656	75	13	abnormalities	abnormality	NOUN
iajs-3656	75	14	in	in	ADP
iajs-3656	75	15	glucose	glucose	NOUN
iajs-3656	75	16	metabolism	metabolism	NOUN
iajs-3656	75	17	,	,	PUNCT
iajs-3656	75	18	along	along	ADP
iajs-3656	75	19	with	with	ADP
iajs-3656	75	20	those	those	PRON
iajs-3656	75	21	of	of	ADP
iajs-3656	75	22	glucose	glucose	NOUN
iajs-3656	75	23	and	and	CCONJ
iajs-3656	75	24	hba1c	hba1c	PROPN
iajs-3656	75	25	,	,	PUNCT
iajs-3656	75	26	persist	persist	VERB
iajs-3656	75	27	(	(	PUNCT
iajs-3656	75	28	2326	2326	NUM
iajs-3656	75	29	)	)	PUNCT
iajs-3656	75	30	.	.	PUNCT
iajs-3656	76	1	additionally	additionally	ADV
iajs-3656	76	2	,	,	PUNCT
iajs-3656	76	3	while	while	SCONJ
iajs-3656	76	4	the	the	DET
iajs-3656	76	5	rise	rise	NOUN
iajs-3656	76	6	in	in	ADP
iajs-3656	76	7	ldl	ldl	NOUN
iajs-3656	76	8	-	-	PUNCT
iajs-3656	76	9	c	c	NOUN
iajs-3656	76	10	levels	level	NOUN
iajs-3656	76	11	vanished	vanish	VERB
iajs-3656	76	12	,	,	PUNCT
iajs-3656	76	13	the	the	DET
iajs-3656	76	14	increase	increase	NOUN
iajs-3656	76	15	in	in	ADP
iajs-3656	76	16	serum	serum	NOUN
iajs-3656	76	17	tg	tg	PROPN
iajs-3656	76	18	levels	level	NOUN
iajs-3656	76	19	in	in	ADP
iajs-3656	76	20	diabetic	diabetic	ADJ
iajs-3656	76	21	patients	patient	NOUN
iajs-3656	76	22	persisted	persist	VERB
iajs-3656	76	23	.	.	PUNCT
iajs-3656	77	1	even	even	ADV
iajs-3656	77	2	if	if	SCONJ
iajs-3656	77	3	there	there	PRON
iajs-3656	77	4	was	be	VERB
iajs-3656	77	5	n't	not	PART
iajs-3656	77	6	much	much	ADJ
iajs-3656	77	7	physical	physical	ADJ
iajs-3656	77	8	activity	activity	NOUN
iajs-3656	77	9	throughout	throughout	ADP
iajs-3656	77	10	the	the	DET
iajs-3656	77	11	epidemic	epidemic	NOUN
iajs-3656	77	12	,	,	PUNCT
iajs-3656	77	13	diabetic	diabetic	ADJ
iajs-3656	77	14	patients	patient	NOUN
iajs-3656	77	15	may	may	AUX
iajs-3656	77	16	find	find	VERB
iajs-3656	77	17	it	it	PRON
iajs-3656	77	18	difficult	difficult	ADJ
iajs-3656	77	19	to	to	PART
iajs-3656	77	20	concentrate	concentrate	VERB
iajs-3656	77	21	because	because	SCONJ
iajs-3656	77	22	of	of	ADP
iajs-3656	77	23	their	their	PRON
iajs-3656	77	24	impaired	impaired	ADJ
iajs-3656	77	25	parameter	parameter	NOUN
iajs-3656	77	26	mean±sd	mean±sd	ADP
iajs-3656	77	27	group1	group1	PROPN
iajs-3656	77	28	group2	group2	PROPN
iajs-3656	77	29	group	group	NOUN
iajs-3656	77	30	3	3	NUM
iajs-3656	77	31	group	group	NOUN
iajs-3656	77	32	4	4	NUM
iajs-3656	77	33	group	group	NOUN
iajs-3656	77	34	5	5	NUM
iajs-3656	77	35	lama4	lama4	NOUN
iajs-3656	77	36	(	(	PUNCT
iajs-3656	77	37	ng	ng	NOUN
iajs-3656	77	38	/	/	SYM
iajs-3656	77	39	ml	ml	PROPN
iajs-3656	77	40	)	)	PUNCT
iajs-3656	77	41	9.70	9.70	NUM
iajs-3656	77	42	±	±	NUM
iajs-3656	77	43	4.10	4.10	NUM
iajs-3656	77	44	a	a	DET
iajs-3656	77	45	13.10	13.10	NUM
iajs-3656	77	46	±	±	NUM
iajs-3656	77	47	4.80	4.80	NUM
iajs-3656	77	48	b	b	NOUN
iajs-3656	77	49	11.20	11.20	NUM
iajs-3656	77	50	±	±	NUM
iajs-3656	77	51	4.70	4.70	NUM
iajs-3656	77	52	c	c	PROPN
iajs-3656	77	53	13.60	13.60	NUM
iajs-3656	77	54	±	±	NUM
iajs-3656	77	55	5.30	5.30	NUM
iajs-3656	77	56	d	d	PROPN
iajs-3656	77	57	4.50	4.50	NUM
iajs-3656	77	58	±	±	NUM
iajs-3656	77	59	0.80	0.80	NUM
iajs-3656	77	60	p	p	NOUN
iajs-3656	77	61	-	-	PUNCT
iajs-3656	77	62	value	value	NOUN
iajs-3656	77	63	=	=	SYM
iajs-3656	77	64	0.001	0.001	NUM
iajs-3656	77	65	mll4	mll4	PROPN
iajs-3656	77	66	(	(	PUNCT
iajs-3656	77	67	ng	ng	PROPN
iajs-3656	77	68	/	/	SYM
iajs-3656	77	69	ml	ml	PROPN
iajs-3656	77	70	)	)	PUNCT
iajs-3656	77	71	2.40	2.40	NUM
iajs-3656	77	72	±	±	NUM
iajs-3656	77	73	1.20	1.20	NUM
iajs-3656	77	74	a	a	DET
iajs-3656	77	75	2.20	2.20	NUM
iajs-3656	77	76	±	±	NUM
iajs-3656	77	77	0.70	0.70	NUM
iajs-3656	77	78	b	b	NOUN
iajs-3656	77	79	2.20	2.20	NUM
iajs-3656	77	80	±	±	NUM
iajs-3656	77	81	1.10	1.10	NUM
iajs-3656	77	82	c	c	NOUN
iajs-3656	77	83	3.40	3.40	NUM
iajs-3656	77	84	±	±	NUM
iajs-3656	77	85	0.90	0.90	NUM
iajs-3656	77	86	d	d	PROPN
iajs-3656	77	87	1.60	1.60	NUM
iajs-3656	77	88	±	±	NUM
iajs-3656	77	89	0.40	0.40	NUM
iajs-3656	77	90	p	p	NOUN
iajs-3656	77	91	-	-	PUNCT
iajs-3656	77	92	value	value	NOUN
iajs-3656	77	93	=	=	SYM
iajs-3656	77	94	0.30	0.30	NUM
iajs-3656	77	95	plxdc2	plxdc2	NOUN
iajs-3656	77	96	(	(	PUNCT
iajs-3656	77	97	pg	pg	NOUN
iajs-3656	77	98	/ml	/ml	SYM
iajs-3656	77	99	)	)	PUNCT
iajs-3656	77	100	1083.0	1083.0	NUM
iajs-3656	77	101	±	±	NUM
iajs-3656	77	102	31.60	31.60	NUM
iajs-3656	77	103	a	a	DET
iajs-3656	77	104	1256.0	1256.0	NUM
iajs-3656	77	105	±	±	NUM
iajs-3656	77	106	38.60	38.60	NUM
iajs-3656	77	107	b	b	PROPN
iajs-3656	77	108	1345.0	1345.0	NUM
iajs-3656	77	109	±	±	NUM
iajs-3656	77	110	30.60	30.60	NUM
iajs-3656	77	111	c	c	PROPN
iajs-3656	77	112	1182.0	1182.0	NUM
iajs-3656	77	113	±	±	NOUN
iajs-3656	77	114	31.70	31.70	NUM
iajs-3656	77	115	d	d	NOUN
iajs-3656	77	116	644.0	644.0	NUM
iajs-3656	77	117	±	±	NUM
iajs-3656	77	118	21.10	21.10	NUM
iajs-3656	77	119	p	p	NOUN
iajs-3656	77	120	-	-	PUNCT
iajs-3656	77	121	value	value	NOUN
iajs-3656	77	122	=	=	SYM
iajs-3656	77	123	0.001	0.001	NUM
iajs-3656	77	124	proz	proz	NOUN
iajs-3656	77	125	(	(	PUNCT
iajs-3656	77	126	ng	ng	NOUN
iajs-3656	77	127	/	/	SYM
iajs-3656	77	128	ml	ml	PROPN
iajs-3656	77	129	)	)	PUNCT
iajs-3656	77	130	21.90	21.90	NUM
iajs-3656	77	131	±	±	NUM
iajs-3656	77	132	6.0	6.0	NUM
iajs-3656	77	133	a	a	DET
iajs-3656	77	134	23.8	23.8	NUM
iajs-3656	77	135	±	±	NUM
iajs-3656	77	136	5.60	5.60	NUM
iajs-3656	77	137	b	b	SYM
iajs-3656	77	138	21.70	21.70	NUM
iajs-3656	77	139	±	±	NUM
iajs-3656	77	140	5.60	5.60	NUM
iajs-3656	77	141	c	c	NOUN
iajs-3656	77	142	23.40	23.40	NUM
iajs-3656	77	143	±	±	NUM
iajs-3656	77	144	5.0	5.0	NUM
iajs-3656	77	145	d	d	SYM
iajs-3656	77	146	62.8	62.8	NUM
iajs-3656	77	147	±	±	NUM
iajs-3656	77	148	5.20	5.20	NUM
iajs-3656	77	149	p	p	NOUN
iajs-3656	77	150	-	-	PUNCT
iajs-3656	77	151	value	value	NOUN
iajs-3656	77	152	=	=	SYM
iajs-3656	77	153	0.03	0.03	NUM
iajs-3656	77	154	ihjpas	ihjpa	NOUN
iajs-3656	77	155	.	.	PUNCT
iajs-3656	78	1	2025	2025	NUM
iajs-3656	78	2	,	,	PUNCT
iajs-3656	78	3	38(4	38(4	NUM
iajs-3656	78	4	)	)	PUNCT
iajs-3656	78	5	234	234	NUM
iajs-3656	78	6	perception	perception	NOUN
iajs-3656	78	7	.	.	PUNCT
iajs-3656	79	1	additionally	additionally	ADV
iajs-3656	79	2	,	,	PUNCT
iajs-3656	79	3	t2	t2	NOUN
iajs-3656	79	4	dm	dm	PROPN
iajs-3656	79	5	patients	patient	NOUN
iajs-3656	79	6	'	'	PART
iajs-3656	79	7	cognitive	cognitive	ADJ
iajs-3656	79	8	function	function	NOUN
iajs-3656	79	9	reportedly	reportedly	ADV
iajs-3656	79	10	suffered	suffer	VERB
iajs-3656	79	11	due	due	ADP
iajs-3656	79	12	to	to	ADP
iajs-3656	79	13	physical	physical	ADJ
iajs-3656	79	14	inactivity	inactivity	NOUN
iajs-3656	79	15	(	(	PUNCT
iajs-3656	79	16	27	27	NUM
iajs-3656	79	17	)	)	PUNCT
iajs-3656	79	18	.	.	PUNCT
iajs-3656	80	1	there	there	PRON
iajs-3656	80	2	is	be	VERB
iajs-3656	80	3	no	no	DET
iajs-3656	80	4	known	know	VERB
iajs-3656	80	5	correlation	correlation	NOUN
iajs-3656	80	6	or	or	CCONJ
iajs-3656	80	7	direct	direct	ADJ
iajs-3656	80	8	association	association	NOUN
iajs-3656	80	9	between	between	ADP
iajs-3656	80	10	the	the	DET
iajs-3656	80	11	lama2	lama2	PROPN
iajs-3656	80	12	,	,	PUNCT
iajs-3656	80	13	mll4	mll4	PROPN
iajs-3656	80	14	,	,	PUNCT
iajs-3656	80	15	plxdc2	plxdc2	NOUN
iajs-3656	80	16	,	,	PUNCT
iajs-3656	80	17	and	and	CCONJ
iajs-3656	80	18	proz	proz	ADJ
iajs-3656	80	19	genes	gene	NOUN
iajs-3656	80	20	and	and	CCONJ
iajs-3656	80	21	t2	t2	NOUN
iajs-3656	80	22	dm	dm	PROPN
iajs-3656	80	23	.	.	PUNCT
iajs-3656	81	1	in	in	ADP
iajs-3656	81	2	contrast	contrast	NOUN
iajs-3656	81	3	,	,	PUNCT
iajs-3656	81	4	t2	t2	NOUN
iajs-3656	81	5	dm	dm	PROPN
iajs-3656	81	6	is	be	AUX
iajs-3656	81	7	a	a	DET
iajs-3656	81	8	multifactorial	multifactorial	ADJ
iajs-3656	81	9	metabolic	metabolic	NOUN
iajs-3656	81	10	condition	condition	NOUN
iajs-3656	81	11	influenced	influence	VERB
iajs-3656	81	12	by	by	ADP
iajs-3656	81	13	a	a	DET
iajs-3656	81	14	combination	combination	NOUN
iajs-3656	81	15	of	of	ADP
iajs-3656	81	16	genetic	genetic	ADJ
iajs-3656	81	17	,	,	PUNCT
iajs-3656	81	18	environmental	environmental	ADJ
iajs-3656	81	19	,	,	PUNCT
iajs-3656	81	20	and	and	CCONJ
iajs-3656	81	21	lifestyle	lifestyle	NOUN
iajs-3656	81	22	factors	factor	NOUN
iajs-3656	81	23	.	.	PUNCT
iajs-3656	82	1	while	while	SCONJ
iajs-3656	82	2	several	several	ADJ
iajs-3656	82	3	genes	gene	NOUN
iajs-3656	82	4	have	have	AUX
iajs-3656	82	5	been	be	AUX
iajs-3656	82	6	identified	identify	VERB
iajs-3656	82	7	as	as	ADP
iajs-3656	82	8	playing	play	VERB
iajs-3656	82	9	a	a	DET
iajs-3656	82	10	role	role	NOUN
iajs-3656	82	11	in	in	ADP
iajs-3656	82	12	the	the	DET
iajs-3656	82	13	development	development	NOUN
iajs-3656	82	14	and	and	CCONJ
iajs-3656	82	15	progression	progression	NOUN
iajs-3656	82	16	of	of	ADP
iajs-3656	82	17	t2	t2	PROPN
iajs-3656	82	18	dm	dm	NOUN
iajs-3656	82	19	,	,	PUNCT
iajs-3656	82	20	they	they	PRON
iajs-3656	82	21	are	be	AUX
iajs-3656	82	22	primarily	primarily	ADV
iajs-3656	82	23	involved	involve	VERB
iajs-3656	82	24	in	in	ADP
iajs-3656	82	25	insulin	insulin	NOUN
iajs-3656	82	26	secretion	secretion	NOUN
iajs-3656	82	27	,	,	PUNCT
iajs-3656	82	28	insulin	insulin	NOUN
iajs-3656	82	29	sensitivity	sensitivity	NOUN
iajs-3656	82	30	,	,	PUNCT
iajs-3656	82	31	and	and	CCONJ
iajs-3656	82	32	glucose	glucose	NOUN
iajs-3656	82	33	metabolism	metabolism	NOUN
iajs-3656	82	34	(	(	PUNCT
iajs-3656	82	35	28	28	NUM
iajs-3656	82	36	)	)	PUNCT
iajs-3656	82	37	.	.	PUNCT
iajs-3656	83	1	they	they	PRON
iajs-3656	83	2	have	have	VERB
iajs-3656	83	3	concerns	concern	NOUN
iajs-3656	83	4	about	about	ADP
iajs-3656	83	5	t2	t2	NOUN
iajs-3656	83	6	dm	dm	PROPN
iajs-3656	83	7	or	or	CCONJ
iajs-3656	83	8	any	any	DET
iajs-3656	83	9	genetic	genetic	ADJ
iajs-3656	83	10	conditions	condition	NOUN
iajs-3656	83	11	;	;	PUNCT
iajs-3656	83	12	it	it	PRON
iajs-3656	83	13	is	be	AUX
iajs-3656	83	14	recommended	recommend	VERB
iajs-3656	83	15	to	to	PART
iajs-3656	83	16	consult	consult	VERB
iajs-3656	83	17	with	with	ADP
iajs-3656	83	18	healthcare	healthcare	NOUN
iajs-3656	83	19	professionals	professional	NOUN
iajs-3656	83	20	,	,	PUNCT
iajs-3656	83	21	such	such	ADJ
iajs-3656	83	22	as	as	ADP
iajs-3656	83	23	physicians	physician	NOUN
iajs-3656	83	24	or	or	CCONJ
iajs-3656	83	25	genetic	genetic	ADJ
iajs-3656	83	26	counselors	counselor	NOUN
iajs-3656	83	27	.	.	PUNCT
iajs-3656	84	1	they	they	PRON
iajs-3656	84	2	can	can	AUX
iajs-3656	84	3	provide	provide	VERB
iajs-3656	84	4	personalized	personalized	ADJ
iajs-3656	84	5	guidance	guidance	NOUN
iajs-3656	84	6	and	and	CCONJ
iajs-3656	84	7	information	information	NOUN
iajs-3656	84	8	based	base	VERB
iajs-3656	84	9	on	on	ADP
iajs-3656	84	10	the	the	DET
iajs-3656	84	11	specific	specific	ADJ
iajs-3656	84	12	situation	situation	NOUN
iajs-3656	84	13	,	,	PUNCT
iajs-3656	84	14	including	include	VERB
iajs-3656	84	15	appropriate	appropriate	ADJ
iajs-3656	84	16	screening	screening	NOUN
iajs-3656	84	17	,	,	PUNCT
iajs-3656	84	18	prevention	prevention	NOUN
iajs-3656	84	19	strategies	strategy	NOUN
iajs-3656	84	20	,	,	PUNCT
iajs-3656	84	21	and	and	CCONJ
iajs-3656	84	22	management	management	NOUN
iajs-3656	84	23	approaches	approach	NOUN
iajs-3656	84	24	,	,	PUNCT
iajs-3656	84	25	as	as	SCONJ
iajs-3656	84	26	noted	note	VERB
iajs-3656	84	27	in	in	ADP
iajs-3656	84	28	previous	previous	ADJ
iajs-3656	84	29	outcomes	outcome	NOUN
iajs-3656	84	30	(	(	PUNCT
iajs-3656	84	31	29	29	NUM
iajs-3656	84	32	)	)	PUNCT
iajs-3656	84	33	.	.	PUNCT
iajs-3656	85	1	5	5	X
iajs-3656	85	2	.	.	X
iajs-3656	85	3	conclusion	conclusion	VERB
iajs-3656	85	4	the	the	DET
iajs-3656	85	5	duration	duration	NOUN
iajs-3656	85	6	of	of	ADP
iajs-3656	85	7	the	the	DET
iajs-3656	85	8	disease	disease	NOUN
iajs-3656	85	9	appears	appear	VERB
iajs-3656	85	10	to	to	PART
iajs-3656	85	11	affect	affect	VERB
iajs-3656	85	12	some	some	DET
iajs-3656	85	13	parameters	parameter	NOUN
iajs-3656	85	14	but	but	CCONJ
iajs-3656	85	15	not	not	PART
iajs-3656	85	16	others	other	NOUN
iajs-3656	85	17	.	.	PUNCT
iajs-3656	86	1	mml4	mml4	NOUN
iajs-3656	86	2	and	and	CCONJ
iajs-3656	86	3	proz	proz	ADV
iajs-3656	86	4	are	be	AUX
iajs-3656	86	5	not	not	PART
iajs-3656	86	6	affected	affect	VERB
iajs-3656	86	7	by	by	ADP
iajs-3656	86	8	the	the	DET
iajs-3656	86	9	duration	duration	NOUN
iajs-3656	86	10	of	of	ADP
iajs-3656	86	11	the	the	DET
iajs-3656	86	12	disease	disease	NOUN
iajs-3656	86	13	,	,	PUNCT
iajs-3656	86	14	while	while	SCONJ
iajs-3656	86	15	lama4	lama4	NOUN
iajs-3656	86	16	and	and	CCONJ
iajs-3656	86	17	plxdc2	plxdc2	NOUN
iajs-3656	86	18	are	be	AUX
iajs-3656	86	19	affected	affect	VERB
iajs-3656	86	20	by	by	ADP
iajs-3656	86	21	prolonged	prolonged	ADJ
iajs-3656	86	22	disease	disease	NOUN
iajs-3656	86	23	duration	duration	NOUN
iajs-3656	86	24	.	.	PUNCT
iajs-3656	87	1	whereas	whereas	SCONJ
iajs-3656	87	2	fbg	fbg	PROPN
iajs-3656	87	3	,	,	PUNCT
iajs-3656	87	4	hba1c	hba1c	PROPN
iajs-3656	87	5	,	,	PUNCT
iajs-3656	87	6	and	and	CCONJ
iajs-3656	87	7	lipid	lipid	NOUN
iajs-3656	87	8	profile	profile	NOUN
iajs-3656	87	9	are	be	AUX
iajs-3656	87	10	affected	affect	VERB
iajs-3656	87	11	by	by	ADP
iajs-3656	87	12	the	the	DET
iajs-3656	87	13	duration	duration	NOUN
iajs-3656	87	14	of	of	ADP
iajs-3656	87	15	the	the	DET
iajs-3656	87	16	disease	disease	NOUN
iajs-3656	87	17	.	.	PUNCT
iajs-3656	88	1	acknowledgment	acknowledgment	NOUN
iajs-3656	88	2	the	the	DET
iajs-3656	88	3	authors	author	NOUN
iajs-3656	88	4	thank	thank	VERB
iajs-3656	88	5	their	their	PRON
iajs-3656	88	6	colleagues	colleague	NOUN
iajs-3656	88	7	at	at	ADP
iajs-3656	88	8	the	the	DET
iajs-3656	88	9	college	college	NOUN
iajs-3656	88	10	of	of	ADP
iajs-3656	88	11	sciences	science	NOUN
iajs-3656	88	12	for	for	ADP
iajs-3656	88	13	women	woman	NOUN
iajs-3656	88	14	,	,	PUNCT
iajs-3656	88	15	university	university	NOUN
iajs-3656	88	16	of	of	ADP
iajs-3656	88	17	baghdad	baghdad	PROPN
iajs-3656	88	18	,	,	PUNCT
iajs-3656	88	19	for	for	ADP
iajs-3656	88	20	their	their	PRON
iajs-3656	88	21	cooperation	cooperation	NOUN
iajs-3656	88	22	in	in	ADP
iajs-3656	88	23	completing	complete	VERB
iajs-3656	88	24	this	this	DET
iajs-3656	88	25	work	work	NOUN
iajs-3656	88	26	,	,	PUNCT
iajs-3656	88	27	and	and	CCONJ
iajs-3656	88	28	they	they	PRON
iajs-3656	88	29	appreciate	appreciate	VERB
iajs-3656	88	30	everyone	everyone	PRON
iajs-3656	88	31	who	who	PRON
iajs-3656	88	32	participated	participate	VERB
iajs-3656	88	33	in	in	ADP
iajs-3656	88	34	the	the	DET
iajs-3656	88	35	study	study	NOUN
iajs-3656	88	36	.	.	PUNCT
iajs-3656	89	1	conflict	conflict	NOUN
iajs-3656	89	2	of	of	ADP
iajs-3656	89	3	interest	interest	NOUN
iajs-3656	89	4	the	the	DET
iajs-3656	89	5	authors	author	NOUN
iajs-3656	89	6	declare	declare	VERB
iajs-3656	89	7	that	that	SCONJ
iajs-3656	89	8	they	they	PRON
iajs-3656	89	9	have	have	VERB
iajs-3656	89	10	no	no	DET
iajs-3656	89	11	conflicts	conflict	NOUN
iajs-3656	89	12	of	of	ADP
iajs-3656	89	13	interest	interest	NOUN
iajs-3656	89	14	.	.	PUNCT
iajs-3656	90	1	funding	fund	VERB
iajs-3656	90	2	none	none	NOUN
iajs-3656	90	3	.	.	PUNCT
iajs-3656	91	1	ethical	ethical	ADJ
iajs-3656	91	2	clearance	clearance	NOUN
iajs-3656	91	3	the	the	DET
iajs-3656	91	4	scientific	scientific	ADJ
iajs-3656	91	5	committee	committee	NOUN
iajs-3656	91	6	approved	approve	VERB
iajs-3656	91	7	this	this	DET
iajs-3656	91	8	study	study	NOUN
iajs-3656	91	9	in	in	ADP
iajs-3656	91	10	the	the	DET
iajs-3656	91	11	college	college	NOUN
iajs-3656	91	12	of	of	ADP
iajs-3656	91	13	science	science	NOUN
iajs-3656	91	14	for	for	ADP
iajs-3656	91	15	women	woman	NOUN
iajs-3656	91	16	,	,	PUNCT
iajs-3656	91	17	and	and	CCONJ
iajs-3656	91	18	this	this	PRON
iajs-3656	91	19	is	be	AUX
iajs-3656	91	20	consistent	consistent	ADJ
iajs-3656	91	21	with	with	ADP
iajs-3656	91	22	the	the	DET
iajs-3656	91	23	instructions	instruction	NOUN
iajs-3656	91	24	of	of	ADP
iajs-3656	91	25	the	the	DET
iajs-3656	91	26	iraqi	iraqi	ADJ
iajs-3656	91	27	ministry	ministry	PROPN
iajs-3656	91	28	of	of	ADP
iajs-3656	91	29	health	health	PROPN
iajs-3656	91	30	and	and	CCONJ
iajs-3656	91	31	environment	environment	NOUN
iajs-3656	91	32	.	.	PUNCT
iajs-3656	92	1	a	a	DET
iajs-3656	92	2	verbal	verbal	ADJ
iajs-3656	92	3	agreement	agreement	NOUN
iajs-3656	92	4	was	be	AUX
iajs-3656	92	5	obtained	obtain	VERB
iajs-3656	92	6	from	from	ADP
iajs-3656	92	7	each	each	DET
iajs-3656	92	8	person	person	NOUN
iajs-3656	92	9	included	include	VERB
iajs-3656	92	10	in	in	ADP
iajs-3656	92	11	the	the	DET
iajs-3656	92	12	survey	survey	NOUN
iajs-3656	92	13	no	no	INTJ
iajs-3656	92	14	.	.	PUNCT
iajs-3656	93	1	22/6435	22/6435	NUM
iajs-3656	93	2	on	on	ADP
iajs-3656	93	3	13/12/2021	13/12/2021	NUM
iajs-3656	93	4	.	.	PUNCT
iajs-3656	94	1	references	reference	NOUN
iajs-3656	94	2	1	1	NUM
iajs-3656	94	3	.	.	PUNCT
iajs-3656	95	1	chen	chen	PROPN
iajs-3656	95	2	x	x	PROPN
iajs-3656	95	3	,	,	PUNCT
iajs-3656	95	4	merovci	merovci	PROPN
iajs-3656	95	5	a	a	NOUN
iajs-3656	95	6	,	,	PUNCT
iajs-3656	95	7	defronzo	defronzo	NOUN
iajs-3656	95	8	ra	ra	NOUN
iajs-3656	95	9	,	,	PUNCT
iajs-3656	95	10	tripathy	tripathy	PROPN
iajs-3656	95	11	d.	d.	PROPN
iajs-3656	95	12	chronic	chronic	ADJ
iajs-3656	95	13	physiologic	physiologic	ADJ
iajs-3656	95	14	hyperglycemia	hyperglycemia	NOUN
iajs-3656	95	15	impairs	impair	VERB
iajs-3656	95	16	insulin	insulin	NOUN
iajs-3656	95	17	-	-	PUNCT
iajs-3656	95	18	mediated	mediate	VERB
iajs-3656	95	19	suppression	suppression	NOUN
iajs-3656	95	20	of	of	ADP
iajs-3656	95	21	plasma	plasma	NOUN
iajs-3656	95	22	glucagon	glucagon	NOUN
iajs-3656	95	23	concentration	concentration	NOUN
iajs-3656	95	24	in	in	ADP
iajs-3656	95	25	healthy	healthy	ADJ
iajs-3656	95	26	humans	human	NOUN
iajs-3656	95	27	.	.	PUNCT
iajs-3656	96	1	metabolism	metabolism	NOUN
iajs-3656	96	2	.	.	PUNCT
iajs-3656	97	1	2023	2023	NUM
iajs-3656	97	2	;	;	PUNCT
iajs-3656	97	3	142	142	NUM
iajs-3656	97	4	:	:	SYM
iajs-3656	97	5	155512	155512	NUM
iajs-3656	97	6	.	.	PUNCT
iajs-3656	98	1	https://doi.org/10.1016/j.metabol.2023.155512	https://doi.org/10.1016/j.metabol.2023.155512	NOUN
iajs-3656	98	2	.	.	PUNCT
iajs-3656	99	1	2	2	X
iajs-3656	99	2	.	.	X
iajs-3656	99	3	patel	patel	PROPN
iajs-3656	99	4	mk	mk	PROPN
iajs-3656	99	5	,	,	PUNCT
iajs-3656	99	6	ramachandran	ramachandran	PROPN
iajs-3656	99	7	a	a	PROPN
iajs-3656	99	8	,	,	PUNCT
iajs-3656	99	9	babulal	babulal	PROPN
iajs-3656	99	10	mk	mk	PROPN
iajs-3656	99	11	,	,	PUNCT
iajs-3656	99	12	vasanthi	vasanthi	PROPN
iajs-3656	99	13	rk	rk	PRON
iajs-3656	99	14	.	.	PROPN
iajs-3656	99	15	will	will	AUX
iajs-3656	99	16	hyperglycemia	hyperglycemia	VERB
iajs-3656	99	17	influence	influence	VERB
iajs-3656	99	18	the	the	DET
iajs-3656	99	19	cardiorespiratory	cardiorespiratory	NOUN
iajs-3656	99	20	endurance	endurance	NOUN
iajs-3656	99	21	and	and	CCONJ
iajs-3656	99	22	other	other	ADJ
iajs-3656	99	23	determinants	determinant	NOUN
iajs-3656	99	24	among	among	ADP
iajs-3656	99	25	community	community	NOUN
iajs-3656	99	26	-	-	PUNCT
iajs-3656	99	27	dwelling	dwell	VERB
iajs-3656	99	28	type	type	NOUN
iajs-3656	99	29	2	2	NUM
iajs-3656	99	30	dm	dm	NOUN
iajs-3656	99	31	patients	patient	NOUN
iajs-3656	99	32	?	?	PUNCT
iajs-3656	100	1	a	a	DET
iajs-3656	100	2	cross	cross	ADJ
iajs-3656	100	3	-	-	ADJ
iajs-3656	100	4	sectional	sectional	ADJ
iajs-3656	100	5	study	study	NOUN
iajs-3656	100	6	.	.	PUNCT
iajs-3656	101	1	jpsp	jpsp	NOUN
iajs-3656	101	2	2022	2022	NUM
iajs-3656	101	3	;	;	PUNCT
iajs-3656	101	4	6(4):10403	6(4):10403	X
iajs-3656	101	5	-	-	PUNCT
iajs-3656	101	6	10408	10408	NUM
iajs-3656	101	7	.	.	PUNCT
iajs-3656	102	1	3	3	X
iajs-3656	102	2	.	.	X
iajs-3656	102	3	gerstein	gerstein	PROPN
iajs-3656	102	4	hc	hc	PROPN
iajs-3656	102	5	,	,	PUNCT
iajs-3656	102	6	santaguida	santaguida	NOUN
iajs-3656	102	7	p	p	NOUN
iajs-3656	102	8	,	,	PUNCT
iajs-3656	102	9	raina	raina	PROPN
iajs-3656	102	10	p	p	PROPN
iajs-3656	102	11	,	,	PUNCT
iajs-3656	102	12	morrison	morrison	PROPN
iajs-3656	102	13	km	km	PROPN
iajs-3656	102	14	,	,	PUNCT
iajs-3656	102	15	balion	balion	NOUN
iajs-3656	102	16	c	c	PROPN
iajs-3656	102	17	,	,	PUNCT
iajs-3656	102	18	hunt	hunt	PROPN
iajs-3656	102	19	d	d	PROPN
iajs-3656	102	20	,	,	PUNCT
iajs-3656	102	21	yazdi	yazdi	PROPN
iajs-3656	102	22	h	h	PROPN
iajs-3656	102	23	,	,	PUNCT
iajs-3656	102	24	booker	booker	PROPN
iajs-3656	102	25	l.	l.	PROPN
iajs-3656	102	26	annual	annual	ADJ
iajs-3656	102	27	incidence	incidence	NOUN
iajs-3656	102	28	and	and	CCONJ
iajs-3656	102	29	relative	relative	ADJ
iajs-3656	102	30	risk	risk	NOUN
iajs-3656	102	31	of	of	ADP
iajs-3656	102	32	diabetes	diabetes	NOUN
iajs-3656	102	33	in	in	ADP
iajs-3656	102	34	people	people	NOUN
iajs-3656	102	35	with	with	ADP
iajs-3656	102	36	various	various	ADJ
iajs-3656	102	37	categories	category	NOUN
iajs-3656	102	38	of	of	ADP
iajs-3656	102	39	dysglycemia	dysglycemia	PROPN
iajs-3656	102	40	:	:	PUNCT
iajs-3656	102	41	a	a	DET
iajs-3656	102	42	systematic	systematic	ADJ
iajs-3656	102	43	overview	overview	NOUN
iajs-3656	102	44	and	and	CCONJ
iajs-3656	102	45	meta	meta	NOUN
iajs-3656	102	46	-	-	PUNCT
iajs-3656	102	47	analysis	analysis	NOUN
iajs-3656	102	48	of	of	ADP
iajs-3656	102	49	prospective	prospective	ADJ
iajs-3656	102	50	studies	study	NOUN
iajs-3656	102	51	.	.	PUNCT
iajs-3656	103	1	diabetes	diabetes	NOUN
iajs-3656	103	2	res	re	VERB
iajs-3656	103	3	clin	clin	PROPN
iajs-3656	103	4	pract	pract	PROPN
iajs-3656	103	5	.	.	PUNCT
iajs-3656	104	1	2007	2007	NUM
iajs-3656	104	2	;	;	PUNCT
iajs-3656	104	3	78(3):305	78(3):305	NUM
iajs-3656	104	4	-	-	SYM
iajs-3656	104	5	312	312	NUM
iajs-3656	104	6	.	.	PUNCT
iajs-3656	104	7	https://doi.org/10.1016/j.diabres.2007.05.004	https://doi.org/10.1016/j.diabres.2007.05.004	PROPN
iajs-3656	104	8	.	.	PUNCT
iajs-3656	105	1	https://doi.org/10.1016/j.metabol.2023.155512	https://doi.org/10.1016/j.metabol.2023.155512	PROPN
iajs-3656	105	2	https://doi.org/10.1016/j.metabol.2023.155512	https://doi.org/10.1016/j.metabol.2023.155512	PROPN
iajs-3656	105	3	https://doi.org/10.1016/j.diabres.2007.05.004	https://doi.org/10.1016/j.diabres.2007.05.004	PROPN
iajs-3656	105	4	ihjpas	ihjpas	PROPN
iajs-3656	105	5	.	.	PUNCT
iajs-3656	106	1	2025	2025	NUM
iajs-3656	106	2	,	,	PUNCT
iajs-3656	106	3	38(4	38(4	NUM
iajs-3656	106	4	)	)	PUNCT
iajs-3656	106	5	235	235	NUM
iajs-3656	106	6	4	4	NUM
iajs-3656	106	7	.	.	PUNCT
iajs-3656	106	8	king	king	PROPN
iajs-3656	106	9	p	p	NOUN
iajs-3656	106	10	,	,	PUNCT
iajs-3656	106	11	peacock	peacock	NOUN
iajs-3656	106	12	i	i	PRON
iajs-3656	106	13	,	,	PUNCT
iajs-3656	106	14	donnelly	donnelly	PROPN
iajs-3656	106	15	r.	r.	PROPN
iajs-3656	106	16	the	the	DET
iajs-3656	106	17	uk	uk	PROPN
iajs-3656	106	18	prospective	prospective	ADJ
iajs-3656	106	19	diabetes	diabetes	NOUN
iajs-3656	106	20	study	study	NOUN
iajs-3656	106	21	(	(	PUNCT
iajs-3656	106	22	ukpds	ukpds	PROPN
iajs-3656	106	23	):	):	PUNCT
iajs-3656	106	24	clinical	clinical	ADJ
iajs-3656	106	25	and	and	CCONJ
iajs-3656	106	26	therapeutic	therapeutic	ADJ
iajs-3656	106	27	implications	implication	NOUN
iajs-3656	106	28	for	for	ADP
iajs-3656	106	29	type	type	NOUN
iajs-3656	106	30	2	2	NUM
iajs-3656	106	31	diabetes	diabetes	NOUN
iajs-3656	106	32	.	.	PUNCT
iajs-3656	107	1	br	br	PROPN
iajs-3656	108	1	j	j	PROPN
iajs-3656	108	2	clin	clin	PROPN
iajs-3656	108	3	pharmacol	pharmacol	PROPN
iajs-3656	108	4	.	.	PUNCT
iajs-3656	108	5	1999	1999	NUM
iajs-3656	108	6	;	;	PUNCT
iajs-3656	108	7	48(5):643	48(5):643	PROPN
iajs-3656	108	8	-	-	SYM
iajs-3656	108	9	648	648	NUM
iajs-3656	108	10	.	.	PUNCT
iajs-3656	109	1	https://doi.org/10.1046/j.1365-2125.1999.00092.x	https://doi.org/10.1046/j.1365-2125.1999.00092.x	NOUN
iajs-3656	109	2	.	.	PUNCT
iajs-3656	110	1	5	5	NUM
iajs-3656	110	2	.	.	NUM
iajs-3656	110	3	bellary	bellary	PROPN
iajs-3656	110	4	s	s	PROPN
iajs-3656	110	5	,	,	PUNCT
iajs-3656	110	6	kyrou	kyrou	PROPN
iajs-3656	110	7	i	i	PROPN
iajs-3656	110	8	,	,	PUNCT
iajs-3656	110	9	brown	brown	PROPN
iajs-3656	110	10	je	je	PROPN
iajs-3656	110	11	,	,	PUNCT
iajs-3656	110	12	bailey	bailey	PROPN
iajs-3656	110	13	cj	cj	PROPN
iajs-3656	110	14	.	.	PUNCT
iajs-3656	110	15	type	type	NOUN
iajs-3656	110	16	2	2	NUM
iajs-3656	110	17	diabetes	diabetes	NOUN
iajs-3656	110	18	mellitus	mellitus	NOUN
iajs-3656	110	19	in	in	ADP
iajs-3656	110	20	older	old	ADJ
iajs-3656	110	21	adults	adult	NOUN
iajs-3656	110	22	:	:	PUNCT
iajs-3656	110	23	clinical	clinical	ADJ
iajs-3656	110	24	considerations	consideration	NOUN
iajs-3656	110	25	and	and	CCONJ
iajs-3656	110	26	management	management	NOUN
iajs-3656	110	27	.	.	PUNCT
iajs-3656	111	1	nat	nat	PROPN
iajs-3656	111	2	rev	rev	PROPN
iajs-3656	111	3	endocrinol	endocrinol	NOUN
iajs-3656	111	4	.	.	PUNCT
iajs-3656	111	5	2021	2021	NUM
iajs-3656	111	6	;	;	PUNCT
iajs-3656	111	7	17(9):534	17(9):534	NUM
iajs-3656	111	8	-	-	SYM
iajs-3656	111	9	548	548	NUM
iajs-3656	111	10	.	.	PUNCT
iajs-3656	111	11	https://doi.org/10.1038/s41574-021-00474-4	https://doi.org/10.1038/s41574-021-00474-4	PROPN
iajs-3656	111	12	.	.	PUNCT
iajs-3656	112	1	6	6	NUM
iajs-3656	112	2	.	.	X
iajs-3656	112	3	ergashev	ergashev	PROPN
iajs-3656	112	4	uy	uy	PROPN
iajs-3656	112	5	,	,	PUNCT
iajs-3656	112	6	ernazarov	ernazarov	NOUN
iajs-3656	112	7	ki	ki	PROPN
iajs-3656	112	8	,	,	PUNCT
iajs-3656	112	9	zohirov	zohirov	PROPN
iajs-3656	112	10	ar	ar	PROPN
iajs-3656	112	11	,	,	PUNCT
iajs-3656	112	12	alzabni	alzabni	PROPN
iajs-3656	113	1	i	i	PRON
iajs-3656	113	2	d.	d.	PROPN
iajs-3656	113	3	complex	complex	PROPN
iajs-3656	113	4	treatment	treatment	NOUN
iajs-3656	113	5	of	of	ADP
iajs-3656	113	6	experimental	experimental	ADJ
iajs-3656	113	7	model	model	NOUN
iajs-3656	113	8	of	of	ADP
iajs-3656	113	9	diabetic	diabetic	ADJ
iajs-3656	113	10	foot	foot	NOUN
iajs-3656	113	11	syndrome	syndrome	NOUN
iajs-3656	113	12	.	.	PUNCT
iajs-3656	114	1	am	be	AUX
iajs-3656	114	2	j	j	PROPN
iajs-3656	114	3	med	med	PROPN
iajs-3656	114	4	sci	sci	PROPN
iajs-3656	114	5	.	.	PROPN
iajs-3656	114	6	2022	2022	NUM
iajs-3656	114	7	;	;	PUNCT
iajs-3656	114	8	12(4):471	12(4):471	NUM
iajs-3656	114	9	-	-	PUNCT
iajs-3656	114	10	480	480	NUM
iajs-3656	114	11	.	.	PUNCT
iajs-3656	115	1	https://doi.org/10.5923/j.ajmms.20221204.02	https://doi.org/10.5923/j.ajmms.20221204.02	PROPN
iajs-3656	115	2	.	.	PUNCT
iajs-3656	116	1	7	7	X
iajs-3656	116	2	.	.	X
iajs-3656	116	3	american	american	ADJ
iajs-3656	116	4	diabetes	diabetes	PROPN
iajs-3656	116	5	association	association	PROPN
iajs-3656	116	6	.	.	PUNCT
iajs-3656	117	1	standards	standard	NOUN
iajs-3656	117	2	of	of	ADP
iajs-3656	117	3	medical	medical	ADJ
iajs-3656	117	4	care	care	NOUN
iajs-3656	117	5	in	in	ADP
iajs-3656	117	6	diabetes	diabetes	NOUN
iajs-3656	117	7	.	.	PUNCT
iajs-3656	118	1	diabetes	diabetes	NOUN
iajs-3656	118	2	care	care	NOUN
iajs-3656	118	3	.	.	PUNCT
iajs-3656	119	1	2021	2021	NUM
iajs-3656	119	2	;	;	PUNCT
iajs-3656	120	1	44(s1	44(s1	NOUN
iajs-3656	120	2	):	):	PUNCT
iajs-3656	120	3	s1	s1	PROPN
iajs-3656	120	4	-	-	PUNCT
iajs-3656	120	5	s232	s232	PROPN
iajs-3656	120	6	.	.	PUNCT
iajs-3656	121	1	https://doi.org/10.2337/dc21-s001	https://doi.org/10.2337/dc21-s001	PROPN
iajs-3656	121	2	.	.	PUNCT
iajs-3656	122	1	8	8	X
iajs-3656	122	2	.	.	X
iajs-3656	123	1	rafiqovich	rafiqovich	PROPN
iajs-3656	123	2	za	za	PROPN
iajs-3656	123	3	.	.	PROPN
iajs-3656	123	4	study	study	NOUN
iajs-3656	123	5	of	of	ADP
iajs-3656	123	6	the	the	DET
iajs-3656	123	7	effect	effect	NOUN
iajs-3656	123	8	of	of	ADP
iajs-3656	123	9	lipid	lipid	ADJ
iajs-3656	123	10	peroxidase	peroxidase	NOUN
iajs-3656	123	11	analysis	analysis	NOUN
iajs-3656	123	12	on	on	ADP
iajs-3656	123	13	the	the	DET
iajs-3656	123	14	body	body	NOUN
iajs-3656	123	15	in	in	ADP
iajs-3656	123	16	diabetic	diabetic	ADJ
iajs-3656	123	17	foot	foot	NOUN
iajs-3656	123	18	syndrome	syndrome	NOUN
iajs-3656	123	19	.	.	PUNCT
iajs-3656	124	1	conferencea	conferencea	PROPN
iajs-3656	124	2	.	.	PUNCT
iajs-3656	125	1	2023	2023	NUM
iajs-3656	125	2	;	;	PUNCT
iajs-3656	125	3	76	76	NUM
iajs-3656	125	4	-	-	SYM
iajs-3656	125	5	82	82	NUM
iajs-3656	125	6	.	.	PUNCT
iajs-3656	126	1	https://conferencea.org/index.php/conferences/article/view/1990	https://conferencea.org/index.php/conferences/article/view/1990	NOUN
iajs-3656	126	2	.	.	PROPN
iajs-3656	126	3	9	9	NUM
iajs-3656	126	4	.	.	X
iajs-3656	126	5	ergashev	ergashev	PROPN
iajs-3656	126	6	uy	uy	PROPN
iajs-3656	126	7	,	,	PUNCT
iajs-3656	126	8	zokhirov	zokhirov	PROPN
iajs-3656	126	9	ar	ar	PROPN
iajs-3656	126	10	,	,	PUNCT
iajs-3656	126	11	minavarkhujaev	minavarkhujaev	PROPN
iajs-3656	126	12	rr	rr	PROPN
iajs-3656	127	1	.	.	PUNCT
iajs-3656	127	2	study	study	NOUN
iajs-3656	127	3	and	and	CCONJ
iajs-3656	127	4	treatment	treatment	NOUN
iajs-3656	127	5	of	of	ADP
iajs-3656	127	6	changes	change	NOUN
iajs-3656	127	7	in	in	ADP
iajs-3656	127	8	biochemical	biochemical	ADJ
iajs-3656	127	9	processes	process	NOUN
iajs-3656	127	10	in	in	ADP
iajs-3656	127	11	complications	complication	NOUN
iajs-3656	127	12	of	of	ADP
iajs-3656	127	13	diabetes	diabetes	NOUN
iajs-3656	127	14	mellitus	mellitus	NOUN
iajs-3656	127	15	.	.	PUNCT
iajs-3656	128	1	2023	2023	NUM
iajs-3656	128	2	.	.	X
iajs-3656	129	1	10	10	NUM
iajs-3656	129	2	.	.	PUNCT
iajs-3656	130	1	ogurtsova	ogurtsova	PROPN
iajs-3656	131	1	k	k	NOUN
iajs-3656	131	2	,	,	PUNCT
iajs-3656	131	3	guariguata	guariguata	PROPN
iajs-3656	131	4	l	l	NOUN
iajs-3656	131	5	,	,	PUNCT
iajs-3656	131	6	barengo	barengo	PROPN
iajs-3656	131	7	nc	nc	PROPN
iajs-3656	131	8	,	,	PUNCT
iajs-3656	131	9	ruiz	ruiz	PROPN
iajs-3656	131	10	pld	pld	PROPN
iajs-3656	131	11	,	,	PUNCT
iajs-3656	131	12	sacre	sacre	PROPN
iajs-3656	131	13	jw	jw	PROPN
iajs-3656	131	14	.	.	PROPN
iajs-3656	131	15	idf	idf	PROPN
iajs-3656	131	16	diabetes	diabetes	PROPN
iajs-3656	131	17	atlas	atlas	PROPN
iajs-3656	131	18	:	:	PUNCT
iajs-3656	131	19	global	global	ADJ
iajs-3656	131	20	estimates	estimate	NOUN
iajs-3656	131	21	of	of	ADP
iajs-3656	131	22	undiagnosed	undiagnosed	ADJ
iajs-3656	131	23	diabetes	diabetes	NOUN
iajs-3656	131	24	in	in	ADP
iajs-3656	131	25	adults	adult	NOUN
iajs-3656	131	26	for	for	ADP
iajs-3656	131	27	2021	2021	NUM
iajs-3656	131	28	.	.	PUNCT
iajs-3656	132	1	diabetes	diabetes	NOUN
iajs-3656	132	2	res	re	VERB
iajs-3656	132	3	clin	clin	PROPN
iajs-3656	132	4	pract	pract	PROPN
iajs-3656	132	5	.	.	PUNCT
iajs-3656	133	1	2022	2022	NUM
iajs-3656	133	2	;	;	PUNCT
iajs-3656	133	3	183:109118	183:109118	NUM
iajs-3656	133	4	.	.	PUNCT
iajs-3656	134	1	https://doi.org/10.1016/j.diabres.2022.109118	https://doi.org/10.1016/j.diabres.2022.109118	PROPN
iajs-3656	134	2	.	.	PUNCT
iajs-3656	135	1	11	11	NUM
iajs-3656	135	2	.	.	PUNCT
iajs-3656	136	1	broze	broze	PROPN
iajs-3656	136	2	gj	gj	PROPN
iajs-3656	136	3	,	,	PUNCT
iajs-3656	136	4	miletich	miletich	NOUN
iajs-3656	136	5	jp	jp	NOUN
iajs-3656	136	6	.	.	PUNCT
iajs-3656	137	1	human	human	ADJ
iajs-3656	137	2	protein	protein	NOUN
iajs-3656	137	3	z.	z.	PROPN
iajs-3656	137	4	j	j	PROPN
iajs-3656	137	5	clin	clin	PROPN
iajs-3656	137	6	invest	invest	PROPN
iajs-3656	137	7	.	.	PUNCT
iajs-3656	138	1	1984	1984	NUM
iajs-3656	138	2	;	;	PUNCT
iajs-3656	138	3	73(3):933	73(3):933	NUM
iajs-3656	138	4	-	-	SYM
iajs-3656	138	5	938	938	NUM
iajs-3656	138	6	.	.	PUNCT
iajs-3656	139	1	https://doi.org/10.1172/jci111987	https://doi.org/10.1172/jci111987	NOUN
iajs-3656	139	2	.	.	PUNCT
iajs-3656	140	1	12	12	NUM
iajs-3656	140	2	.	.	PUNCT
iajs-3656	141	1	kaiafa	kaiafa	PROPN
iajs-3656	141	2	g	g	PROPN
iajs-3656	141	3	,	,	PUNCT
iajs-3656	141	4	veneti	veneti	PROPN
iajs-3656	141	5	s	s	NUM
iajs-3656	141	6	,	,	PUNCT
iajs-3656	141	7	polychronopoulos	polychronopoulos	PROPN
iajs-3656	141	8	g	g	PROPN
iajs-3656	141	9	,	,	PUNCT
iajs-3656	141	10	pilalas	pilalas	PROPN
iajs-3656	141	11	d	d	AUX
iajs-3656	141	12	,	,	PUNCT
iajs-3656	141	13	daios	daio	NOUN
iajs-3656	141	14	s	s	PROPN
iajs-3656	141	15	,	,	PUNCT
iajs-3656	141	16	kanellos	kanellos	PROPN
iajs-3656	141	17	i.	i.	PROPN
iajs-3656	141	18	is	be	AUX
iajs-3656	141	19	hba1c	hba1c	PROPN
iajs-3656	141	20	an	an	DET
iajs-3656	141	21	ideal	ideal	ADJ
iajs-3656	141	22	biomarker	biomarker	NOUN
iajs-3656	141	23	of	of	ADP
iajs-3656	141	24	well	well	ADV
iajs-3656	141	25	-	-	PUNCT
iajs-3656	141	26	controlled	control	VERB
iajs-3656	141	27	diabetes	diabetes	NOUN
iajs-3656	141	28	?	?	PUNCT
iajs-3656	142	1	postgrad	postgrad	PROPN
iajs-3656	142	2	med	med	PROPN
iajs-3656	142	3	j.	j.	PROPN
iajs-3656	142	4	2021	2021	NUM
iajs-3656	142	5	;	;	PUNCT
iajs-3656	142	6	97(1148):380	97(1148):380	NOUN
iajs-3656	142	7	-	-	SYM
iajs-3656	142	8	383	383	NUM
iajs-3656	142	9	.	.	PUNCT
iajs-3656	143	1	https://doi.org/10.1136/postgradmedj-2020-137861	https://doi.org/10.1136/postgradmedj-2020-137861	NOUN
iajs-3656	143	2	.	.	PUNCT
iajs-3656	144	1	13	13	NUM
iajs-3656	144	2	.	.	PUNCT
iajs-3656	145	1	takahashi	takahashi	PROPN
iajs-3656	145	2	e	e	PROPN
iajs-3656	145	3	,	,	PUNCT
iajs-3656	145	4	okumura	okumura	DET
iajs-3656	145	5	a	a	DET
iajs-3656	145	6	,	,	PUNCT
iajs-3656	145	7	unoki	unoki	NOUN
iajs-3656	145	8	-	-	PUNCT
iajs-3656	145	9	kubota	kubota	PROPN
iajs-3656	145	10	h	h	PROPN
iajs-3656	145	11	,	,	PUNCT
iajs-3656	145	12	hirano	hirano	PROPN
iajs-3656	145	13	h	h	PROPN
iajs-3656	145	14	,	,	PUNCT
iajs-3656	145	15	kasuga	kasuga	ADJ
iajs-3656	145	16	m.	m.	NOUN
iajs-3656	145	17	differential	differential	NOUN
iajs-3656	145	18	proteome	proteome	ADJ
iajs-3656	145	19	analysis	analysis	NOUN
iajs-3656	145	20	of	of	ADP
iajs-3656	145	21	serum	serum	NOUN
iajs-3656	145	22	proteins	protein	NOUN
iajs-3656	145	23	associated	associate	VERB
iajs-3656	145	24	with	with	ADP
iajs-3656	145	25	the	the	DET
iajs-3656	145	26	development	development	NOUN
iajs-3656	145	27	of	of	ADP
iajs-3656	145	28	type	type	NOUN
iajs-3656	145	29	2	2	NUM
iajs-3656	145	30	diabetes	diabetes	NOUN
iajs-3656	145	31	mellitus	mellitus	NOUN
iajs-3656	145	32	in	in	ADP
iajs-3656	145	33	the	the	DET
iajs-3656	145	34	kk	kk	PROPN
iajs-3656	145	35	-	-	PUNCT
iajs-3656	145	36	a(y	a(y	PROPN
iajs-3656	145	37	)	)	PUNCT
iajs-3656	145	38	mouse	mouse	NOUN
iajs-3656	145	39	model	model	NOUN
iajs-3656	145	40	using	use	VERB
iajs-3656	145	41	the	the	DET
iajs-3656	145	42	itraq	itraq	ADJ
iajs-3656	145	43	technique	technique	NOUN
iajs-3656	145	44	.	.	PUNCT
iajs-3656	146	1	j	j	NOUN
iajs-3656	146	2	proteomics	proteomic	NOUN
iajs-3656	146	3	.	.	PUNCT
iajs-3656	146	4	2013	2013	NUM
iajs-3656	146	5	;	;	PUNCT
iajs-3656	146	6	84:40–51	84:40–51	NUM
iajs-3656	146	7	.	.	PUNCT
iajs-3656	147	1	https://doi.org/10.1016/j.jprot.2013.03.014	https://doi.org/10.1016/j.jprot.2013.03.014	PROPN
iajs-3656	147	2	.	.	PROPN
iajs-3656	147	3	14	14	NUM
iajs-3656	147	4	.	.	PUNCT
iajs-3656	148	1	scoville	scoville	PROPN
iajs-3656	148	2	dw	dw	PROPN
iajs-3656	148	3	,	,	PUNCT
iajs-3656	148	4	cyphert	cyphert	PROPN
iajs-3656	148	5	ha	ha	INTJ
iajs-3656	148	6	,	,	PUNCT
iajs-3656	148	7	liao	liao	PROPN
iajs-3656	148	8	l	l	PROPN
iajs-3656	148	9	,	,	PUNCT
iajs-3656	148	10	xu	xu	PROPN
iajs-3656	148	11	j	j	PROPN
iajs-3656	148	12	,	,	PUNCT
iajs-3656	148	13	reynolds	reynolds	PROPN
iajs-3656	148	14	a	a	PROPN
iajs-3656	148	15	,	,	PUNCT
iajs-3656	148	16	guo	guo	PROPN
iajs-3656	148	17	s.	s.	PROPN
iajs-3656	148	18	mll3	mll3	PROPN
iajs-3656	148	19	and	and	CCONJ
iajs-3656	148	20	mll4	mll4	PROPN
iajs-3656	148	21	methyltransferases	methyltransferase	NOUN
iajs-3656	148	22	bind	bind	VERB
iajs-3656	148	23	to	to	ADP
iajs-3656	148	24	the	the	DET
iajs-3656	148	25	mafa	mafa	NOUN
iajs-3656	148	26	and	and	CCONJ
iajs-3656	148	27	mafb	mafb	NOUN
iajs-3656	148	28	transcription	transcription	NOUN
iajs-3656	148	29	factors	factor	NOUN
iajs-3656	148	30	to	to	PART
iajs-3656	148	31	regulate	regulate	VERB
iajs-3656	148	32	islet	islet	NOUN
iajs-3656	148	33	beta	beta	NOUN
iajs-3656	148	34	-	-	PUNCT
iajs-3656	148	35	cell	cell	NOUN
iajs-3656	148	36	function	function	NOUN
iajs-3656	148	37	.	.	PUNCT
iajs-3656	149	1	diabetes	diabetes	NOUN
iajs-3656	149	2	.	.	PUNCT
iajs-3656	150	1	2015	2015	NUM
iajs-3656	150	2	;	;	PUNCT
iajs-3656	150	3	64(10):3772–3783	64(10):3772–3783	NUM
iajs-3656	150	4	.	.	PUNCT
iajs-3656	151	1	https://doi.org/10.2337/db15-0281	https://doi.org/10.2337/db15-0281	PROPN
iajs-3656	151	2	.	.	PROPN
iajs-3656	151	3	15	15	NUM
iajs-3656	151	4	.	.	PUNCT
iajs-3656	152	1	miller	miller	PROPN
iajs-3656	152	2	-	-	PUNCT
iajs-3656	152	3	delaney	delaney	PROPN
iajs-3656	152	4	sf	sf	PROPN
iajs-3656	152	5	,	,	PUNCT
iajs-3656	152	6	lieberam	lieberam	VERB
iajs-3656	152	7	i	i	PRON
iajs-3656	152	8	,	,	PUNCT
iajs-3656	152	9	murphy	murphy	PROPN
iajs-3656	152	10	p	p	PROPN
iajs-3656	152	11	,	,	PUNCT
iajs-3656	152	12	mitchell	mitchell	PROPN
iajs-3656	152	13	kj	kj	PROPN
iajs-3656	152	14	.	.	PUNCT
iajs-3656	153	1	plxdc2	plxdc2	PROPN
iajs-3656	153	2	is	be	AUX
iajs-3656	153	3	a	a	DET
iajs-3656	153	4	mitogen	mitogen	NOUN
iajs-3656	153	5	for	for	ADP
iajs-3656	153	6	neural	neural	ADJ
iajs-3656	153	7	progenitors	progenitor	NOUN
iajs-3656	153	8	.	.	PUNCT
iajs-3656	154	1	plos	plos	PROPN
iajs-3656	154	2	one	one	NUM
iajs-3656	154	3	.	.	PUNCT
iajs-3656	155	1	2011	2011	NUM
iajs-3656	155	2	;	;	PUNCT
iajs-3656	155	3	6(1):e14565	6(1):e14565	NUM
iajs-3656	155	4	.	.	PUNCT
iajs-3656	156	1	https://doi.org/10.1371/journal.pone.0014565	https://doi.org/10.1371/journal.pone.0014565	NOUN
iajs-3656	156	2	.	.	PUNCT
iajs-3656	157	1	16	16	NUM
iajs-3656	157	2	.	.	PUNCT
iajs-3656	158	1	daniel	daniel	PROPN
iajs-3656	158	2	ww	ww	PROPN
iajs-3656	158	3	.	.	PROPN
iajs-3656	159	1	biostatistics	biostatistics	PROPN
iajs-3656	159	2	:	:	PUNCT
iajs-3656	159	3	a	a	DET
iajs-3656	159	4	foundation	foundation	NOUN
iajs-3656	159	5	for	for	ADP
iajs-3656	159	6	analysis	analysis	NOUN
iajs-3656	159	7	in	in	ADP
iajs-3656	159	8	the	the	DET
iajs-3656	159	9	health	health	NOUN
iajs-3656	159	10	sciences	sciences	PROPN
iajs-3656	159	11	.	.	PUNCT
iajs-3656	160	1	wiley	wiley	PROPN
iajs-3656	160	2	;	;	PUNCT
iajs-3656	160	3	2018	2018	NUM
iajs-3656	160	4	,	,	PUNCT
iajs-3656	160	5	11	11	NUM
iajs-3656	160	6	th	th	NUM
iajs-3656	160	7	ed	ed	NOUN
iajs-3656	160	8	.	.	PROPN
iajs-3656	161	1	17	17	NUM
iajs-3656	161	2	.	.	PUNCT
iajs-3656	162	1	fossati	fossati	PROPN
iajs-3656	162	2	p	p	PROPN
iajs-3656	162	3	,	,	PUNCT
iajs-3656	162	4	prencipe	prencipe	PROPN
iajs-3656	162	5	l.	l.	PROPN
iajs-3656	162	6	serum	serum	NOUN
iajs-3656	162	7	triglycerides	triglyceride	NOUN
iajs-3656	162	8	determined	determine	VERB
iajs-3656	162	9	colorimetrically	colorimetrically	ADV
iajs-3656	162	10	with	with	ADP
iajs-3656	162	11	an	an	DET
iajs-3656	162	12	enzyme	enzyme	NOUN
iajs-3656	162	13	that	that	PRON
iajs-3656	162	14	produces	produce	VERB
iajs-3656	162	15	hydrogen	hydrogen	NOUN
iajs-3656	162	16	peroxide	peroxide	NOUN
iajs-3656	162	17	.	.	PUNCT
iajs-3656	163	1	clin	clin	PROPN
iajs-3656	163	2	chem	chem	PROPN
iajs-3656	163	3	.	.	PUNCT
iajs-3656	164	1	1982	1982	NUM
iajs-3656	164	2	;	;	PUNCT
iajs-3656	164	3	28(10):2077	28(10):2077	NUM
iajs-3656	164	4	-	-	SYM
iajs-3656	164	5	2080	2080	NUM
iajs-3656	164	6	.	.	PUNCT
iajs-3656	165	1	pmid	pmid	NOUN
iajs-3656	165	2	:	:	PUNCT
iajs-3656	165	3	6812986	6812986	NUM
iajs-3656	165	4	.	.	PUNCT
iajs-3656	166	1	18	18	NUM
iajs-3656	166	2	.	.	PUNCT
iajs-3656	166	3	zoungas	zoungas	PROPN
iajs-3656	166	4	s	s	PART
iajs-3656	166	5	,	,	PUNCT
iajs-3656	166	6	chalmers	chalmer	VERB
iajs-3656	166	7	j	j	PROPN
iajs-3656	166	8	,	,	PUNCT
iajs-3656	166	9	neal	neal	PROPN
iajs-3656	166	10	b	b	PROPN
iajs-3656	166	11	,	,	PUNCT
iajs-3656	166	12	billot	billot	NOUN
iajs-3656	166	13	l	l	NOUN
iajs-3656	166	14	,	,	PUNCT
iajs-3656	166	15	li	li	PROPN
iajs-3656	166	16	q	q	PROPN
iajs-3656	166	17	,	,	PUNCT
iajs-3656	166	18	hirakawa	hirakawa	PROPN
iajs-3656	166	19	y	y	PROPN
iajs-3656	166	20	,	,	PUNCT
iajs-3656	166	21	arima	arima	PROPN
iajs-3656	166	22	h	h	PROPN
iajs-3656	166	23	,	,	PUNCT
iajs-3656	166	24	monaghan	monaghan	PROPN
iajs-3656	166	25	h	h	PROPN
iajs-3656	166	26	,	,	PUNCT
iajs-3656	166	27	joshi	joshi	PROPN
iajs-3656	166	28	r	r	PROPN
iajs-3656	166	29	,	,	PUNCT
iajs-3656	166	30	colagiuri	colagiuri	PROPN
iajs-3656	166	31	s	s	PROPN
iajs-3656	166	32	,	,	PUNCT
iajs-3656	166	33	cooper	cooper	PROPN
iajs-3656	166	34	me	i	PRON
iajs-3656	166	35	,	,	PUNCT
iajs-3656	166	36	glasziou	glasziou	VERB
iajs-3656	166	37	p	p	PRON
iajs-3656	166	38	,	,	PUNCT
iajs-3656	166	39	grobbee	grobbee	PROPN
iajs-3656	166	40	d	d	PROPN
iajs-3656	166	41	,	,	PUNCT
iajs-3656	166	42	hamet	hamet	X
iajs-3656	166	43	p	p	X
iajs-3656	166	44	,	,	PUNCT
iajs-3656	166	45	harrap	harrap	PROPN
iajs-3656	166	46	s	s	PROPN
iajs-3656	166	47	,	,	PUNCT
iajs-3656	166	48	heller	heller	NOUN
iajs-3656	166	49	s	s	PROPN
iajs-3656	166	50	,	,	PUNCT
iajs-3656	166	51	lisheng	lisheng	PROPN
iajs-3656	166	52	l	l	PROPN
iajs-3656	166	53	,	,	PUNCT
iajs-3656	166	54	mancia	mancia	PROPN
iajs-3656	166	55	g	g	PROPN
iajs-3656	166	56	,	,	PUNCT
iajs-3656	166	57	marre	marre	X
iajs-3656	166	58	m	m	PROPN
iajs-3656	166	59	,	,	PUNCT
iajs-3656	166	60	matthews	matthews	PROPN
iajs-3656	166	61	dr	dr	PROPN
iajs-3656	166	62	,	,	PUNCT
iajs-3656	166	63	mogensen	mogensen	PROPN
iajs-3656	166	64	ce	ce	PROPN
iajs-3656	166	65	,	,	PUNCT
iajs-3656	166	66	perkovic	perkovic	PROPN
iajs-3656	166	67	v	v	NOUN
iajs-3656	166	68	,	,	PUNCT
iajs-3656	166	69	poulter	poulter	NOUN
iajs-3656	166	70	n	n	CCONJ
iajs-3656	166	71	,	,	PUNCT
iajs-3656	166	72	rodgers	rodger	VERB
iajs-3656	166	73	a	a	DET
iajs-3656	166	74	,	,	PUNCT
iajs-3656	166	75	williams	williams	PROPN
iajs-3656	166	76	b	b	PROPN
iajs-3656	166	77	,	,	PUNCT
iajs-3656	166	78	macmahon	macmahon	PROPN
iajs-3656	166	79	s	s	PROPN
iajs-3656	166	80	,	,	PUNCT
iajs-3656	166	81	patel	patel	PROPN
iajs-3656	166	82	a	a	PRON
iajs-3656	166	83	,	,	PUNCT
iajs-3656	166	84	woodward	woodward	PROPN
iajs-3656	166	85	m	m	PROPN
iajs-3656	166	86	;	;	PUNCT
iajs-3656	167	1	advance	advance	NOUN
iajs-3656	167	2	-	-	PUNCT
iajs-3656	167	3	on	on	ADP
iajs-3656	167	4	collaborative	collaborative	ADJ
iajs-3656	167	5	group	group	NOUN
iajs-3656	167	6	.	.	PUNCT
iajs-3656	168	1	follow	follow	VERB
iajs-3656	168	2	-	-	PUNCT
iajs-3656	168	3	up	up	NOUN
iajs-3656	168	4	of	of	ADP
iajs-3656	168	5	bloodpressure	bloodpressure	NOUN
iajs-3656	168	6	lowering	lowering	NOUN
iajs-3656	168	7	and	and	CCONJ
iajs-3656	168	8	glucose	glucose	NOUN
iajs-3656	168	9	control	control	NOUN
iajs-3656	168	10	in	in	ADP
iajs-3656	168	11	type	type	NOUN
iajs-3656	168	12	2	2	NUM
iajs-3656	168	13	diabetes	diabetes	NOUN
iajs-3656	168	14	.	.	PUNCT
iajs-3656	169	1	n	n	PRON
iajs-3656	169	2	engl	engl	PROPN
iajs-3656	169	3	j	j	PROPN
iajs-3656	169	4	med	med	PROPN
iajs-3656	169	5	.	.	PROPN
iajs-3656	169	6	2014	2014	NUM
iajs-3656	169	7	;	;	PUNCT
iajs-3656	169	8	371(15):1392	371(15):1392	PROPN
iajs-3656	169	9	-	-	PUNCT
iajs-3656	169	10	1406	1406	NUM
iajs-3656	169	11	.	.	PUNCT
iajs-3656	170	1	https://doi.org/10.1056/nejmoa1407963	https://doi.org/10.1056/nejmoa1407963	PROPN
iajs-3656	170	2	.	.	PUNCT
iajs-3656	171	1	19	19	NUM
iajs-3656	171	2	.	.	PUNCT
iajs-3656	171	3	alicic	alicic	PROPN
iajs-3656	171	4	rz	rz	PROPN
iajs-3656	171	5	,	,	PUNCT
iajs-3656	171	6	neumiller	neumiller	PROPN
iajs-3656	171	7	jj	jj	PROPN
iajs-3656	171	8	.	.	PROPN
iajs-3656	171	9	incretin	incretin	NOUN
iajs-3656	171	10	therapies	therapy	NOUN
iajs-3656	171	11	for	for	ADP
iajs-3656	171	12	patients	patient	NOUN
iajs-3656	171	13	with	with	ADP
iajs-3656	171	14	type	type	NOUN
iajs-3656	171	15	2	2	NUM
iajs-3656	171	16	diabetes	diabetes	NOUN
iajs-3656	171	17	and	and	CCONJ
iajs-3656	171	18	chronic	chronic	ADJ
iajs-3656	171	19	kidney	kidney	NOUN
iajs-3656	171	20	disease	disease	NOUN
iajs-3656	171	21	.	.	PUNCT
iajs-3656	172	1	j	j	PROPN
iajs-3656	172	2	clin	clin	PROPN
iajs-3656	172	3	med	med	PROPN
iajs-3656	172	4	.	.	PUNCT
iajs-3656	172	5	2023	2023	NUM
iajs-3656	172	6	;	;	PUNCT
iajs-3656	173	1	13(1):201	13(1):201	NUM
iajs-3656	173	2	.	.	PUNCT
iajs-3656	173	3	https://doi.org/10.3390/jcm13010201	https://doi.org/10.3390/jcm13010201	PROPN
iajs-3656	173	4	.	.	PUNCT
iajs-3656	174	1	20	20	NUM
iajs-3656	174	2	.	.	PUNCT
iajs-3656	175	1	guo	guo	PROPN
iajs-3656	175	2	f	f	PROPN
iajs-3656	175	3	,	,	PUNCT
iajs-3656	175	4	moellering	moellering	PROPN
iajs-3656	175	5	dr	dr	PROPN
iajs-3656	175	6	,	,	PUNCT
iajs-3656	175	7	garvey	garvey	PROPN
iajs-3656	175	8	wt	wt	PROPN
iajs-3656	175	9	.	.	PUNCT
iajs-3656	175	10	use	use	NOUN
iajs-3656	175	11	of	of	ADP
iajs-3656	175	12	hba1c	hba1c	PROPN
iajs-3656	175	13	for	for	ADP
iajs-3656	175	14	diagnoses	diagnosis	NOUN
iajs-3656	175	15	of	of	ADP
iajs-3656	175	16	diabetes	diabetes	NOUN
iajs-3656	175	17	and	and	CCONJ
iajs-3656	175	18	prediabetes	prediabete	NOUN
iajs-3656	175	19	:	:	PUNCT
iajs-3656	175	20	comparison	comparison	NOUN
iajs-3656	175	21	with	with	ADP
iajs-3656	175	22	diagnoses	diagnosis	NOUN
iajs-3656	175	23	based	base	VERB
iajs-3656	175	24	on	on	ADP
iajs-3656	175	25	fasting	fast	VERB
iajs-3656	175	26	and	and	CCONJ
iajs-3656	175	27	2	2	NUM
iajs-3656	175	28	-	-	PUNCT
iajs-3656	175	29	hr	hr	NOUN
iajs-3656	175	30	glucose	glucose	NOUN
iajs-3656	175	31	values	value	NOUN
iajs-3656	175	32	and	and	CCONJ
iajs-3656	175	33	effects	effect	NOUN
iajs-3656	175	34	of	of	ADP
iajs-3656	175	35	gender	gender	NOUN
iajs-3656	175	36	,	,	PUNCT
iajs-3656	175	37	race	race	NOUN
iajs-3656	175	38	,	,	PUNCT
iajs-3656	175	39	and	and	CCONJ
iajs-3656	175	40	age	age	NOUN
iajs-3656	175	41	.	.	PUNCT
iajs-3656	176	1	metab	metab	ADJ
iajs-3656	176	2	syndr	syndr	PROPN
iajs-3656	176	3	relat	relat	PROPN
iajs-3656	176	4	disord	disord	NOUN
iajs-3656	176	5	.	.	PUNCT
iajs-3656	177	1	2014	2014	NUM
iajs-3656	177	2	;	;	PUNCT
iajs-3656	177	3	12(5):258	12(5):258	NUM
iajs-3656	177	4	-	-	SYM
iajs-3656	177	5	268	268	NUM
iajs-3656	177	6	.	.	PUNCT
iajs-3656	178	1	https://doi.org/10.1089/met.2013.0128	https://doi.org/10.1089/met.2013.0128	NOUN
iajs-3656	178	2	.	.	PUNCT
iajs-3656	179	1	21	21	NUM
iajs-3656	179	2	.	.	PUNCT
iajs-3656	180	1	palladino	palladino	PROPN
iajs-3656	180	2	r	r	PROPN
iajs-3656	180	3	,	,	PUNCT
iajs-3656	180	4	tabak	tabak	PROPN
iajs-3656	180	5	ag	ag	PROPN
iajs-3656	180	6	,	,	PUNCT
iajs-3656	180	7	khunti	khunti	PROPN
iajs-3656	180	8	k	k	PROPN
iajs-3656	180	9	,	,	PUNCT
iajs-3656	180	10	valabhji	valabhji	PROPN
iajs-3656	180	11	j	j	PROPN
iajs-3656	180	12	,	,	PUNCT
iajs-3656	180	13	majeed	majeed	PROPN
iajs-3656	180	14	a	a	PRON
iajs-3656	180	15	,	,	PUNCT
iajs-3656	180	16	millett	millett	PROPN
iajs-3656	180	17	c	c	PROPN
iajs-3656	180	18	,	,	PUNCT
iajs-3656	180	19	vamos	vamos	PROPN
iajs-3656	180	20	ep	ep	PROPN
iajs-3656	180	21	.	.	PROPN
iajs-3656	180	22	association	association	PROPN
iajs-3656	180	23	between	between	ADP
iajs-3656	180	24	pre	pre	NOUN
iajs-3656	180	25	-	-	NOUN
iajs-3656	180	26	diabetes	diabetes	NOUN
iajs-3656	180	27	and	and	CCONJ
iajs-3656	180	28	microvascular	microvascular	NOUN
iajs-3656	180	29	and	and	CCONJ
iajs-3656	180	30	macrovascular	macrovascular	ADJ
iajs-3656	180	31	disease	disease	NOUN
iajs-3656	180	32	in	in	ADP
iajs-3656	180	33	newly	newly	ADV
iajs-3656	180	34	diagnosed	diagnose	VERB
iajs-3656	180	35	type	type	NOUN
iajs-3656	180	36	2	2	NUM
iajs-3656	180	37	diabetes	diabetes	NOUN
iajs-3656	180	38	.	.	PUNCT
iajs-3656	181	1	bmj	bmj	PROPN
iajs-3656	181	2	open	open	ADJ
iajs-3656	181	3	diabetes	diabetes	NOUN
iajs-3656	181	4	res	re	NOUN
iajs-3656	181	5	care	care	NOUN
iajs-3656	181	6	.	.	PUNCT
iajs-3656	182	1	2020	2020	NUM
iajs-3656	182	2	;	;	PUNCT
iajs-3656	182	3	8(1):e001061	8(1):e001061	NUM
iajs-3656	182	4	.	.	PUNCT
iajs-3656	183	1	https://doi.org/10.1136/bmjdrc-2020001061	https://doi.org/10.1136/bmjdrc-2020001061	PROPN
iajs-3656	183	2	.	.	PUNCT
iajs-3656	184	1	22	22	NUM
iajs-3656	184	2	.	.	PUNCT
iajs-3656	185	1	hopp	hopp	PROPN
iajs-3656	185	2	a	a	PROPN
iajs-3656	185	3	,	,	PUNCT
iajs-3656	185	4	jones	jones	PROPN
iajs-3656	185	5	k	k	PROPN
iajs-3656	185	6	,	,	PUNCT
iajs-3656	185	7	meng	meng	PROPN
iajs-3656	185	8	h	h	PROPN
iajs-3656	185	9	,	,	PUNCT
iajs-3656	185	10	ott	ott	PROPN
iajs-3656	185	11	e	e	PROPN
iajs-3656	185	12	,	,	PUNCT
iajs-3656	185	13	basuni	basuni	NOUN
iajs-3656	185	14	n	n	CCONJ
iajs-3656	185	15	,	,	PUNCT
iajs-3656	185	16	axon	axon	PROPN
iajs-3656	185	17	sp	sp	NOUN
iajs-3656	185	18	.	.	NOUN
iajs-3656	185	19	184	184	NUM
iajs-3656	185	20	defining	define	VERB
iajs-3656	185	21	the	the	DET
iajs-3656	185	22	pathological	pathological	ADJ
iajs-3656	185	23	natural	natural	ADJ
iajs-3656	185	24	https://doi.org/10.1046/j.1365-2125.1999.00092.x	https://doi.org/10.1046/j.1365-2125.1999.00092.x	NOUN
iajs-3656	185	25	.	.	PUNCT
iajs-3656	186	1	https://doi.org/10.1046/j.1365-2125.1999.00092.x	https://doi.org/10.1046/j.1365-2125.1999.00092.x	PROPN
iajs-3656	186	2	.	.	PUNCT
iajs-3656	187	1	https://doi.org/10.1038/s41574-021-00474-4	https://doi.org/10.1038/s41574-021-00474-4	PROPN
iajs-3656	188	1	https://doi.org/10.1038/s41574-021-00474-4	https://doi.org/10.1038/s41574-021-00474-4	PROPN
iajs-3656	188	2	https://doi.org/10.5923/j.ajmms.20221204.02	https://doi.org/10.5923/j.ajmms.20221204.02	PROPN
iajs-3656	188	3	https://doi.org/10.5923/j.ajmms.20221204.02	https://doi.org/10.5923/j.ajmms.20221204.02	PROPN
iajs-3656	188	4	https://doi.org/10.2337/dc21-s001	https://doi.org/10.2337/dc21-s001	PROPN
iajs-3656	188	5	https://doi.org/10.2337/dc21-s001	https://doi.org/10.2337/dc21-s001	PROPN
iajs-3656	188	6	https://conferencea.org/index.php/conferences/article/view/1990	https://conferencea.org/index.php/conferences/article/view/1990	ADP
iajs-3656	188	7	https://doi.org/10.1016/j.diabres.2022.109118	https://doi.org/10.1016/j.diabres.2022.109118	PROPN
iajs-3656	188	8	https://doi.org/10.1016/j.diabres.2022.109118	https://doi.org/10.1016/j.diabres.2022.109118	PROPN
iajs-3656	188	9	https://doi.org/10.1172/jci111987	https://doi.org/10.1172/jci111987	NOUN
iajs-3656	188	10	https://doi.org/10.1136/postgradmedj-2020-137861	https://doi.org/10.1136/postgradmedj-2020-137861	AUX
iajs-3656	188	11	https://doi.org/10.1016/j.jprot.2013.03.014	https://doi.org/10.1016/j.jprot.2013.03.014	AUX
iajs-3656	188	12	https://doi.org/10.2337/db15-0281	https://doi.org/10.2337/db15-0281	ADV
iajs-3656	188	13	https://doi.org/10.1371/journal.pone.0014565	https://doi.org/10.1371/journal.pone.0014565	ADJ
iajs-3656	188	14	https://doi.org/10.1056/nejmoa1407963	https://doi.org/10.1056/nejmoa1407963	NOUN
iajs-3656	188	15	.	.	PUNCT
iajs-3656	189	1	https://doi.org/10.1056/nejmoa1407963	https://doi.org/10.1056/nejmoa1407963	PROPN
iajs-3656	189	2	.	.	PUNCT
iajs-3656	190	1	.%20https:/doi.org/10.3390	.%20https:/doi.org/10.3390	NOUN
iajs-3656	190	2	/	/	SYM
iajs-3656	190	3	jcm13010201	jcm13010201	X
iajs-3656	190	4	https://doi.org/10.1089/met.2013.0128	https://doi.org/10.1089/met.2013.0128	NOUN
iajs-3656	190	5	https://doi.org/10.1136/bmjdrc-2020-001061	https://doi.org/10.1136/bmjdrc-2020-001061	PROPN
iajs-3656	190	6	https://doi.org/10.1136/bmjdrc-2020-001061	https://doi.org/10.1136/bmjdrc-2020-001061	PROPN
iajs-3656	190	7	ihjpas	ihjpa	VERB
iajs-3656	190	8	.	.	PUNCT
iajs-3656	191	1	2025	2025	NUM
iajs-3656	191	2	,	,	PUNCT
iajs-3656	191	3	38(4	38(4	NUM
iajs-3656	191	4	)	)	PUNCT
iajs-3656	191	5	236	236	NUM
iajs-3656	191	6	history	history	NOUN
iajs-3656	191	7	of	of	ADP
iajs-3656	191	8	lama2	lama2	NOUN
iajs-3656	191	9	muscular	muscular	ADJ
iajs-3656	191	10	dystrophy	dystrophy	NOUN
iajs-3656	191	11	.	.	PUNCT
iajs-3656	192	1	neuromuscul	neuromuscul	PROPN
iajs-3656	192	2	dis	dis	PROPN
iajs-3656	192	3	.	.	PUNCT
iajs-3656	193	1	2022	2022	NUM
iajs-3656	193	2	;	;	PUNCT
iajs-3656	193	3	32(1):s121	32(1):s121	NUM
iajs-3656	193	4	-	-	PUNCT
iajs-3656	193	5	s121	s121	PROPN
iajs-3656	193	6	.	.	PUNCT
iajs-3656	194	1	https://doi.org/10.1016/j.nmd.2022.07.327	https://doi.org/10.1016/j.nmd.2022.07.327	NOUN
iajs-3656	194	2	.	.	PROPN
iajs-3656	195	1	23	23	NUM
iajs-3656	195	2	.	.	PUNCT
iajs-3656	196	1	sadiq	sadiq	PROPN
iajs-3656	196	2	ch	ch	PROPN
iajs-3656	196	3	,	,	PUNCT
iajs-3656	196	4	hussein	hussein	PROPN
iajs-3656	196	5	rh	rh	PROPN
iajs-3656	196	6	,	,	PUNCT
iajs-3656	196	7	maulood	maulood	NOUN
iajs-3656	197	1	i	i	PRON
iajs-3656	197	2	m.	m.	NOUN
iajs-3656	197	3	ghrelin	ghrelin	NOUN
iajs-3656	197	4	and	and	CCONJ
iajs-3656	197	5	leptin	leptin	NOUN
iajs-3656	197	6	and	and	CCONJ
iajs-3656	197	7	their	their	PRON
iajs-3656	197	8	relations	relation	NOUN
iajs-3656	197	9	with	with	ADP
iajs-3656	197	10	insulin	insulin	NOUN
iajs-3656	197	11	resistance	resistance	NOUN
iajs-3656	197	12	in	in	ADP
iajs-3656	197	13	diabetes	diabetes	NOUN
iajs-3656	197	14	mellitus	mellitus	NOUN
iajs-3656	197	15	type	type	VERB
iajs-3656	197	16	2	2	NUM
iajs-3656	197	17	patients	patient	NOUN
iajs-3656	197	18	.	.	PUNCT
iajs-3656	198	1	baghdad	baghdad	PROPN
iajs-3656	198	2	sci	sci	PROPN
iajs-3656	198	3	j.	j.	PROPN
iajs-3656	198	4	2022	2022	PROPN
iajs-3656	198	5	;	;	PUNCT
iajs-3656	198	6	19(1):33	19(1):33	NUM
iajs-3656	198	7	-	-	SYM
iajs-3656	198	8	42	42	NUM
iajs-3656	198	9	.	.	PUNCT
iajs-3656	199	1	https://doi.org/10.21123/bsj.2022.19.1.0033	https://doi.org/10.21123/bsj.2022.19.1.0033	NOUN
iajs-3656	199	2	.	.	PUNCT
iajs-3656	200	1	24	24	NUM
iajs-3656	200	2	.	.	PUNCT
iajs-3656	200	3	espeland	espeland	PROPN
iajs-3656	200	4	ma	ma	PROPN
iajs-3656	200	5	,	,	PUNCT
iajs-3656	200	6	lipska	lipska	PROPN
iajs-3656	200	7	k	k	PROPN
iajs-3656	200	8	,	,	PUNCT
iajs-3656	200	9	miller	miller	PROPN
iajs-3656	200	10	me	i	PRON
iajs-3656	200	11	,	,	PUNCT
iajs-3656	200	12	rushing	rush	VERB
iajs-3656	200	13	j	j	PROPN
iajs-3656	200	14	,	,	PUNCT
iajs-3656	200	15	cohen	cohen	PROPN
iajs-3656	200	16	ra	ra	PROPN
iajs-3656	200	17	,	,	PUNCT
iajs-3656	200	18	verghese	verghese	PROPN
iajs-3656	200	19	j	j	PROPN
iajs-3656	200	20	,	,	PUNCT
iajs-3656	200	21	mcdermott	mcdermott	PROPN
iajs-3656	200	22	mm	mm	PROPN
iajs-3656	200	23	,	,	PUNCT
iajs-3656	200	24	king	king	PROPN
iajs-3656	200	25	ac	ac	PROPN
iajs-3656	200	26	,	,	PUNCT
iajs-3656	200	27	strotmeyer	strotmeyer	PROPN
iajs-3656	200	28	es	es	PROPN
iajs-3656	200	29	,	,	PUNCT
iajs-3656	200	30	blair	blair	PROPN
iajs-3656	200	31	sn	sn	PROPN
iajs-3656	200	32	,	,	PUNCT
iajs-3656	200	33	pahor	pahor	PROPN
iajs-3656	200	34	m	m	PROPN
iajs-3656	200	35	,	,	PUNCT
iajs-3656	200	36	reid	reid	PROPN
iajs-3656	200	37	k	k	PROPN
iajs-3656	200	38	,	,	PUNCT
iajs-3656	200	39	demons	demons	PROPN
iajs-3656	200	40	j	j	PROPN
iajs-3656	200	41	,	,	PUNCT
iajs-3656	200	42	kritchevsky	kritchevsky	PROPN
iajs-3656	200	43	sb	sb	PROPN
iajs-3656	200	44	;	;	PUNCT
iajs-3656	200	45	life	life	NOUN
iajs-3656	200	46	study	study	NOUN
iajs-3656	200	47	investigators	investigator	NOUN
iajs-3656	200	48	.	.	PUNCT
iajs-3656	201	1	effects	effect	NOUN
iajs-3656	201	2	of	of	ADP
iajs-3656	201	3	physical	physical	ADJ
iajs-3656	201	4	activity	activity	NOUN
iajs-3656	201	5	intervention	intervention	NOUN
iajs-3656	201	6	on	on	ADP
iajs-3656	201	7	physical	physical	ADJ
iajs-3656	201	8	and	and	CCONJ
iajs-3656	201	9	cognitive	cognitive	ADJ
iajs-3656	201	10	function	function	NOUN
iajs-3656	201	11	in	in	ADP
iajs-3656	201	12	sedentary	sedentary	ADJ
iajs-3656	201	13	adults	adult	NOUN
iajs-3656	201	14	with	with	ADP
iajs-3656	201	15	and	and	CCONJ
iajs-3656	201	16	without	without	ADP
iajs-3656	201	17	diabetes	diabetes	NOUN
iajs-3656	201	18	.	.	PUNCT
iajs-3656	202	1	j	j	PROPN
iajs-3656	202	2	gerontol	gerontol	VERB
iajs-3656	202	3	a	a	DET
iajs-3656	202	4	biol	biol	PROPN
iajs-3656	202	5	sci	sci	PROPN
iajs-3656	202	6	med	med	PROPN
iajs-3656	202	7	sci	sci	PROPN
iajs-3656	202	8	.	.	PROPN
iajs-3656	202	9	2017	2017	NUM
iajs-3656	202	10	;	;	PUNCT
iajs-3656	202	11	72(6):861	72(6):861	NUM
iajs-3656	202	12	-	-	PUNCT
iajs-3656	202	13	866	866	NUM
iajs-3656	202	14	.	.	PUNCT
iajs-3656	203	1	https://doi.org/10.1093/gerona/glw179	https://doi.org/10.1093/gerona/glw179	NOUN
iajs-3656	203	2	.	.	PUNCT
iajs-3656	204	1	25	25	NUM
iajs-3656	204	2	.	.	PUNCT
iajs-3656	204	3	triggle	triggle	PROPN
iajs-3656	204	4	cr	cr	PROPN
iajs-3656	204	5	,	,	PUNCT
iajs-3656	204	6	mohammed	mohammed	PROPN
iajs-3656	204	7	i	i	PRON
iajs-3656	204	8	,	,	PUNCT
iajs-3656	204	9	bshesh	bshesh	PROPN
iajs-3656	204	10	k	k	NOUN
iajs-3656	204	11	,	,	PUNCT
iajs-3656	204	12	marei	marei	VERB
iajs-3656	204	13	i	i	PRON
iajs-3656	204	14	,	,	PUNCT
iajs-3656	204	15	ye	ye	PROPN
iajs-3656	204	16	k	k	PROPN
iajs-3656	204	17	,	,	PUNCT
iajs-3656	204	18	ding	ding	NOUN
iajs-3656	204	19	h	h	NOUN
iajs-3656	204	20	,	,	PUNCT
iajs-3656	204	21	macdonald	macdonald	PROPN
iajs-3656	204	22	r	r	PROPN
iajs-3656	204	23	,	,	PUNCT
iajs-3656	204	24	hollenberg	hollenberg	PROPN
iajs-3656	204	25	md	md	PROPN
iajs-3656	204	26	.	.	PUNCT
iajs-3656	205	1	metformin	metformin	PROPN
iajs-3656	205	2	:	:	PUNCT
iajs-3656	205	3	is	be	AUX
iajs-3656	205	4	it	it	PRON
iajs-3656	205	5	a	a	DET
iajs-3656	205	6	drug	drug	NOUN
iajs-3656	205	7	for	for	ADP
iajs-3656	205	8	all	all	DET
iajs-3656	205	9	reasons	reason	NOUN
iajs-3656	205	10	and	and	CCONJ
iajs-3656	205	11	diseases	disease	NOUN
iajs-3656	205	12	?	?	PUNCT
iajs-3656	206	1	metabolism	metabolism	NOUN
iajs-3656	206	2	.	.	PUNCT
iajs-3656	207	1	2022	2022	NUM
iajs-3656	207	2	;	;	PUNCT
iajs-3656	207	3	133:155223	133:155223	NUM
iajs-3656	207	4	.	.	PUNCT
iajs-3656	208	1	https://doi.org/10.1016/j.metabol.2022.155223	https://doi.org/10.1016/j.metabol.2022.155223	NOUN
iajs-3656	208	2	.	.	PUNCT
iajs-3656	209	1	26	26	NUM
iajs-3656	209	2	.	.	PUNCT
iajs-3656	210	1	mohammed	mohammed	PROPN
iajs-3656	210	2	sk	sk	PROPN
iajs-3656	210	3	,	,	PUNCT
iajs-3656	210	4	taha	taha	PROPN
iajs-3656	210	5	em	em	PRON
iajs-3656	210	6	,	,	PUNCT
iajs-3656	210	7	muhi	muhi	PROPN
iajs-3656	210	8	sa	sa	PROPN
iajs-3656	210	9	.	.	PUNCT
iajs-3656	211	1	a	a	DET
iajs-3656	211	2	case	case	NOUN
iajs-3656	211	3	-	-	PUNCT
iajs-3656	211	4	control	control	NOUN
iajs-3656	211	5	study	study	NOUN
iajs-3656	211	6	to	to	ADP
iajs-3656	211	7	determination	determination	NOUN
iajs-3656	211	8	fbxw7	fbxw7	NOUN
iajs-3656	211	9	and	and	CCONJ
iajs-3656	211	10	fetuin	fetuin	NOUN
iajs-3656	211	11	-	-	PUNCT
iajs-3656	211	12	a	a	DET
iajs-3656	211	13	levels	level	NOUN
iajs-3656	211	14	in	in	ADP
iajs-3656	211	15	patients	patient	NOUN
iajs-3656	211	16	with	with	ADP
iajs-3656	211	17	type	type	NOUN
iajs-3656	211	18	2	2	NUM
iajs-3656	211	19	diabetes	diabetes	NOUN
iajs-3656	211	20	in	in	ADP
iajs-3656	211	21	iraq	iraq	PROPN
iajs-3656	211	22	.	.	PUNCT
iajs-3656	212	1	j	j	PROPN
iajs-3656	212	2	diabetes	diabete	VERB
iajs-3656	212	3	metab	metab	NOUN
iajs-3656	212	4	disord	disord	NOUN
iajs-3656	212	5	.	.	PUNCT
iajs-3656	212	6	2021	2021	NUM
iajs-3656	212	7	;	;	PUNCT
iajs-3656	212	8	20(1):237	20(1):237	X
iajs-3656	212	9	-	-	SYM
iajs-3656	212	10	243	243	NUM
iajs-3656	212	11	.	.	PUNCT
iajs-3656	213	1	https://doi.org/10.1007/s40200-021-00738-x	https://doi.org/10.1007/s40200-021-00738-x	PROPN
iajs-3656	213	2	.	.	PROPN
iajs-3656	214	1	27	27	NUM
iajs-3656	214	2	.	.	PUNCT
iajs-3656	215	1	american	american	ADJ
iajs-3656	215	2	diabetes	diabetes	PROPN
iajs-3656	215	3	association	association	PROPN
iajs-3656	215	4	.	.	PUNCT
iajs-3656	216	1	5	5	X
iajs-3656	216	2	.	.	X
iajs-3656	216	3	prevention	prevention	NOUN
iajs-3656	216	4	or	or	CCONJ
iajs-3656	216	5	delay	delay	NOUN
iajs-3656	216	6	of	of	ADP
iajs-3656	216	7	type	type	NOUN
iajs-3656	216	8	2	2	NUM
iajs-3656	216	9	diabetes	diabetes	NOUN
iajs-3656	216	10	:	:	PUNCT
iajs-3656	216	11	standards	standard	NOUN
iajs-3656	216	12	of	of	ADP
iajs-3656	216	13	medical	medical	ADJ
iajs-3656	216	14	care	care	NOUN
iajs-3656	216	15	in	in	ADP
iajs-3656	216	16	diabetes-2018	diabetes-2018	NOUN
iajs-3656	216	17	.	.	PUNCT
iajs-3656	217	1	diabetes	diabetes	NOUN
iajs-3656	217	2	care	care	NOUN
iajs-3656	217	3	.	.	PUNCT
iajs-3656	218	1	2018	2018	NUM
iajs-3656	218	2	;	;	PUNCT
iajs-3656	218	3	41(suppl	41(suppl	NUM
iajs-3656	218	4	1):s51	1):s51	NUM
iajs-3656	218	5	-	-	PUNCT
iajs-3656	218	6	s54	s54	NOUN
iajs-3656	218	7	.	.	PUNCT
iajs-3656	219	1	https://doi.org/10.2337/dc18s005	https://doi.org/10.2337/dc18s005	PROPN
iajs-3656	219	2	.	.	PROPN
iajs-3656	219	3	28	28	NUM
iajs-3656	219	4	.	.	PUNCT
iajs-3656	220	1	bouman	bouman	PROPN
iajs-3656	220	2	k	k	PROPN
iajs-3656	220	3	,	,	PUNCT
iajs-3656	220	4	gubbels	gubbels	PROPN
iajs-3656	220	5	m	m	PROPN
iajs-3656	220	6	,	,	PUNCT
iajs-3656	220	7	van	van	PROPN
iajs-3656	220	8	den	den	PROPN
iajs-3656	220	9	heuvel	heuvel	PROPN
iajs-3656	220	10	fma	fma	PROPN
iajs-3656	220	11	,	,	PUNCT
iajs-3656	220	12	groothuis	groothuis	PROPN
iajs-3656	220	13	jt	jt	PROPN
iajs-3656	220	14	,	,	PUNCT
iajs-3656	220	15	erasmus	erasmus	PROPN
iajs-3656	220	16	ce	ce	PROPN
iajs-3656	220	17	,	,	PUNCT
iajs-3656	220	18	nijveldt	nijveldt	ADJ
iajs-3656	220	19	r	r	NOUN
iajs-3656	220	20	,	,	PUNCT
iajs-3656	220	21	udink	udink	VERB
iajs-3656	220	22	ten	ten	NUM
iajs-3656	220	23	cate	cate	PROPN
iajs-3656	220	24	fea	fea	PROPN
iajs-3656	220	25	,	,	PUNCT
iajs-3656	220	26	voermans	voermans	PROPN
iajs-3656	220	27	nc	nc	PROPN
iajs-3656	220	28	.	.	PROPN
iajs-3656	220	29	cardiac	cardiac	ADJ
iajs-3656	220	30	involvement	involvement	NOUN
iajs-3656	220	31	in	in	ADP
iajs-3656	220	32	two	two	NUM
iajs-3656	220	33	rare	rare	ADJ
iajs-3656	220	34	neuromuscular	neuromuscular	ADJ
iajs-3656	220	35	diseases	disease	NOUN
iajs-3656	220	36	:	:	PUNCT
iajs-3656	220	37	lama2related	lama2relate	VERB
iajs-3656	220	38	muscular	muscular	ADJ
iajs-3656	220	39	dystrophy	dystrophy	NOUN
iajs-3656	220	40	and	and	CCONJ
iajs-3656	220	41	selenon	selenon	NOUN
iajs-3656	220	42	-	-	PUNCT
iajs-3656	220	43	related	relate	VERB
iajs-3656	220	44	myopathy	myopathy	ADJ
iajs-3656	220	45	.	.	PUNCT
iajs-3656	221	1	neuromuscul	neuromuscul	PROPN
iajs-3656	221	2	disord	disord	PROPN
iajs-3656	221	3	.	.	PUNCT
iajs-3656	222	1	2022	2022	NUM
iajs-3656	222	2	;	;	PUNCT
iajs-3656	222	3	32(8):635	32(8):635	PROPN
iajs-3656	222	4	-	-	SYM
iajs-3656	222	5	642	642	NUM
iajs-3656	222	6	.	.	PUNCT
iajs-3656	222	7	https://doi.org/	https://doi.org/	VERB
iajs-3656	222	8	10.1016	10.1016	NUM
iajs-3656	222	9	/	/	SYM
iajs-3656	222	10	j.nmd.2022.06.004	j.nmd.2022.06.004	PROPN
iajs-3656	222	11	.	.	PUNCT
iajs-3656	223	1	29	29	NUM
iajs-3656	223	2	.	.	PUNCT
iajs-3656	224	1	santacroce	santacroce	VERB
iajs-3656	224	2	r	r	PROPN
iajs-3656	224	3	,	,	PUNCT
iajs-3656	224	4	sarno	sarno	PROPN
iajs-3656	224	5	m	m	PROPN
iajs-3656	224	6	,	,	PUNCT
iajs-3656	224	7	cappucci	cappucci	PROPN
iajs-3656	224	8	f	f	X
iajs-3656	224	9	,	,	PUNCT
iajs-3656	224	10	sessa	sessa	PROPN
iajs-3656	224	11	f	f	PROPN
iajs-3656	224	12	,	,	PUNCT
iajs-3656	224	13	colaizzo	colaizzo	VERB
iajs-3656	224	14	d	d	PROPN
iajs-3656	224	15	,	,	PUNCT
iajs-3656	224	16	brancaccio	brancaccio	PROPN
iajs-3656	224	17	v	v	NOUN
iajs-3656	224	18	,	,	PUNCT
iajs-3656	224	19	grandone	grandone	NOUN
iajs-3656	224	20	e	e	NOUN
iajs-3656	224	21	,	,	PUNCT
iajs-3656	224	22	margaglione	margaglione	NOUN
iajs-3656	224	23	m.	m.	NOUN
iajs-3656	224	24	low	low	ADJ
iajs-3656	224	25	protein	protein	NOUN
iajs-3656	224	26	z	z	NOUN
iajs-3656	224	27	levels	level	NOUN
iajs-3656	224	28	and	and	CCONJ
iajs-3656	224	29	risk	risk	NOUN
iajs-3656	224	30	of	of	ADP
iajs-3656	224	31	occurrence	occurrence	NOUN
iajs-3656	224	32	of	of	ADP
iajs-3656	224	33	deep	deep	ADJ
iajs-3656	224	34	vein	vein	ADJ
iajs-3656	224	35	thrombosis	thrombosis	NOUN
iajs-3656	224	36	.	.	PUNCT
iajs-3656	225	1	j	j	PROPN
iajs-3656	225	2	thromb	thromb	PROPN
iajs-3656	225	3	haemost	haemost	VERB
iajs-3656	225	4	.	.	PUNCT
iajs-3656	226	1	2006	2006	NUM
iajs-3656	226	2	;	;	PUNCT
iajs-3656	226	3	4(11):2417	4(11):2417	NUM
iajs-3656	226	4	-	-	PUNCT
iajs-3656	226	5	2422	2422	NUM
iajs-3656	226	6	.	.	PUNCT
iajs-3656	227	1	https://doi.org/10.1111/j.1538-7836.2006.02186.x	https://doi.org/10.1111/j.1538-7836.2006.02186.x	X
iajs-3656	227	2	.	.	PUNCT
iajs-3656	228	1	https://doi.org/10.1016/j.nmd.2022.07.327	https://doi.org/10.1016/j.nmd.2022.07.327	PROPN
iajs-3656	228	2	https://doi.org/10.21123/bsj.2022.19.1.0033	https://doi.org/10.21123/bsj.2022.19.1.0033	PROPN
iajs-3656	228	3	https://doi.org/10.1093/gerona/glw179	https://doi.org/10.1093/gerona/glw179	VERB
iajs-3656	228	4	https://doi.org/10.1016/j.metabol.2022.155223	https://doi.org/10.1016/j.metabol.2022.155223	NOUN
iajs-3656	228	5	.	.	PUNCT
iajs-3656	229	1	https://doi.org/10.1007/s40200-021-00738-x	https://doi.org/10.1007/s40200-021-00738-x	PROPN
iajs-3656	229	2	https://doi.org/10.2337/dc18-s005	https://doi.org/10.2337/dc18-s005	PROPN
iajs-3656	229	3	https://doi.org/10.2337/dc18-s005	https://doi.org/10.2337/dc18-s005	PROPN
iajs-3656	229	4	https://doi.org/%2010.1016/j.nmd.2022.06.004	https://doi.org/%2010.1016/j.nmd.2022.06.004	NOUN
iajs-3656	229	5	https://doi.org/10.1111/j.1538-7836.2006.02186.x	https://doi.org/10.1111/j.1538-7836.2006.02186.x	ADJ